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Abstract 
 
Atrial fibrillation (AF) is an abnormal heart rhythm (cardiac arrhythmia). In AF, the atrial 
contraction is rapid and irregular, and the filling of the ventricles becomes incomplete, 
leading to reduce cardiac output. Atrial fibrillation may result in symptoms of 
palpitations, fainting, chest pain, or even heart failure. AF is an also an important risk 
factor for stroke. Coronary artery bypass graft surgery (CABG) is a surgical procedure to 
restore the perfusion of the cardiac tissue in case of severe coronary heart disease. 10% to 
65% of patients who never had a history of AF develop AF on the second or third post 
CABG surgery day. The occurrence of postoperative AF is associated with worse 
morbidity and longer and more expensive intensive-care hospitalization. The fundamental 
mechanism responsible of AF, especially for post-surgery patients, is not well 
understood. Identification of patients at high risk of AF after CABG would be helpful in 
prevention of postoperative AF. The present project is based on the analysis of cardiac 
electrograms recorded in patients after CABG surgery. The first aim of the research is to 
investigate whether the recordings display typical changes prior to the onset of AF. A 
second aim is to identify predictors that can discriminate the patients that will develop 
AF. 
 
Recordings were made by the team of Dr. Pierre Pagé on 137 patients treated with CABG 
surgery. Three unipolar electrodes were sutured on the epicardium of the atria to record 
continuously during the first 4 post-surgery days. As a first stage of the research, an 
automatic and unsupervised algorithm was developed to detect and distinguish atrial and 
ventricular activations on each channel, and join together the activation of the different 
channels belonging to the same cardiac event. The algorithm was developed and 
optimized on a training set, and its performance assessed on a test set. Validation 
software was developed to prepare these two sets and to correct the detections over all 
recordings that were later used in the analyses. It was complemented with tools to detect, 
label and validate normal sinus beats, atrial and ventricular premature activations (PAA, 
PVC) as well as episodes of arrhythmia. 
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Pre-CABG clinical data were then analyzed to establish the preoperative risk of AF. Age, 
serum creatinine and prior myocardial infarct were found to be the most important 
predictors. While the preoperative risk score could to a certain extent predict who will 
develop AF, it was not correlated with the post-operative time of AF onset. 
 
Then the set of AF patients was analyzed, considering the last two hours before the onset 
of the first AF lasting for more than 10 minutes. This prolonged AF was found to be 
usually triggered by a premature atrial PAA most often originating from the left atrium. 
However, along the two pre-AF hours, the distribution of PAA and of the fraction of 
these coming from the left atrium was wide and inhomogeneous among the patients. PAA 
rate, duration of transient atrial arrhythmia, sinus heart rate, and low frequency portion of 
heart rate variability (LF portion) showed significant changes in last hour before the onset 
of AF.  Comparing all other PAA, the triggering PAA were characterized by their 
prematurity, the small value of the maximum derivative of the electrogram nearest to the 
site of origin, as well as the presence of transient arrhythmia and increase LF portion of 
the sinus heart rate variation prior to the onset of the arrhythmia.  
 
The final step was to compare AF and Non-AF patients to find predictors to discriminate 
the two groups. Five types of logistic regression models were compared, achieving 
similar sensitivity, specificity, and ROC curve area, but very low prediction accuracy for 
Non-AF patients. A weighted moving average method was proposed to design to improve 
the accuracy for Non-AF patient. Two models were favoured, selected on the criteria of 
robustness, accuracy, and practicability. Around 70% Non-AF patients were correctly 
classified, and around 75% of AF patients in the last hour before AF. The  PAA rate, the 
fraction of PAA initiated in the left atrium,  pNN50, the atrio-ventricular conduction time, 
and  the correlation between the latter and the heart rhythm were common predictors of 
these two models. 
 
Key words: 
Coronary artery bypass graft surgery, Postoperative Atrial Fibrillation, Atrial 
Electrogram, statistical analysis, predictor.
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                                     Résumé 
 
La fibrillation auriculaire (FA) est une arythmie touchant les oreillettes. En FA, la 
contraction auriculaire est rapide et irrégulière. Le remplissage des ventricules devient 
incomplet, ce qui réduit le débit cardiaque. La FA peut entraîner des palpitations, des 
évanouissements, des douleurs thoraciques ou l’insuffisance cardiaque. Elle augmente 
aussi le risque d'accident vasculaire. Le pontage coronarien est une intervention 
chirurgicale réalisée pour restaurer le flux sanguin dans les cas de maladie coronarienne 
sévère. 10% à 65% des patients qui n'ont jamais subi de FA, en sont victime le plus 
souvent lors du deuxième ou troisième jour postopératoire. La FA est particulièrement 
fréquente après une chirurgie de la valve mitrale, survenant alors dans environ 64% des 
patients. L'apparition de la FA postopératoire est associée à une augmentation de la 
morbidité, de la durée et des coûts d'hospitalisation. Les mécanismes responsables de la 
FA postopératoire ne sont pas bien compris. L'identification des patients à haut risque de 
FA après un pontage coronarien serait utile pour sa prévention. Le présent projet est basé 
sur l'analyse d’électrogrammes cardiaques enregistrées chez les patients après pontage un 
aorte-coronaire. Le premier objectif de la recherche est d'étudier si les enregistrements 
affichent des changements typiques avant l'apparition de la FA. Le deuxième objectif est 
d'identifier des facteurs prédictifs permettant d’identifier les patients qui vont  développer 
une  FA. 
 
Les enregistrements ont été réalisés par l'équipe du Dr Pierre Pagé sur 137 patients traités 
par pontage coronarien. Trois électrodes unipolaires ont été suturées sur l'épicarde des 
oreillettes pour enregistrer en continu pendant les 4 premiers jours postopératoires. La 
première tâche était de développer un algorithme pour détecter et distinguer les 
activations auriculaires et ventriculaires sur chaque canal, et  pour combiner les 
activations des trois canaux appartenant à un même événement cardiaque. L'algorithme a 
été développé et optimisé sur un premier ensemble de marqueurs, et sa performance 
évaluée sur un second ensemble. Un logiciel de validation a été développé pour préparer 
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ces deux ensembles et pour corriger les détections sur tous les enregistrements qui ont été 
utilisés plus tard dans les analyses. Il a été complété par des outils pour former, étiqueter 
et valider les battements sinusaux normaux, les activations auriculaires et ventriculaires 
prématurées (PAA, PVA),  ainsi que les épisodes d'arythmie. 
 
Les données cliniques préopératoires ont ensuite été analysées pour établir le risque 
préopératoire de FA. L’âge, le niveau de créatinine sérique et un diagnostic  d'infarctus 
du myocarde se sont révélés être les plus importants facteurs de prédiction. Bien que le 
niveau du risque préopératoire puisse dans une certaine mesure prédire qui développera la 
FA, il n'était pas corrélé avec le temps de l'apparition de la FA postopératoire. 
 
Pour l'ensemble des patients ayant eu au moins un épisode de FA d’une durée de 10 
minutes ou plus, les deux heures précédant la première FA prolongée ont été analysées.  
Cette première FA prolongée était toujours déclenchée par un PAA dont l’origine était le 
plus souvent sur l'oreillette gauche. Cependant, au cours des deux heures pré-FA, la 
distribution des PAA et de la fraction de ceux-ci provenant de l'oreillette gauche était 
large et inhomogène parmi les patients. Le nombre de PAA, la durée des arythmies 
transitoires, le rythme cardiaque sinusal, la portion basse fréquence de la variabilité du 
rythme cardiaque (LF portion) montraient des changements significatifs dans la dernière 
heure avant le début de la FA. 
 
La dernière étape consistait à comparer les patients avec et sans  FA prolongée  pour 
trouver des facteurs permettant de discriminer les deux groupes. Cinq types de modèles 
de régression logistique ont été comparés. Ils avaient une sensibilité, une spécificité et 
une courbe opérateur-receveur similaires, et tous avaient un niveau de prédiction des 
patients sans FA très faible. Une méthode de moyenne glissante a été proposée pour 
améliorer la discrimination, surtout pour les patients sans FA. Deux modèles ont été 
retenus, sélectionnés sur les critères de robustesse, de précision, et d’applicabilité. Autour 
70% patients sans FA et 75% de patients avec FA ont été correctement identifiés dans la 
dernière heure avant la FA. Le taux de PAA, la fraction des PAA initiés dans l'oreillette 
gauche,  le pNN50, le temps de conduction auriculo-ventriculaire, et la corrélation entre 
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ce dernier et le rythme cardiaque étaient les variables de prédiction communes à ces deux 
modèles. 
 
Mots-clés : 
Pontage coronarien, fibrillation auriculaire postopératoire, électrogramme auriculaire, 
analyse statistique, facteurs de prédiction. 
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Chapter 1 Introduction 
 
 
1.1 Post-operative Atrial Fibrillation 
 
The cardiovascular system transports and distributes essential substances to each part of 
the body and removes by-products of metabolism. The heart consists of two pumps in 
series: the right ventricle propels blood to exchange of oxygen and carbon dioxide within 
the lungs and the left ventricle propels blood to all other tissues of the body. The 
functions of different cardiac chambers must be precisely controlled and electrically 
synchronized. In normal resting heart rhythm, the heart rate varies from 60 to 100 beats 
per minute. Normal electrical activation is initiated in the sinoatrial (SA), from which the 
impulse propagates in the atria and then induces the atrial contraction. The wave of 
excitation ultimately reaches the atrioventricular (AV) node. Conduction is slow in the 
AV node, which provides a delay between the atrial and ventricular depolarization that 
assures a complete filling of the ventricles. Then the impulse spreads rapidly across the 
ventricles through the Purkinje fibers to make them contract [1, 2]. 
.  
Atrial fibrillation (AF) is a cardiac arrhythmia, involving the two atria. During AF, the 
atrial contraction is rapid and irregular. The filling of the ventricles becomes incomplete, 
and their frequency, which is limited by the refractory period of the AV node, may 
become very rapid and irregular, leading to reduce of cardiac output [3-5]. The regular 
electrical impulses travelling from the sinoatrial node are replaced by disorganized and 
rapid electrical impulses, which result in irregular heartbeats [6]. Atrial fibrillation may 
result in symptoms of palpitations, fainting, chest pain, or even heart failure. In addition, 
the erratic motion of the atria leads to blood stagnation, which increases the risk of 
formation of blood clots that may travel from the heart to the brain and other areas. AF is 
  
  2 
generally explained by the phenomenon of reentry, in which the propagation of an 
activation front becomes self-sustained. Two scenarios have been proposed: 
uncoordinated multiple wavelets of excitation circulating throughout the atria or 
fibrillatory conduction front generated by  a single mother rotor [5, 7]. 
 
Coronary artery bypass graft surgery (CABG) is a surgical procedure performed to 
relieve angina and restore the blood flow. Arteries or veins from elsewhere in the 
patient's body are grafted from the aorta to the coronary arteries to bypass atherosclerotic 
narrowing and improve the blood supply to the coronary circulation supplying the 
myocardium [5, 8-11]. Despite the increased rate of percutaneous coronary intervention, 
CABG is still a common surgery.  In Ontario for example, around 8,0000  interventions 
have been performed each year from 1998 to 2004 [12].  About 500,000 CABG 
operations are performed annually in the United States. 10% to 65% of patients who 
never had a history of AF develop AF on the second or third post CABG surgery day [13-
15]. The patients undergoing valve surgery or combined valve and CABG have higher 
incidence of postoperative AF than patients having CABG alone. AF is especially 
common after mitral valve surgery, occurring in as many as 64% of patients. The 
occurrence of postoperative AF is associated with worse morbidity and longer and more 
expensive intensive-care hospitalization [16-19]. There is evidence that AF associates 
with adverse events: patient discomfort, the need for additional medications and 
treatments, decrease in cardiac output, hypotension, and congestive heart failure. The 
most serious complication of AF is stroke. The prolongation of stay in hospital leads to 
negative social and economic aftereffects. In the United States, the cost for the intensive 
care against postoperative AF is substantial, with annual estimated expenditures 
exceeding 1 billion US dollars [20]-[21]. 
 
Although the understanding of cardiac arrhythmias has advanced considerably during the 
last half century, it is only during the last 20 years that the pathology of AF has become a 
popular topic for physicians and researchers in the cardiology field. The fundamental 
mechanism responsible of AF, especially for post-surgery patients, is not well 
understood.  Prophylactic medical therapy decreases the incidence of postoperative AF 
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after CABG. The most effective preventive methods, either medical prevention or 
preventive pacing, require additional nursing and medical resources and expense. 
Prophylaxis of the whole patient population undergoing GABG is not an optimal choice. 
Unless the pathophysiological mechanisms of AF are identified, the design of adequate 
strategy of prevention will remain problematic. Identification of patients at high risk of 
AF after CABG would be very helpful and cost-effective [20] [9, 10, 19]. 
 
Therefore, the aim of the present research is to investigate to which extent multi-channel 
unipolar atrial electrograms (AEG) can be used to predict the onset of AF and 
discriminate AF from non-AF patients 
 
1.2 Review of the Literature 
 
In the last 20 years with the development and maturing of the CABG operation, more and 
more researchers and physicians turn toward research of mechanism, prediction and 
management of AF [7, 20-27]. Many studies aimed to develop methods of AF prediction 
based on the analysis of ECG, with focus on different aspects such as P wave duration, 
autonomic balance, non-linear analysis or advanced signal processing [24, 28-35]. 
However, so far, there is not adequate explanation for why some patients develop 
postoperative AF whereas others remain in sinus rhythm. The next section will discuss 
the current development and hypotheses regarding the electrophysiological mechanisms, 
the prevention, the treatment and the prediction of AF.  
 
1.2.1 Electrophysiological Mechanism 
 
Publications are still controversial regarding the mechanisms responsible for the onset of 
post-CABG AF as well as the identification of patients at risk [7, 11, 20, 21, 36-38]. 
However, all forms of AF are believed to share common basic electrophysiological 
mechanisms, while some studies indicated possible localized pathoelectrophysiological 
mechanisms [37-43] 
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The search for AF mechanism could be traced as early in 1907 when Winterberg 
proposed that multiple rapidly firing foci located throughout the atria led to occurrence of 
AF [44]. GR Mines and WE Garrey advanced independently the concept of reentry, 
whereby the conduction of an excitation front around a closed circuit can become self-
sustained. They then proposed that AF or VF could be caused by ‘multiple-simultaneous-
reentrant circuits’ coexisting in the tissue [7, 45, 46]. In a later 1924 review paper, Garrey 
stated that its original proposal did “not mean, and never was intended to mean that 
multiple circuits were fixed in their isolated paths and independent of each other,…,  but 
it was intended to convey the idea that impulses looped back upon its old path, 
completing a circuit now here, now there. Such reentrant circuit can exist side by side 
transiently” [47]. Until the mid 20’th century, the debate between the multiple foci and 
multiple reentries hypotheses, as well as on the exact nature of these reentries (unique or 
multiple, fixed or transient) was still open [48]. In 1959, Moe and Abildskov, in fact 
revisiting the arguments of Garrey, proposed that the occurrence of AF was 
fundamentally different from multiple ectopic discharges [3]. Afterwards, Moe put 
forward the ‘multiple wavelets hypothesis’, which differed from the fixed multiple-
circuit-reentry concept. It states that multiple independent wavelets circulate around 
functionally refractory tissue without returning to their initial starting points. Some 
wavelets are able to propagate through tissues of adequate excitability and maintain 
themselves with or without producing daughter wavelets. They exemplified their multiple 
wavelets hypothesis by a two dimensional cellular automata model [49]. From then, 
Moe's theory was more generally accepted compared to the foci origination theory. The 
idea of Moe's theory, in brief, is that atrial fibrillation was considered to be a 
fundamentally turbulent and self-sustaining process, occurring in inhomogeneous 
excitable medium. The process could be initiated by an impulse propagating through the 
medium at a time when some of its components have recovered while others remain 
partially or fully refractory as a result of a preceding activation [3, 49]. The mother wave 
hypothesis, in which a one or a few anchored or locally meandering high frequency 
reentries result in complex patterns of propagation, has been proposed as an alternative to 
the multiple wavelet hypothesis [44]. Nowadays, both scenarios are considered to occur, 
suggesting that they may require different types of intervention. 
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Reentry can occur around an anatomical obstacle, in which case it can be labeled as 
closed circuit reentry. Two-dimensional simulation plans of the depolarization front 
along one direction and the reentry are showed in Figure 1.1.  However, both mother 
wave and multiple-wavelet AF implicitly refer to functional reentry which does not 
necessitate an unexcitable core. An example of reentry induced by premature stimulation 
is a two-dimensional model cardiac tissue is showed in Figure 1.1. There exist two 
competing models of functional reentry in cardiac tissue: the leading circle which is a 
qualitative model based on experimental observations [50], the spiral wave model, based 
on theoretical considerations and numerical simulations of ionic models[7, 51, 52].  The 
latter provides a more realistic representation of the electrical properties of the tissue and 
a more correct prediction of state of the core around which propagation takes place [53]. 
In the classical view of closed circuit and leading circle reentry, the wavelength of 
reentrant wavelets, the product of the conduction velocity and refractory period, is the 
main determinant of the persistence of AF. The wavelength determines the size of each 
functional reentry circuit and limits the number of simultaneous reentry wavelets that can 
exist during fibrillation. The relation becomes more complex in the spiral model, since it 
involves the curvature of the front and the electronic effect during repolarization [53]. 
Nevertheless, both models predict that the shortening of the refractory period (ERP) has a 
crucial role in increasing wavelets number and is a major determinant in sustaining of AF 
[54].  
                                 A                                                             B          
 
Figure 1. 1 A) A normal plane depolarization front travelling along the vertical direction; 
B) reentry. It was induced by applying a second stimulus covering half of the plane in the 
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horizontal direction. The abscissa and ordinate are  the coordinate of the tissue in the unit 
of pixel. The color stands for the membrane potential, corresponding values indicated in 
the color bar (mv). (Figure provided by Elhacene Matene, student of Dr. V. Jacquemet,  
Centre de recherche de l'Hôpital du Sacré-Cœur and Institut de Génie biomédical, 
Université Montréal. It shows a simulation of reentry in a model of atrial tissu). 
 
Patients developing postoperative AF are speculated to have a vulnerable heterogeneous 
substrate prone to develop AF, such as non-uniform and dissimilar refractoriness, a 
depolarizing wave front becomes fragmented when encountering both refractory and 
excitable myocardium. This allows wave fronts to return and stimulate previously 
refractory but now repolarized myocardium, which can lead to self-sustained propagation 
or reentry [55, 56]. However, other elements such as the slope of the action potential 
restitution curve, the curvature of the wave front and the distribution of gap junctions also 
contribute to the dynamics and stability of reentry [54, 57]. Han et al. proposed that 
dispersion of recovery of excitability in the atria or ventricles of the heart predispose to 
the development of both atrial and ventricular arrhythmias [58, 59]. Comtois et al. also 
explained that the difference of adjacent atrial cells can predispose to pulse conduction 
reentry [53]. Beside, fibrosis has been strongly associated with the presence of heart 
diseases/arrhythmias. It was recently considered to alter atrial electrical conduction and 
excitability and provides a substrate for AF onset and perpetuation [60, 61].  
 
Although the pathological substrate may favors the incidence of AF, ectopic focal 
activation is a mechanism to trigger the AF [62]. Ectopic foci can be found in many areas 
of the atrium including the pulmonary veins, the superior cava, the coronary sinus ostium, 
as well as the posterior and anterior left atrium [63-65]. In Holter ECG monitoring, a 
triggering premature atrial complex (PAC) was present in more than 90% percent of AF 
episodes. According to the polarity of the ectopic P-wave, triggering PACs were left 
atrial origin in 74.3%, right atrial in 15.3%, not determined in 10.4% of cases. Frequency 
of PACs was significantly higher in the hour preceding the onset of AF. Among PAC, 
two-thirds had a left atrial origin [66]. 
 
The intrinsic cardiac autonomic nervous system is also believed to play a role in the 
occurrence and maintenance of AF. Heterogeneous electrophysiological properties could 
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be due to autonomic innervations [34, 37, 67]. It is reported that either vagal nerve 
activation or sympathetic nerve stimulation, both could facilitate the occurrence of AF. 
Either vagal stimulation or acetylcholine administration decreases the atrial refractory 
period in a spatially heterogeneous way [68, 69]. In addition, vagal stimulation promotes 
both the production of PAA and their propensity to start AF [7, 70]. Sympathetic 
stimulation can also promote the initiation of AF. Sympathetic nerve stimulation also 
shortens atrial refractoriness in a comparable degree. The difference between vagal and 
sympathetic stimulation might lie in the more spatially heterogeneous effect of vagal 
nerve activation. Two major patterns of AF initiation can be observed. AF occurring after 
a slowing heart rate, thought to be triggered by a dominant parasympathetic tone that 
frequently occurs in patients with normal hearts. Adrenergic-induced AF is more frequent 
in older patients with structural heart disease, and typically occurs during exercise [71, 
72]. The possible implication of the autonomic nervous system in postoperative AF was 
discussed in many publications, and the atrial electrophysiological effects caused by 
autonomic nervous system stimulation are complex, sometimes even controversial [20, 
33, 71, 73, 74]. Amar reported an increase both in heart rate and in heart rate variability 
(HRV) prior to the onset of postoperative AF. These findings are consistent with 
parasympathetic resurgence competing with increasing sympathetic activity as a 
triggering mechanism for postoperative AF [33]. It has been put forward that elevated 
norepinephrine levels suggested that sympathetic activation may be important in the 
pathogenesis of post CABG AF. Sympathetic activation, however, is highest the first 24 
hours after operation, whereas the onset of AF usually occurs between the second and 
third postoperative days [75].  Some findings suggested divergent autonomic conditions 
to occur before arrhythmia onset, which could be either heightened sympathetic or 
parasympathetic tone, or event dysfunctional autonomic heart rate control, with higher or 
lower measures of heart rate variable [71, 76].  
 
1.2.2 Risk Factors: Preoperative, Intraoperative, and Postoperative of 
Postoperative AF 
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Many risk factors for postoperative AF have been identified, but the results of different 
studies have often been inconsistent. This might be due to the factors as: 1. the 
mechanism of AF is complex and multi-factorial; 2. most studies are observational and 
retrospective, with varying inclusion criteria. This is illustrated in Table 1.1, which shows 
the patients characteristics in four studies on post-operative AF.  The distribution of 
preoperative factors found to be related to AF occurrence in some studies is not even 
reported in others (empty boxed if not available). Table 1.2 compares the risk score (a 
risk index to indicate risk degree, definition seen in [77]) or odds ratio associated to 
different variables in these same four studies. It shows that using different data and/or 
study population can leads to very different results. The following reviews current 
knowledge on the preoperative, intraoperative and postoperative risk factors.  
 
Preoperative Risk Factors 
 
The following variables have been reported as potential preoperative and perioperative 
risk factors: age, sex, right coronary artery stenosis of 90% or higher, left ventricular 
abnormality as ejection fraction, enlargement, hypertrophy; dilation, aortic 
atherosclerosis, hypokalemia, history of atrial fibrillation, valvular disease, 
CHF(congestive heart failure), vascular disease, neurological event, diabetes, any 
MI(myocardial infarction), hypertension or chronic obstructive pulmonary disease 
(COPD), prior CABG surgery or valve surgery, previous congestive heart failure, and 
preopeative absorption of beta-blockers, angiotensin-converting enzyme (ACE) 
inhibitors, calcium channel blockers, amiodarone, or nonsteroidal anti-inflammatory 
drugs (NSAIDs) [17, 36, 38, 75, 76, 78-80].  
 
Age has a significant relation with the incidence of postoperative AF. The incidence rate 
of  post-CABG AF  is more than 50% for patients older than 80 years, but less than 5% 
for those that are less than 50 years [76, 81]. The association could be attributable to age-
related structural changes in the atrium such as dilation, muscle atrophy and fibrosis. 
Patients with a history of AF appear to have the underlying substrate conducive to the 
development of AF and may be more susceptible to postoperative AF [77, 82]. This 
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would be consistent with the concepts of electrical remodeling and “AF begets AF” that 
is supported by numerous clinical and experimental studies [7]. 
 
Men appear more likely to develop AF after CABG than women [83, 84]. Sex differences 
in ion-channel expression and hormonal effects on autonomic tone may explain this 
difference between genders However, there exist conflicting reports, in which male 
gender was not an independent predictor of AF [80]. 
 
Hypertension was regarded as a predictor of postoperative AF, and this may be related to 
increased fibrosis and dispersion of atrial refractoriness [85, 86]. However, such a 
relation was not found in another study involving a larger number of patients [87].  
 
Chronic obstructive pulmonary disease (COPD) is a predictor of AF after cardiac 
surgery. It might be related to fact that COPD patients have frequent premature atrial 
contractions that can act as a trigger for the initiation of AF [84].  
 
The right coronary artery also conveys the blood supply to the right atrium, the sinoatrial 
node and the atrioventricular node. Patients with a total occlusion or severe stenosis of 
the proximal right artery had postoperative AF more often when retrograde cardioplegia 
was used. In other studies, obstructive disease in the sinoatrial nodal and atrioventricular 
nodal arteries was more common in patients developing AF after CABG than in those 
who remained in sinus rhythm. Stenosis of the sinoatrial artery or the right coronary 
artery has been found to be independent predictors of AF after CABG by other 
investigators [14, 88]. 
 
Many studies showed that obesity, or body mass index and metabolic syndrome are risk 
factors of postoperative AF [13, 89-93]. Echahidi demonstrated that obesity was a 
powerful and independent risk factor for the occurrence of postoperative AF in patients 
older than 50 years. In a younger population, obesity was not a risk factor whereas 
metabolic syndrome remained an independent risk factor [13] . 
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There was also the study about preoperative renal function associated with the risk of 
atrial fibrillation after surgery [94, 95]. It was found the patients measured higher level of 
serum creatinine, were more risky to develop postoperative AF.   
 
Several studies have examined the relationship between left atrial dysfunction [96, 97].  
Leung found that the patients subsequently developing post-operative AF had a larger LA 
and LA appendage area, and lower LA ejection fraction measured in the pre-bypass 
period. Their results demonstrate that some of the structural and functional changes in the 
atria common to chronic AF in the elderly population are also prevalent in surgical 
patients who develop post-operative AF, suggesting that both may share similar 
pathophysiology.  LA enlargement was also found to be a predictor of postoperative AF 
either in CABG patients [98]  after cardiac valvular surgery [99]. However, Zaman et al. 
did not find any difference in the size of LA between the patients who had AF and those 
who remained in sinus rhythm. Their study included only 64 patients and was subgroup 
of a larger study population [100].  
 
Some studies proposed that preoperative withdrawal of beta-adrenergic blockers was 
associated with increased risk for postoperative AF [80, 101]. The withdraw effect is 
characterized by an increased plasma concentration of catecholamine that may increase 
the incidence of AF. It has been demonstrated that the bioavailability of perioperative 
metoprolol (beta-adrenergic blockers) is markedly reduced when administered in tablet 
early after CABG.  The poor absorption of oral beta blocker immediately cardiac surgery 
may further strengthen the withdrawal effect [102]. The prophylaxis with moderate doses 
of amiodarone in the postoperative period of cardiac surgery (coronary artery bypass 
grafting and/or valve surgery), was shown to reduce the incidence of AF in high risk 
patients with high risk patients, raising the possibility that it could also be protective for a 
larger class of patients [103].  
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Table 1.1 Baseline Characters of Patients of Study Population 
 
 
 
Mathew 
[77] 
Zaman 
[100] 
Amar 
[104] 
Auer 
[80] 
Age(mean, SD), years 
  AF 
Non-AF 
 
67.8(8.2, n=976) 
61.8(9.8, n=2117) 
(p<0.0005) 
65.9(n=92) 
61.7(n=234) 
(p<0.0001) 
68(9,n=508) 
62(11, n=1.045) 
(p=0.008) 
67.5(9.1,n=99) 
63.7(11.4,n=154) 
Incidence of AF 32.27% 28.22%   
Men, No. (%) 
   AF 
 Non-AF  
 
770(78.9, DC) 
1682(79.5, DC) 
(p=0.084) 
81(88) 
187(80) 
(p=0.63) 
336(66) 
704(67) 
(p=0.29) 
55(55.5) 
98(63) 
SAPD(ms) 
   AF 
 Non-AF 
 
 
(p<0.0005) 
158 
145 
(p=0.02) 
117 ± 17 
115 ± 18 
 
LVEF, % 
   AF 
 Non-AF 
 (p=0.751) 
56 
56 
  
Left atrial size, cm* 
   AF 
 Non-AF 
 (p=0.831) 
3.8 
3.9 
  
History, No. (%) 
   Atrial fibrillation 
     AF 
  Non-AF 
Valvular disease 
   AF 
  Non-AF 
Myocardial Infarction 
    AF 
  Non-AF 
COPD 
    AF 
  Non-AF 
Hypertension (%) 
    AF 
 
 
142(14.6, DC) 
126(6.0, DC) 
 
271(27.8, DC) 
316(14.9, DC) 
 
612(62.7, DC) 
1334(63.0, DC) 
 
137(14.0, DC) 
183(8.6, DC) 
 
668(68.4, DC) 
  
(p<0.0001) 
57(11) 
27(3) 
 
 
 
(p=0.48) 
265(52) 
525(50) 
(p=0.13) 
46(9) 
72(7) 
(p=0.17) 
371(73) 
 
 
 
 
 
 
 
 
 
 
 
 
 
(p=0.68) 
(60.6) 
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  Non-AF 
Diabetes(%) 
    AF 
  Non-AF 
1348(63.7, DC) 
 
303(31.1, DC) 
660(31.2, DC) 
728(70) 
(p=0.19) 
167(33) 
379(36) 
(64) 
(p=0.12) 
(19.2) 
(28.6) 
Preop. treatment, No.(%) 
β -Blockers 
    AF 
  Non-AF 
Calcium channel  blockers 
    AF 
  Non-AF 
ACE inhibitors 
    AF 
  Non-AF    
 
 
645(66.1, DC) 
1480(69.9, DC) 
 
 
391(40.1, DC) 
768(36.3, DC) 
 
447(45.8, DC) 
875(41.3, DC) 
 
 
54(59) 
164(70) 
 
(p=0.05) 
239(47) 
547(52) 
 
Cross-clamp, mean(SD),min 
    AF 
  Non-AF 
 
69.5(35.1, DC) 
61.8(29.3, DC) 
(p=0.306) 
45 
43 
(p=0.33) 
63 ± 22 
64 ± 22 
 
Heart valve surgery(%) 
    AF 
  Non-AF 
   (P<0.0001) 
62.6 
33.1 
RCA graft(% of CABG) 
    AF 
  Non-AF 
   (P=0.08) 
58.1 
72.3 
CPB time, mean(SD), min 
    AF 
  Non-AF 
 
108.6(45.7, DC) 
98.7(39.8, DC) 
   
Pre-operative Q-waves, n(%) 
    AF 
   Non-AF 
 (p=0.506) 
31(34) 
70(30) 
  
RCA stenosis, n(%) 
    AF 
   Non-AF 
 (p=0.212) 
55(60) 
122(52) 
  
CPB time, min 
    AF 
 (p=0.025) 
81 
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   Non-AF 74 
Grafts>3, n(%) 
    AF 
   Non-AF 
 (p=0.040) 
31(34) 
53(23) 
  
Preoperative creatinine 
>125 μ mol/L, n(%) 
    AF 
   Non-AF 
 (p=0.260) 
 
22(23) 
43(18) 
  
Postoperative Low cardiac 
output, n(%) 
    AF 
   Non-AF 
  
 
 
 
<0.0001 
36(7) 
24(2) 
 
Postoperative 
complications(%) 
    AF 
   Non-AF 
   (p<0.05) 
 
12.1 
5.8 
 
DC: Derivation Cohort;  
ACE: angiotensin converting enzyme;  
SAPD: signal-averaged P-wave duration;  
LVEF: left ventricular ejection fraction;  
CPB=cardiopulmonary bypass time.  
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Table 1.2 Multivariable Predictors of Postoperative Atrial Fibrillation 
 Mathew 
[77] 
Zaman 
[100] 
Amar 
[104] 
Auer 
[80] 
 Risk Score,  
(R.S., p) 
Odds Ratio 
(O.R., p) 
Odds Ratio 
(O.R., p) 
Odds Ratio 
(O.R.,  
95% CI, p) 
Age, y 
<30 (R.S.) 
30-39(R.S.) 
40-49(R.S.) 
50-59(R.S.) 
60-69(R.S.) 
70-79(R.S.) 
≥ 80(R.S.) 
(R.S., 
 Risk Score) 
p<0.001 
6 
12 
18 
24 
30 
36 
42 
1.53(<0.0005) 
(per 5-y increase) 
1.1  (p<0.0001) 
(per year incre.) 
2.6(1.2-3.9) 
<0.01 
Medical history 
AF(R.S.), p 
COPD(R.S.), p 
 
7(<0.001) 
4(.009) 
  
3.7(p<0.0001, O.R.) 
 
Concurrent valve 
surgery 
6(<.001)   2.8(1.1-3.5) 
<0.01 
Withdrawal of 
treatment 
β -Blockers 
  ACE inhibitors 
 
 
6(<.001) 
5(<0.001) 
   
Preop. and postop. 
 treatment 
 β -Blockers 
ACE inhibitors 
 
 
-7(<0.001) 
-5(<0.001) 
   
Postop. β -
Blockers treatment 
-11(<0.001)    
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Other treatment 
Potassium 
supplementation 
NSAIDs 
 
-5(<0.001) 
 
-7(<0.001) 
   
SAPD>155ms  5.37(<0.0005)   
p-wave duration 
>110ms 
  1.3(p=0.02)  
Male sex  2.88(0.0092)   
Postoperative low 
cardiac output 
(O.R.) 
  3.0(p=0.0001)  
Postoperative 
complication 
   1.9(1.0-7.5) 
<0.05 
Non-use 
preoperative beta-
adrenergic blocker 
   1.7(1.1-4.9) 
<0.05 
O.R.: odds ratio 
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Intraoperative Risk Factors 
 
Auer proposed that the type of surgery may affect the risk of AF after cardiac surgery 
[80], and higher risk of postoperative AF and mortality were observed  after mitral valve 
surgery [105].  
 
Whether the risk of AF is different for On-pump versus off-pump CABG is still 
contentious. Murphy reported a lower incidence of AF after off-pump than on-pump 
CABG [106] , while Topal found  that  on-pump no significant difference as long as the 
operating time did not exceed a certain duration [107]. 
 
The association between the duration of aortic cross-clamp and the risk postoperative AF 
also remains controversial. Mathew proposed that the risk was increased by prolonged 
cross-clamp [108], an observation contradicted by the study of Salaria el al [109].  
 
Postoperative Risk Factors 
 
Many studies have considered the association of inflammation with the occurrence of 
postoperative AF [110-113]. C-reactive protein (CRP) is the classic acute phase reactant. 
During severe inflammation or infection, its blood levels may increase up to 500 times to 
1,000 times above normal. The reason why inflammation markers in atrial fibrillation 
may become high after CABG is a puzzling problem. The peak levels of C-reactive 
protein (CRP) were paralleled to the incidence of postoperative AF. In  the general 
population, CRP was also higher in patients with AF than those who do not develop [114]. 
The reported efficacy of anti-inflammatory drugs such as steroids in the prevention of AF 
supports the association between AF and inflammation [115]. However, Ahlsson found 
that postoperative AF has no correlation to CRP level in heart surgery patients [116]. 
 
Postoperative pneumonia and mechanical ventilation for more than 24 hours have been 
shown to be independent postoperative predictors of AF [75]. Another study reported that 
low postoperative mixed venous oxygen saturation and the need for postoperative 
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mechanical circulatory support were also independent predictors of post-CABG AF 
[117].  
 
1.2.3 Prophylaxis and Postoperative AF Treatment 
 
The prevention of post-cardiac surgery AF arouses much interest because of its high 
incidence and the associated morbidity, mortality, and cost. Prophylactic drug 
administration has been shown to decrease the incidence of post-CABG atrial fibrillation 
and Prophylactic appears to be more effective than postoperative administration [103, 
118-120]. The most promising  drugs  include β -blockers, amiodarone and calcium 
channel blocker, which are also administered for a wide range of ventricular and 
supraventricular arrhythmias [118]. The effectiveness of beta-blockers in the prevention 
of AF after cardiac surgery has been demonstrated in numerous studies [120, 121]. 
Indeed, according to the recent guideline, beta-blocker prophylaxis should be given to 
every patients undergoing cardiac surgery when there is no contraindications.  
 
If AF does occur after cardiac surgery, the guidelines recommend managing patients as 
non-surgical AF patients [122, 123]. Two management strategies are available to treat AF 
after CABG: rate control or rhythm control. For patients who less urgently require sinus 
rhythm restoration, β -blockers are considered as the first-line therapy. When β -
blockers alone inadequately control the heart rate, calcium channel blockers may be 
administered [122]. Infusion of amiodarone can also be used for adequate rate control in 
AF.  For hemodynamically unstable, highly symptomatic patients or for those having a 
contraindication to anticoagulation, rhythm management is preferred. These patients 
should undergo urgent electrical cardioversion to sinus rhythm.  
 
1.2.4 Methods for Predicting Postoperative Atrial Fibrillation 
 
Many studies aim to develop methods for the prediction of postoperative. Risk 
stratification would be very useful either to optimize the prophylactic antiarrhythmic 
treatment in high risk patients, or to limit drugs administration in low risk subjects. The 
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works published so far managed to achieve good results in terms of sensitivity and 
specificity. However, since these methods were not completely reliable, their clinical 
application is still limited. Methods were based on ECG analysis in the time or frequency 
domain,  or on the measure of biochemical markers such as atrial natriuretic peptides [15, 
24, 28, 31, 124, 125]. 
 
It is generally believed that an abnormal prolongation of P wave duration on the ECG 
reflects the presence of intra-atrial conduction defects [24, 29-32, 126-133]. A slowed 
conduction may promote the development of arrhythmia by shortening the wavelength 
necessary to sustain reentry. P wave dispersion is also considered as a predictor for AF 
after CABG. The main limitations of the methods based on P wave duration come from 
the fact that there is no accepted definition of normal duration. Beside, the use of 
different methods to measure of P wave duration makes the comparison of the results 
achieved by various groups difficult. P wave delineation is more difficult to implement 
than QRS complex one, mainly owing to the low signal-to-noise ratio and the shape 
variability of the P wave [134].  
 
The autonomic nervous system (ANS) has been recognized as a potential contributor to 
the initiation of AF [20, 33, 37, 67, 69, 71, 73, 82]. Perturbation the sympathovagal 
balance has been hypothesized to be associated to AF. The notion that certain ranges of 
frequencies in the power spectrum of the heart rhythm may be indicative of either 
sympathetic or parasympathetic tone has stimulated the of heart rate variability (HRV) as 
a diagnostic tool. The parasympathetic influence on heart rate is mediated via release of 
acetylcholine by the vagus nerve. Higher sympathetic /parasympathetic tone usually 
related with higher/lower heart rate [2]. The efferent vagal activity is a major contributor 
to the high frequency component. More controversial is the interpretation of the low 
frequency component, which is considered by some as a marker of sympathetic 
modulation (especially when expressed in normalized units) and by others as a parameter 
that includes both sympathetic and vagal influences. This discrepancy is due to the fact 
that in some conditions associated with sympathetic excitation, a decrease in the absolute 
power of the LF component has been observed [135]. Divergent results have been 
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reported the link between heart rate variability (HRV) and post-cardiac surgery AF. 
Dimmer et al. observed a shift in the autonomic balance, with a loss of vagal tone and a 
moderate increase in sympathetic tone, before the onset of AF [71], while Hogue et al., 
performing HRV analysis after CABG surgery, observed either lower or higher values of 
different frequencies content before AF. They concluded that their patients could have 
either heightened sympathetic or vagal tone or dysfunctional autonomic heart rate control 
before AF onset [136]. Marco Bettoni concluded that  the occurrence of AF greatly 
depended on the variation of the autonomic tone, with a primary increase in adrenergic 
tone followed by an abrupt shift toward vagal predominance [137]. David Amar et al 
evaluated autonomic change preceding AF after thoracotomy. They found a significant 
increase in HRV and heart rate prior to the onset of AF, consistent with vagal resurgence 
competing in a background of increasing sympathetic activity as a mechanism to trigger 
AF   [33].  
 
Recent studies have shown that the new nonlinear measures, particularly fractal analysis 
methods of heart rate dynamics, could perform better than traditional analysis methods as 
a predictor of sudden cardiac death in post-infarction populations [134, 138]. Altered 
short-term fractal properties of heart rate dynamics have also been shown to precede the 
onset of ventricular tachyarrhythmias in patients with heart disease. Approximate 
entropy, a measure of complexity of heart rate variability has been used to predict the 
onset of paroxysmal atrial fibrillation. However, these methods have not been applied yet 
to post- CABG AF [134].  
 
Currently, most electrophysiological methods to predict the onset of postoperative AF are 
based on the ECG. The intrinsic limitation of P wave studies is that P wave cannot give 
precise information of atrial activity. P wave is a complex expression of the whole 
electrical activity in left and right atrium, and it cannot give a detail picture of the 
electrical propagation in the atrium. Furthermore, the criteria of calibration of P wave sets 
quite rely on the individuals, which may explain the discrepancies between the published 
articles [134]. Authors also use different methods to choose subjects, to treat the 
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premature beats, saturations periods, etc., which further contribute to the differences 
between their results.  
 
A M Pichlmaier et al utilized the monophasic action potential continuously recorded from 
the epicardial surface to predict the onset of atrial fibrillation after cardiac surgery [139]. 
They found that the morphological changes in the MAP could be good indicators that the 
atrial rhythm is likely to become unstable and to deteriorate to AF, and concluded that 
epicardium MAP recording could be a valid tool for detecting imminent AF after cardiac 
surgery.  
 
Atrial natriuretic peptides (ANP) are produced primarily in the cardiac atria. The 
dominant stimulus controlling their release is the increase of the atrial wall tension, 
reflecting rising intravascular volume. Different studies have examined the possible link 
between ANP level and AF [15, 124, 140, 141]. Hakala et al. found that, in the univariate 
analysis, high ANP level were associated with the development of postoperative AF. 
However, ANP did not appear in forward conditional multivariate analysis in which only 
age and left atrial enlargement were left as independent predictors. In their cohort, ANP 
level did not act as an independent predictor because it was correlated to age. They 
concluded that the wide variation in the peptide levels observed in their cohort renders 
the implementation of this measure in clinical practise superfluous [15]. 
  
1.3 Analysis on Atrial Electrograms (AEG) to Study the Mechanism and 
Prediction 
 
1.3.1 Hypothesis and Objectives 
 
Postoperative AF is the most common complication after surgery.  Its mechanisms are 
not fully understood. Both “structural” and “electrical” remodelling of the atrium may act 
to promote AF [142].  The remodeling may involve pathological alterations in the 
structure, function and geometry of the atria, such as changes of the atrial electrical and 
contractile properties or in the amount and the composition of the extracellular matrix, 
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which may facilitate the induction of AF. Studies on the induction of AF by neural 
stimulation in canine preparation have shown that the autonomic can be involved. [143]. 
Pichlmaier also noticed significant change of MAP waveforms prior to the onset of AF 
[139]. Our study relies on the analysis of three channels unipolar electrograms recorded 
on the atria (AEG). The advantage to use AEG rather than ECG is that AEG can provide 
some measures relevant to the occurrence of AF that are difficult or even impossible to 
obtain from ECG. For example, AF is often preceded by multiple atrial premature 
activations [62, 66]. Simultaneous recording of unipolar electrograms from different sites 
can supply more precise information on the origin of these premature activations.  The 
hypotheses guiding our analyses are:  
 
1) The onset of AF after CABG is preceded by typical changes that are reflected in 
the time series derived from the AEG.  
 
2) These time series, in addition for pre-CABG risk factors, can be used to 
discriminate patients with and without AF, and predict the onset of AF soon 
enough to allow for prophylactic interventions  
 
1.3.2 Choice of Subjects 
 
Patients admitted for CABG surgery at Hôpital du Sacré-Coeur de Montréal (HSC) and 
Institut de Cardiologie de Montréal (ICM) were screened. Patients were excluded if they 
were not in sinus rhythm at admission, were taking class I or III antiarrhythmic drugs or 
digoxin, had a prior history of AF, were diagnosed for congestive heart failure, were 
receiving hemodialysis, or had a permanent pacemaker. We realized that these exclusions 
criteria were meant to avoid such confounding effects as the effect of class I drugs on 
conduction times and atrial ectopy or the parasympathicomimetic effects of digoxin. 
Informed written consent was obtained. A total of 137 patients were included, 108 from 
HSC and 29 from ICM.  
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The criteria to decide a patient belonging to AF group, it is upon whether the patient 
develop sustained atrial fibrillation with duration longer than 10 minutes after CAGB 
surgery [101]. Among these 137 patients, 41 patients developed at least sustained AF 
lasting for 10 minutes or more after the CABG surgery. Herein, these 41 patients were 
classified as AF patients. Among AF group, the distribution of the first sustained AF 
duration time was very inhomogeneous, with a minimum value of 10 minutes, maximum 
duration time of 3732 minutes. 75% of AF group patients have the fist sustained AF 
duration time between 150 and 650 minutes. Among remaining 96 patients classified as 
Non-AF group, some of them had very short transient supraventricular arrhythmias, from 
several second to 2 or 3 minutes, and with a maximum duration close to 5 minutes.  
 
1.3.2 Study Plan 
 
AEG were recorded continuously during the first four post-operative days. The First task 
was to detect, distinguish and validate the markers corresponding to the atrial and 
ventricular activation on each channel. The markers of the three channels belonging to 
the same cardiac event had to be grouped together and the nature of each event (e.g. 
normal sinus beat, premature atrial or premature ventricular beat) resolved. Then, 
different time series were constructed, reflecting either the intra-beat or inter-beat 
dynamics. Finally, statistical analysis of the time series characteristics was performed to 
discriminate the AF group (patients with AF ≥  10 minutes) and non-AF group and obtain 
predictors. 
 
 
Figure 1. 2 Flow chart of the project research method 
 
 
Results are presented in the three following chapters. Chapter 2 presents the methods of 
activation and events detection and labeling . In chapter 3, the time series of AF patients 
are analyzed to see if changes occur in the two hours before the onset of the first long 
lasting AF. In chapter 4, AF and Non-AF are compared regarding their preoperative risk 
Data Collection Build Time Series Analyze Time Series Predictors 
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factors. In chapter 5, the preoperative predictors and AEG time series are used together to 
discriminate AF and Non-AF patients. The final chapter summarizes the results and 
draws the conclusions over the whole studies.   
 
1.3.3 Statistical Methods 
 
 
In the following chapters, diverse statistical methods were used to analyze the 
preoperative data as well as the time series extracted from the electrograms.  Two 
softwares,  Matlab (The MathWorks Inc, Mass, USA)  and SPSS (IBM), were used for 
the analysis.  The main statistical methods used in the analysis are explained below. 
 
1. Repeated measures analysis of variance (ANOVA)  
Repeated measures ANOVA test the equality of the means as any ANOVA. It is used 
when the measurement of dependent variable is repeated under different condition for 
each subject  [144].  The sphericity assumption of repeated measures ANOVA means that 
the variances of the differences between all combinations of the groups are assumed to be 
equal.  If sphericity is violated, then the variance calculations may be distorted, which 
could result in an inflated F-ratio [145]. In the project, Huynh-Feldt correction was 
applied to assess the significance of the F-ratio.  
 
2. Logistic regression  
 
Logistic regression is widely used to model the outcomes of a categorical dependent 
variable based on one or more predictor variables. The probabilities describing the 
possible outcome of a single trial are modeled as a function of explanatory variables 
through the logistic function. For binary outcome (y=0, 1), the probability for a subject i 
to get the reference outcome (y=1) is given by: 
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in which xi,j is the value of the j’th independent variable for patient i, and jβ the value of 
the parameters. In the project, the logistic regression was done using either  SPSS or an 
in-house Matlab program in which part of code was originally contributed as freeware by 
Britt Anderson (http://brittlab4.uwaterloo.ca). A Conditional forward stepwise method 
was used, of the predictor selection was used with p value criterion for variables to enter 
and remain in the model usually set at 0.05 and 0.10 respectively  
 
Parameters are obtained by maximum likelihood estimation. The likelihood function is 
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where yi is the outcome (0 or 1) of the i’th subject and wi the weight that can be given to 
the observation (1 by default). The significance of the contribution of each variable 
included in the model is assessed by a chi-square test over the improvement that it brings 
to the likelihood functio[146], [147]. The logistic regression provides a value Pi 
(probability of having y=1) for each patient. In logistic regression, the patient would be 
assigned to outcome 0 or 1 if Pi is less or greater than 0.5 respectively  
 
However, Pi can also be treated as a propensity score. In that case, an arbitrary threshold 
between 0 and 1 can be selected to allocate each subject to one of the outcomes. For each 
value of the threshold, the sensitivity (number of subjects with y=1 correctly classified) 
and specificity (number of subjects with y=0 correctly classified) can be computed.  The 
set of [1-specificity, sensitivity] for all values of the threshold can be plotted together as a 
ROC (receiver operating characteristic) curve. The area under the curve measures the 
probability that a randomly selected pair of y=1 and y=0 subjects would be correctly 
classified (i.e. score of subject with y=1 > score of subject with y=0), such that the scores 
do not provide any discrimination if the area ≤ 0.5. The significance of the discrimination 
can be evaluated from the excess of the area beyond 0.5 [148].  Methods and the software 
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also exist to compare different ROC curves based on their difference of area 
(http://www.medcalc.org/manual/comparison_of_roc_curves.php). Upon stepwise 
logistic regression, it is expected that the ROC curves associated to successive significant 
improvement of the maximum likelihood ratio by addition of new variables would also 
bring significant changes of the ROC area. As we will see in the next chapters, it may 
occur that the two tests differ because they are based on different concepts. 
 
 
3.  Survival analysis and Cox regression model 
 
Survival analysis is generally defined as a set of methods for analyzing data where the 
outcome is the time elapsed until the occurrence of an event of interest.  The Cox model 
is a statistical technique for exploring the relationship between the temporal evolution of 
the proportion of surviving subjects and several explanatory variables whose values are 
distributed among the subjects [149].  
 
Consider S(t), the survival curve giving the proportion of subject for which the event has 
not yet occurs at time t. The hazard function is defined as: 
 
)(
)(
tS
dt
dS
th −=  
The proportional hazard Cox model postulates that the hazard function with a set of 
variable X=[x1,…,xn] is expressed as: 

=
i
ii x
ethXth
β
)()/( 0  
 
A positive iβ  coefficient means that the hazard increases with xi higher and thus that the 
prognosis is worse. 
4. Cluster analysis  
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Cluster analysis is a set of techniques to separate a set of subjects in different groups (also 
called cluster) based on some index of similarity. It can be achieved by various 
algorithms that differ in the choice of the index of similarity and the way the index 
calculated between clusters [150].  Since diverse methods has been used in different 
phases of our study, details will be given in the sections where they appear.  
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Chapter 2 Detection, Validation and Time Series 
Building of AEG 
 
The aim of the project is to study how time series extracted from 3-channel atrial unipolar 
electrograms (AEG) can help to predict the onset of AF in post-CABG patients. As seen 
in Figure 2.1, the morphology of the signals is very different from standard ECG. The 
local atrial activations (A) are brief with amplitude most often larger than the deflections 
associated to the far-field ventricular activation (V). Since standard ECG timing methods 
were ineffective, the first task was to develop an automatic and unsupervised algorithm 
(Find AV) to automatically detect and distinguish A and V activations.  To develop the 
algorithm and assess its performance, sets of activation times were required for which 
both the temporal position and the labeling (A or V) of the markers were validated. 
Validation software was elaborated and implemented (Validate AV) for this purpose, 
which was also later used to validate all the results of the automatic timing prior to the 
analysis.  
 
Figure 2. 1 Posterior view of the heart showing the 3 electrodes sutured to the right (S1, 
S2) and left (S3) atrium and their electrograms. The atrial (A) and ventricular activations 
(V) are indicated for three beats, as well as the ventricular T wave (T).  
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Because the electrodes are distributed in the two atriums, their A activations in a cardiac 
beat are not simultaneous. Hence, atrial and ventricular activations of the different 
channels belonging to the same cardiac beat must be grouped together.  Different types of 
events must also be distinguished, such as normal sinus beats, premature atrial or 
ventricular activations, atrial activations that do not reach the ventricles, as well as runs 
of ventricular or atrial arrhythmias. Software for automatic beat formation and labeling 
(Form Beat), complemented by a validation tool (Validate Beat), was also developed.  
The flowchart in Figure 2.2 resumes the different steps of the process leading to the 
activation markers that are needed for the construction of the time series used in the 
analysis. This chapter presents some details on each stage of the processing.  We have 
been associated closely to development of Find AV. We have designed and implemented 
Validate AV, Form Beat and Validate Beat, and have performed most of the validation of 
the data. 
 
                                             
 
Figure 2. 2 Flow chart of building time series from AEG 
 
Validate AV
Form Beat
Recorded Signals
Find AV
Validation  
Software 
Validate Beat
Build Time Series
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2.1 Data Collection 
 
Recordings were made by the team of Dr. Pierre Pagé on patients on which he had 
performed CABG surgery at the Hôpital du Sacré-Coeur de Montreal or at the Institut de 
Cardiologie de Montréal. The protocol was approved by the Ethics Committee of  Hôpital 
du Sacré-Coeur de Montréal. Recordings were made for the first 4 consecutive days 
following CABG using a modified (class III) three-channel Holter digital recorder with 
16 bits encoding, providing  a ± 5 mV input range with 0.16 μ V resolution  (Burdick, 
model 6632). The sampling rate was set at 500 Hz per channel. This setting was chosen 
such that batteries and the storage memory card had to be changed only once every 24 
hours.  Three atrial unipolar electrodes (ETHICON model TPW40) were sutured on the 
epicardium of the atria and connected to the positive poles of the Holter by wires fixed on 
the patient’s thoracic wall. The three negative poles of the Holter were connected 
together to serve as a reference electrode positioned on the lateral side of the thigh.  
 
Then recordings were transferred to a PC for off-line analysis. A short stretch of signal is 
shown in Figure 2.1, in which A and V activations are identified. More than 100 patients 
were recorded. In the course of the project, five different configurations of electrodes 
were used, which are shown in Figure 2.3.  
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Figure 2. 3 The five spatial configurations of unipolar electrodes on the posterior atria. 
LAA: Left Atrial Appendage. RAA: Right Atrial Appendage. LA: Left Atrium. RA: 
Right Atrium. PV: Pulmonary Vein. SVC: Superior Vena Cava. IVC: Inferior Vena 
Cava. 
 
 
The number of patients of the five recording configuration were 49 (I, 35.8%), 6 (II, 
4.4%), 2 (III, 1.5%), 62 (IV, 45.3%) and 18 (V, 13.1%).  All recordings methods have 
one electrode near the sinus node, where the electricity pulse normally initiates and at 
least another close to the pulmonary veins, from where the ectopic beats are known to 
often originate.  All configurations thus allow discriminating whether an ectopic beat was 
produced from the left or right and give similar total conduction times for normal sinus 
beats. 
 
 
2.2 Detection and Classification of Atrial and Ventricular Activations  
 
2.2.1 Detection Challenges 
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AEG recorded both the local A and the far field V activations. Because the positions of 
the electrodes on the atrial epicardium were not the same among the patients and their 
health status were different and varied during the recordings, so the morphology of the 
signals were usually very different between patients, channels and even in time within 
one channel. The challenge of activation detection was further enhanced by the possible 
disproportion of the amplitudes between the channels, the presence of artifacts related to 
the movement of the subjects or to poor contact and polarization of the electrodes, as well 
as bouts of saturation. Some of these difficult circumstances are illustrated in Figure 2.4.  
                   
 
Figure 2. 4 Four example of difficulties encountered in the detection process: A) Holter 
device saturation, B) Baseline wandering, C) Noise in signal, D) Disproportion within 
and between channels.  
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Assuming a normal heart rate of 75 beats/min, the analysis of the recordings necessitates 
the determination of 27,000 markers/hr (60 min/h * 75 b/min* 3 channels * 2 markers (A, 
V)/beat), which made mandatory the development of a reliable automatic and 
unsupervised method of A and V timing and discrimination. 
 
2.2.2 A and V Detection and Discrimination 
 
The detection of algorithm was developed using a validated test set of ~46,000 markers 
from 19 patients, and its final performance assessed from ~1.6 millions validated markers 
coming from 27 patients. In this section, we only describe the main original features of 
the method whose flowchart is presented in Figure 2.5. For more details, the reader is 
referred to the article “Automatic detection and classification of human epicardial atrial 
unipolar electrograms” [151] included in Annexe II. 
 
The detection of the activations was done on a pseudo-energy computed from the square 
of the derivative of the signals, a quantity commonly used for ECG processing [152, 
153]. A global energy, constructed by adding the energy of the three channels, was used 
to identify the A or V global events and set their limits. Afterward, activations of the 
individual channels were located by analyzing their own energy within these limits. 
Ideally, each local and global event should be associated with an isolated bell-shaped 
peak of the energy functions, such as shown in Figure 2.6. To reach this result, the 
energies must be computed as a moving average to remove the notches associated with 
the zero-crossing of the derivatives and obtain a function whose amplitude remains high 
during the activation. Optimal averaging windows were determined, specific to the global 
and individual channel energy (given by eq. 2, 3, 4, 5 in paper). This was the first 
specificity of the method. 
 
A second originality of the method was the pre-processing of the derivatives prior to the 
computation of the energy. Two sample-by-sample functions were computed from the 
raw signal to quantify saturation and baseline wandering (QoSSat in flowchart), as well as 
the local high frequency noise content (QoS35). QoSSat was convoluted with the 
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derivative, while QoS35 triggers conditional low-pass filtering of the derivative along 
noisy segments.  Another function (QoSart), which provided a sample-by-sample measure 
of the density of the low frequency fluctuations, was used to adjust the threshold of 
detection. 
 
Typically, high energy events corresponding to A activations are followed by lower 
energy V events. The detection of the Global events relied on a two-step process. In the 
first step, an adaptive sample-by-sample threshold function was constructed from the 
distribution of the minima and maxima of the global energy in an interval around each 
point. Once high amplitude events had been detected using this threshold function 
(energy > threshold for at least 40 ms), the energy was blanked in the intervals associated 
to each global event, and detection was repeated with a new threshold function whose 
computation also took into account the density of low frequency fluctuations measured 
by QoSart (See Figure 2.6). The dual detection process, involving time-varying adapting 
threshold, was another original feature of the method. 
 
The detection of global events and their temporal delineation was followed by the 
detection of the events in each individual channel. Within the time limit of each global 
event, the threshold was fixed to a fraction of the maximum energy of each channel, 
which depended on the type of global detection (first or second pass) associated to the 
interval and on the local density of fluctuation (i.e. QoSart). At the end of this step of the 
processing, there was a sequence of temporally delineated global events, each associated 
with local events detected on the individual channels. 
 
The last innovative aspect of the algorithm was the method to discriminate A from V 
events. Because A activations corresponded to sharp deflections produced by the 
travelling of activation fronts beneath the electrodes, they usually had higher frequency 
content than the far-field V events.  The discrimination was based on the comparison of 
the energy computed from the [6, 90] (I90) and [6, 25] (I25) Hz band-pass filtered 
derivatives. The I25/I90 ratio is usually lower for A than V events (See Figure 2.7). The 
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ratio discriminating threshold was based on a moving average of the ratio computed from 
event to event (See Figure 2.8).  
 
Similar rules were applied for both global and individual channel events, based on the 
global or channel energy respectively. The final diagnosis (A or V) of the global and 
associated local events was completed with test of coherence over their labels. Finally, 
the temporal markers of local events, which would be needed to build the time series to 
be analyzed, were put at the location where the cumulative energy within the limits of an 
event reaches 50%. 
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Figure 2. 5 Detection and labelling algorithm (From the paper [151] with permission of 
the editor). The acronyms in the figure refer to variables that are defined in the paper 
presented in Annexe I.  
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Figure 2. 6 Detection of global activations (step 8).a) Original signals S1, S2, and S3. The 
horizontal lines show the extent of the global activations, from their onset (TPeakon) and 
to their offset (TPeakoff). b) Pass 1: events are segments with E90g ≥  Thresh1 (gray line) 
for at least 40 ms, from Tacton(*) to Tactoff (o). The upper dash line maxE1 is the maximum 
of energy used to calculate the threshold (line labelled Thresh1). TPeakon and TPeakoff, 
used to delineate the extent of the global in panel A, are the first minimum before Tacton 
and after Tactoff respectively.  Each event is removed and replaced by a 3 samples pivot 
with an amplitude = 5% of energy at Tacton. If the limits of two events are separated by 
less than 50ms, as the two events in the middle of the panel, a pivot in inserted in the 
middle, with an amplitude = 50% of energy at the first Tacton. c) Pass 2: The residual E90g 
is analyzed as in Pass 1, with the new threshold Thresh2 (gray line), calculated from the 
updated maxE2 function (upper dash line, Eq. 2.8) (from the paper [151] with permission 
of the editor) 
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Figure 2. 7 Eg90 (continuous line) and Eg25 (dash line).I90 and I25 are the integral on a 
±40ms interval around the maximum of E90 and E25 respectively. The ratio R=100 I25/ 
I90 is used to calculate the threshold to discriminate A and V events. (From the paper 
[151] with permission of the editor) 
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Figure 2. 8 Detection and identification in a sequence containing a salvo of atrial 
premature activations. a) Discriminating function (continuous line, DF) and of a sequence 
of R ratio (described in Figure 2.7) for global events, showing discrimination of A (under 
DF) and V (over DF). When an activation is missed (3 V in that example), DF, which 
also depends on past values, maintains the discrimination. b) The DF function for channel 
S2 shown in the panel c. Even if one V is detected after 4 successive A, the discrimination 
is maintained.  c)  A and V detection and discrimination for a salvo of premature atrial 
activation (PAA) whose energy was highly depressed.  All the PAA’s were correctly 
detected and labelled as A, even when much depressed as in channel S3 (only 2 channel 
shown for clarity).  In S2, the first fusion beat was detected, but the depressed A was 
labelled as a possible V.  In S3, the three fusion beats were labelled as A (from the paper 
[151] with permission of the editor) 
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2.2.3 Detection Results 
 
As described in the Annexe, the final algorithm was tested on a set of 1,593,697 validated 
activations that were also classified as normal A or V activations (A, V) or premature 
atrial or ventricular activations. (PAA, PVA). These were from 2-hours recordings from 
29 patients taken just before the onset of their first prolonged (> 30 min) AF. They were 
selected because it was a moment where the heart rhythm was known to become more 
irregular, and where activation would be more difficult to detect. 99.92% of the 
activations were detected, and among these, 99.91% of the A and 99.75% of the V 
activations were correctly labeled. In the subset of the 39705 PAA, 99.85% were detected 
and 99.21% were correctly classified as A. The false positive rate was 0.34%. The 
detailed results can be found in Table 1 and 2 of the article in the Annexe. In summary, 
an automatic and unsupervised detection and labeling method had been successfully 
developed. 
 
2.3 Validation 
 
The timing software provided a list of global events with their temporal limits, and the 
temporal location of the activations detected on each channel within the limits of each 
global. The global events were labeled as A or V if the global and all markers of the three 
channels received the same label (A or V). The global could also be classified as mixed 
when there were discrepancies between the global and some local labels.  The Validate 
AV software permitted to change, delete or add makers on selected channels, to correct or 
modify their labels including the addition of new labels (such as premature atrial or 
ventricular activation, PAA, PVA, or other user defined categories). It also allowed to 
suppress existing global activations, to modify their limits and/or labels, to merge global 
activations (e.g. when delayed atrial activation in one channel ended up in a separate 
global), or create new global activations with specific user defined signatures (e.g. stretch 
of signal associated to atrial flutter, AF, or other atrial or ventricular arrhythmias).  
 
The basic functions of the software are: 
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1. Location of dubious global or local markers for manual editing. 
2. Deletion, repositioning or relabeling of activations based on waveform analysis; 
3. New timing also based on waveform analysis. 
 
Herein, we just describe the main features of the software. Details were given in a user 
manual and it is available at the Sacré-Coeur hospital research center. The software was 
written in Matlab (MathWorks Inc). 
 
2.3.1 Selection of the Interval to Validate 
 
The choice of markers or intervals to validate is based on the examination of time series 
computed from individual channels or global activations. For individual channels, the 
user can display AA, VV, AV and VA time series, (i.e. time between successive A and/or 
V markers). For global activations, these time series, calculated from the mean values of 
the markers within each global, are also available. Panels showing the sequence of the 
type of global activations (A, V or Mixed) and of the number of activations within these 
global events can also be selected. Any number of these time series can be displayed in 
the main or supplementary panels (see Figure 2.9). 
 
To help locating problematic intervals, points lying beyond two standard deviations of 
the mean value are highlighted by red dots. Clicking on a position in any of these panels 
display the three channels over an adaptable interval centered on the selected location. 
Beside, the chosen location is indicated in all panels. As seen in Figure 2.9, the signals, 
the positions and labels of each marker, as well as the extent and label of each global 
appear in the main panel.  
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Figure 2. 9 Principal interface of the validation software. The upper panel shows the 
tendencies, in this case AA of an electrode. Lines showing the mean value ± 2 standard 
deviations are displayed and outliers are highlighted by red dots. The orange heart shape 
dot indicated the position that is selected for examination. The lower panel shows the 
signal of three channels, the A and V markers, and the extent and labels of the global (A 
red, V green) in an adjustable interval around the location selected in the upper panel. 
The operation control menus and buttons appear on the right of the figure.  
 
 
 
2.3.2 Correction of Individual Local or Global Event 
 
Once a problematic detection area has been identified, the following functions are 
available: Change the signature of the local or global markers, remove or add markers.  It 
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is also possible to define new global events bringing together new and/or existing 
markers. All displayed time series are immediately updated after any modification. As 
shown in Figure 2.10, global events can receive labels such as atrial fibrillation, atrial 
flutter and ventricular tachycardia. For these, two distinct global events are necessarily 
given the same label, to locate the beginning and end of the arrhythmia. The same 
method is used to delineate intervals where the quality of the signals does not allow 
reliable detections.  
 
Figure 2.10 The context menu serves to remove or to change the label of the markers or 
modify their location. B) Pop-up menu for adding a marker. 
 
 
2.3.3 Template Matching  
 
Template matching, another option allows a waveform analysis of all or a few types of 
markers from a channel in a preselected time interval. The user first chooses the duration 
of the signal around each marker to be included in the waveform. The intervals preceding 
and following the markers are set independently. Afterwards, cluster analysis is 
performed on the waveforms using criteria that are described in the next section. At the 
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end of the process, the reference waveform and the number of member of each cluster are 
reported (See Figure 2.11). From there, all the markers belonging to a specific cluster can 
be deleted or relabeled. Any cluster can also be selected for further processing. The 
position of the marker in the template can be changed, which is applied to all members of 
the cluster. If the waveform is chosen long enough, other markers can also appear in 
some or all members of  the cluster (e.g. V before or after waveform driven  by A 
activation, see Figure 2.11). These secondary markers can be removed, added, or 
relabeled, and then such modification can be applied to all events in the cluster. 
 
 
Figure 2. 11 Classification in selected time interval and pop-up menu providing choices 
for group modification of the attributes of markers in a cluster.  
 
2.3.4 Classification Algorithm 
 
The classification theory has been much developed in the past thirty years with the 
introduction of artificial neural networks and advanced signal and image processing 
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methods. Several algorithms have been proposed for classification of ECG beats and 
reported results that left room for improvement. [154-168]. One major problem is the 
wide variations in the morphologies of ECG waveforms within and among patients. For 
example, an ECG beats classifier which performs well for a given training database often 
fails miserably when presented with different patient’s ECG. Such an inconsistency is a 
major hurdle preventing fully automated ECG processing systems to be widely used 
clinically. Our classification method is very general and fast implementing, based on 
template matching.   
 
Cluster analysis requires a measure of distance between the objects to be compared, and a 
rule to group together objects considered as similar [169]. In our case, the objects are N-
samples waveforms ( { }NxX i ,1== ), corresponding stretches of signal around the 
markers selected for analysis. We use two measures of distance between waveform X and 
Y. 
 
1. Pearson’s correlation coefficient 
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Statisticians in medical data analysis generally refer to a correlation close to zero as 
indicating ‘no correlation’, a correlation between 0 and 0.3 as ‘weak’, a correlation 
between 0.3 to 0.6 as ‘moderate’, a correlation between 0.6 and 1.0 as ‘strong’, and a 
correlation of 1.0 as ‘perfect’ [170]. In our program, the value for clustering can be 
selected by the user, but is set at a default value of 0.8. This measure is independent of 
the baseline and amplitude of the signals. 
 
2. Minimum distance 
 
  
  45 
Alternatively, the Euclidean distance 
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is also often used in pattern classification. We have implemented a variant that has been 
used in ECG classification[171]. It started by setting a threshold 0θ >  to define 
  θ+= XXX 1:1   
                                                        θ−= XXX 2:2                                               (2.3) 
 The choice of θ is done through an interactive panel (See Figure 2.12) on which the first 
waveform to analyze is displayed. 
 
Then, Y belongs to the same class X if   
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      Note that the vector taken as a reference does not matter since ( ) ( )21 ,, YXDYXD EE =  
and ( ) ( )12 ,, YXDYXD EE = .  
  
Classification:  
Considering a set of waveforms { }NXXX ,,, 21  , the algorithm of the classification 
proceeds as follow: Choose the metric to compare waveforms (correlation and/or 
distance), and set the required threshold (rthr and/or θ ). If both metrics are selected, a 
waveform will be included in a cluster as soon as one of the criteria is satisfied. 
1.  Set the reference waveform Z1=X1; 
2. Calculate r(Z1, X2) and/or DE(Z1, X2). If the criterion on r or DE is met, put X2 in 
cluster Z1. Otherwise, create a new cluster with Z2=X2;  
Then for Xi=2,N 
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3. Apply step 2 to Xi using the reference waveform of each existing cluster Z1 to ZK 
and stopping the search as soon as the clustering criterion is fulfill. Otherwise create a 
new cluster ZK+1 with reference waveform Xi; 
4. Sort the order of the existing clusters according to their number of member, and 
their order of creation for ties. 
 
More complex algorithms could have been implemented. However, we kept this simple 
cluster-seeking algorithm because it ends up being very efficient in our context of 
validation. Figure 2.12, is an example of a first reference waveform, which is used to set 
the clustering criteriaθ . Figure 2.13 shows the reference waveforms of the cluster found 
in a stretch of signal.   
 
Figure 2. 12 Signal (blue line) around the position of a selected marker (green), and 
boundaries (red) set by choosingθ . 
 
 
Figure 2. 13 The set of reference waveforms of the clusters. 
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2.3.5 Template Driven Timing 
 
A template driven timing module is also integrated to the Validate AV software. The 
module is based on linear adaptive filtering method [172]. It is used to localize the 
segments of the signal that are similar to the template. Any stretch H(n) of the signal X 
can be picked a template.  Then H is convoluted with the portion of X selected for 
analysis to produce a new function Z (Figure 2.14). 
                          
Figure 2. 14 Adaptive filtering method XHZ *=  
 
Figure 2.14 shows an example where an atrial activation was chosen as template from a 
signal X (Figure 2.16), to produce the output Z (Figure 2.17). Then a threshold can be 
selected to detect activation similar to H.                  
 
 
Figure 2. 15 One atrial activation chosen as the filter (template H) 
 
H (n) 
(template) 
     X Z 
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Figure 2. 16 The signal X as input of filtering 
 
 
Figure 2. 17 The output of the convolution of H with X. Maximum beyond an adjustable 
threshold (red hatched line) localizes the position of similar waveform to H in X 
 
2.4 Beat Formation 
 
Once local and global activations are validated, the final processing step is to form beats, 
in which atrial and ventricular events belonging to the same cardiac cycle are linked 
together, and where final identification are given to all events.  The analysis is performed 
on successive frames of five minutes.  This is done because, as explained below, 
premature activations are identified with reference to the mean atrial frequencies, which 
needed to be updated.   The procedure is as follows: 
 
1. For each global ventricular activation, search for the closest immediate (i.e. 
without any other intercalated event) global atrial activation. The search is done in 
5 sec. windows both before and after the ventricular global, allowing for the 
detection of retrograde activation of the auricles by premature ventricular 
activation.  
2. For all the couples formed at step 1, calculate the absolute value of the time 
distances between the V and the associated atrial activation (DAV, Figure 2.18), 
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build the DAV cumulative distribution, and remove the first and last deciles of the 
distribution before computing the mean value (MDAV). The distribution is 
truncated to get rid of possible outliers. 
3. Couples in which DAV ≤  3*MDAV are joined together and define events which are 
consider as AV cardiac beats. All other global are considered as isolated events.  
4.  From AV consecutive cardiac beats, get the time series of coupling times AA 
(difference between the time of the first atrial activation in each beat, most often 
A1A1, as in Figure 2.19). 
5. For beats in which the atrial activations precede the ventricular activation (as in 
Figure 2.18), extract the atrial firing order of the three channels and identify the 
most frequent order, which corresponds to that of  normal sinus beats. Calculate 
the mean coupling time (MeanAAref) from consecutive beats of this class. 
6. Finally, each beat or isolated global is labeled as: 
i) SNAC(Sinus normal activation): beats formed by an atrial global followed 
by a ventricular global for which the atrial firing order belongs to the most  
frequent group and AA ≥  0.7* MeanAAref; 
ii) PAA (Premature Atrial Activation): beats formed by an atrial global 
followed by a ventricular global for which the atrial firing order is not the 
most  frequent   and/or AA<0.7 MeanAAref; 
iii) PVC (premature ventricular conduction): beats formed by an ventricular 
global followed by an atrial global; 
iv) BA/BV (Blocked atrial/ventricular conduction): isolated atrial or ventricular 
activation; 
v) ARE (atrial retrograde conduction): isolated mixed global, holding both 
atrial and ventricular activations;  
vi) VT (ventricular tachycardia), AF (atrial fibrillation), AFL (atrial flutter), 
SATUE (invalid interval): as described in section 2.3.2, the beginning and 
end of these kinds of intervals are labeled by the user in the validation step. 
All global activations between these limits are then put together to define 
either an invalid or arrhythmia episode.   
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Figure 2. 18 Intra-Atrial conduction time (CTA), atrial firing order, an atrio-ventricular 
conduction time (CTAV) 
 
 
Figure 2. 19 AA intervals of two consecutive beats with the same order of atrial firing 
 
2.5 Validate Beat  
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As for global and local activations, the results of the Form Beat software have to be 
validated. This is done by the module Validate Beat that offers five main functions 
(Figure 2.20): 
 
Figure 2. 20 The main menu of Validate Beat. 
1. Demo Beat: the information of any particular beat can be displayed and edited. as 
shown in Figure 2.21; 
 
Figure 2. 21 Indices of a beat, which can be edited. 
 
2.  Change Beat Type  
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Figure 2. 22 Interactive panel to perform beat modification. 
 
3.   Detach Beat:   uncombined global activations linked in a beat or arrhythmia, such that 
they become available for the formation of new events; 
4.  Combine Beat: combine two consecutive events into one beat;  
5. Reset Children: reset the beat information if the local markers or global markers 
information has been modified;  
6.  Delete Beat: delete the existing beats if local or global markers have been deleted; 
 
Actions 2 to 6 can be performed in an interactive panel shown in Figure 2.22. Figure 2.23 
shows an example a final validated sequence of events.  
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Figure 2. 23 After detection and validation, the activations of three channels are grouped 
into beats with a label corresponding to their type (Normal sinus beat, PAA…) 
 
2.6 Beat Time Series Building 
 
Different time series were built from the validated markers and events. The following 
section provides a definition of the variables and how they are computed. 
  
1. PAA(premature atrial activation) related measures 
 
The origin (left or right, LPPA, RPAA) of the PAA is set by the location of the first 
activated channel in the beat. 
 
PAA  Rate: The total ( PAAR ), left (
L
PAAR ) and right (
R
PAAR ) rate: number of PAA occurring 
in a reference period (e.g. 5 minutes) divided by the time without atrial and ventricular 
arrhythmia during the reference period. 
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 PAA proportion ( PAAP ,
L
PAAP , 
R
PAAP ):  corrected number of PAA in a reference period 
(CNi= rate in the i’th period* duration of the period) divided by CNT, the sum of the CNi. 
Anova was performed on the Freeman-Tukey arc-sine transformed proportion [173] 
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Besides, in the few instances where the total number of Right PAA was zero, RPAAP  was 
set to sin2 (F-T ( RPAAP )=0); 
 
LPAA Fraction (LPAAFraction): the number of LPAA in the reference period divided the 
total number of PAA in the period.  Anova was also performed using the Freeman-Tukey 
transformed fraction. When the total number of PAA was 0, then LPAAFraction was set 
as 0.5.  
 
2. Sinus atrial rhythm related measures 
 
In events defined as normal sinus beats, the first atrial activation always occurs in the 
same channel, which is used to calculated AA (ms), the time interval between successive 
normal sinus beats. The following measures are also computed in each reference time 
interval (most often, 5 minutes): 
Mean ( AAMean ) and Standard deviation of AA ( AAStd ); 
rMSSD : Root mean square of difference between successive AA ; 
50pNN : Proportion of successive AA  with a difference > 50ms; 
 
3. PAA prematurity 
 
Two measure of PAA prematurity are used in the analysis 
 
Premabs, the absolute prematurity:  the time from the previous activation to the premature 
activation calculated from the electrode first activated in the PAA. 
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Premrel,, the relative prematurity: Premabs divided by the mean AA interval of the normal 
sinus beats in the minute before the PAA. 
 
4. Premature ventricle activation (PVA) related measured. 
 
PVA rate ( PVAR ): The total number of PVA in the reference period of time (e.g. 5 
minutes) divided by the duration of the interval without of atrial or ventricular 
arrhythmia;  
 
 
5. Arrhythmia Duration( ionArrhyDurat ) 
 
ionArrhyDurat : Duration of all arrhythmias during in each reference period. An episode 
of arrhythmia was considered to occur when there was more than 3 consecutive atrial or 
ventricular ectopic beats. In these cases, the first ectopic beat was kept as a PAA or PVC, 
while the other was joined in an arrhythmia.   
 
6. Intra-atrial conduction time ( CTA ) related measures 
 
For all events, CTA  is computed as the time between the first and last atrial activation. 
Then, the Mean ( CTAMean ) and standard deviation ( CTAStd ) are computed from 
normal sinus beats in each reference time interval. 
 
7. AV node conduction time (CTAV ) 
 
Atrio-ventricular conduction time (CTAV , ms) correspond to the time elapsed between 
the last atrial activation and the following ventricular activation within each beat. Then, 
the mean (CTAVMean ) and standard deviation (CTAVStd ) of CTAV are computed from 
normal sinus beats in each reference time interval. 
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8. Local derivative ( dt
dv ) 
dt
dv  (mV/ms): the maximum slopes of negative deflections of each atrial activation ( 
dt
dv−max  ); 
 
9. CANS (Cardiac Autonomic Nervous System) measures from spectral analysis of AA 
 
Five minutes AA time series of normal sinus beats were analyzed by Fast Fourier 
transformation (FFT).  All events different from normal sinus beats were excluded, as 
well as normal sinus beats immediately following a PAA. The resulting time series was 
interpolated with a fixed time step of 1 second and convoluted with a Hamming window 
[174]. Then following a common rule, the power contained in low (LF: 0.04-0.15) and 
high frequency (HF: 0.15-0.40 Hz) was computed [175-178].  The following quantities 
were considered: 
 
Low Frequency (LF) component: The summation of low-frequency spectrum ( LF :0.04-
0.15 HZ);   
High Frequency (HF) component: The summation of high-frequency spectrum 
( HF :0.15-0.4 HZ). 
LF Portion:  LF/ (LF+HF); 
HF Portion: HF/ (LF+HF);  
LF HF Ratio: LF/HF.   
 
10. Correlation of conduction time series 
 
The following Pearson correlation of normal sinus beats time series were built within 
each five-minute interval:  
 
AVCorrAA_ : Correlation of AA  series and CTAV series; 
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CTACorrAA_ : Correlation of AA  series and CTA series; 
 
CTACorrAV _ : Correlation of AV  series and CTA series. 
 
2.7 Discussion 
 
2.7.1 Recording  
 
Although methods were devised to continuously monitor the noise level of the signals in 
order to activate conditional filtering and adjust the detection thresholds, a few recordings 
had to be excluded because the quality was too poor to provide reliable time series.  
Different configurations of electrodes were used. Although their sequence of activations 
in a beat differed, all of them allowed to decide whether ectopic beats were originating 
from the left or right atrium and provided similar measure of atrial and atrio-ventricular 
conduction times for normal sinus beats. Because the number and position of the 
electrodes in the left atrium was changed, the measure of the prematurity of left atrium 
premature activation was probably the variable that could be the most affected by the 
change of configuration. It is acknowledged that would have been more appropriate to get 
data from a single recording configuration. Nevertheless, we decided to keep and analyze 
all patients together because of the limited number of subjects, especially among patients 
with episodes of AF.   
 
 
 
2.7.2 Detection 
 
The final performance of the detection algorithm was assessed using more than 1.5 
million validated markers taken in the 2 hours before the onset of a prolonged AF, a 
period that most often encloses complex rhythms. The problem of detection and labelling 
in our project was somewhat similar to that encountered in the analysis of signals 
recorded by ICD or pacemaker, i.e., to capture activations during atrial ectopy, 
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tachycardia, and fibrillation and avoid false detections caused by noise or far-field R-
waves (FFRW).  The top panel of Figure 2.24 is an example where the plot of activation 
amplitude versus dV/dtmin shows a continuous spectrum, thus invalidating separation by 
clustering. In the bottom panel of Figure 2.24, PAA and V activations fall in between two 
separated clusters of atrial activations. In both cases, our method based on energy 
frequency content was able to correctly label most of the activations.  
 
 
Figure 2. 24 Dispersion of the activations Amplitude vs. dV/dtmin from two channels from 
different patients. All activations from 2hr recording prior to AF onset are shown:  A (red 
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dot), V (blue circle) and PAA (green dot), PAC (black star). Top panel: the distribution 
forms a continuous cluster, with PAA spread between A and V. Bottom panel:  PAA and 
V are in a cluster between two separated clusters of A.  
 
Another study proposed to use A and V wave templates to detect and label the activations 
[179]. However, this study ignored highly changing conditions and inter-individual 
variability, as well as the complex rhythms that frequently arise just before AF. That 
makes the template approach less appropriate for our work.  
 
The problem of faulty detections due to noise was handled by continuous monitoring of 
the quality of the signal to guide local filtering and threshold adjustment. The signal was 
also blanked during episodes of saturation and clipped to equilibrate the amplitude of the 
different channels. This brought an improvement of the false positive and false negative 
detections by a factor 4 and 3.5 respectively. The parameters adjusting the threshold as a 
function of the quality of the signals were optimized   to detect PAA and PVC even at the 
expense of some false positive. These can also be adjusted for other requirements or 
different types of signals.  
 
2.7.3 Validation software 
 
The development of the validation software (Validate AV) was mandatory to obtain both 
the training and evaluation sets of A and V activations needed for the development and 
assessment of the automatic timing algorithm. Beside, much emphasis was put on 
strengthening the method to detect PAA and PVC that firstly had to be authenticated 
manually. After the development of the algorithm, validation was still needed to correct 
missed or mistaken global or local activations and defined episodes of arrhythmia prior to 
the analyses. Along with the progress of the project, new functions were added, such as 
the automatic formation and labeling of beats, as well as associated tools of validation. 
The final result is user-friendly interactive software specifically adapted for multichannel 
AEG analysis, with no commercial equivalent. It is acknowledged that the final manual 
validation of the activation times, beats and beats types is to some extent operator 
dependent, which may have so impact on the reproducibility of the resulting time series. 
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To reduce the inter- and intra-user differences, a proper training of the validation 
software is strongly suggested.  The optimal method which will compare the results 
obtained by different users to reach a consensus would be too much time-consuming.   
 
The classification module is an important part of validation software. Diverse methods of 
ECG analysis have been proposed, based on artificial neural networks or signal 
processing methods [153, 159, 161, 162]. Classification is usually performed by feature 
extraction from raw data waveforms, or from compressed waveforms constructed by 
principal component analysis [180, 181], independent component analysis [182], or 
wavelet analysis [183-185]. Class formation then relies on some measure of similarity. 
Since the markers of activation were already available, we found that the option to define 
the extent of the waveform both before and after the markers very useful for analysis and 
classification.  Our clustering method, using either correlation coefficient or minimum 
distance without prior processing, was at once simple, fast and reliable. 
 
The initial purpose of the classification module was to validate the identification of A or 
V activations.  Then the module was strengthened to validate the detection of cardiac 
beats.  In addition, once the templates of the classes were defined, they could be used to 
delete, move, positioned or label any number of markers simultaneously for all events 
belonging to a chosen cluster.  This much improved the efficiency and the speed of the 
validation process especially in time periods enclosing many of detection errors.  
 
The grouping of neighboring global atrial and ventricular activations within cardiac beats 
was based on the computation of the mean CTAV  over 80% of the adjacent pairs in each 
five minutes period. Even for normal sinus beats,   CTAV  was found to range from 50 to 
100 ms among different time interval and patients. Finally, we have chosen 3 times the 
mean CTAV as an upper bound for beat formation. This criterion was appropriate for 
most beats, except during arrhythmia episodes such as atrial fibrillation, atrial flutter and 
ventricular tachycardia. In these types of episodes, especially with long lasting time, 
CTAV could become very irregular, with complex and even asynchronous A-to-V or V-
to-A activations ratio. This is why all intervals of arrhythmia were defined manually. The 
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automatic detection of atrial retrograde activation was also often difficult. For activations 
presumably starting in the Hiss or Purkinje system, some atrial activations were often 
close or even within the ventricular activation, such that they could be included in the 
same mixed global event. Sometimes, the waveform of atrial retrograde looked like 
premature ventricular activation. The morphology of atrial retrograde beats also 
frequently varied from beat to beat and channel to channel.  
 
The detection and identification of PAA was imperative because of their suspected 
relation with the occurrence of AF. The detection was maximized by the two-step process 
of detection, both with moving threshold. They were identified by either their prematurity 
or their firing sequence with respect to the normal sinus beats. They were assumed to 
originate from the atria where the first activated channel was located. Obviously, this 
remains an approximation since the time for the activation front to reach an electrode is 
not only related to its distance from the ectopic focus, but also depends on the conduction 
speed and the conduction path.  
 
2.7.4 Time Series Building 
 
 Our basic hypothesis was that the onset of AF could be linked to the distribution and 
prematurity of PAA, as well as to the presence of a proarrhythmic substratum. Therefore, 
variables related to these two factors were computed. Some were used to typify each 
PAA: localization, prematurity, intra atrial and atrio-ventricular conduction times, dv/dt 
of the first activated channel. Others were considered to characterize the state of the 
substratum: density of PAA, PVC and duration of transient arrhythmia; diverse measures 
computed during normal sinus rhythm. 
 
The use of AEG gives access to information that is difficult or impossible to obtain from 
ECG.  The value of local derivative ( dt
dv
) associated to each atrial activation, which is 
related to the local pulse propagation velocity, provides a measure of the local excitability 
of the tissue. The atrial firing sequence permits at least a partial identification of the 
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location of the ectopic focus, which would have been difficult to be known from three 
channels ECG Holter recordings. The intra-atrium conduction time (CTA ), although it 
does not correspond to the full time needed for the front to cover both atria, is a more 
reliable and stable measure that the duration of P wave which is often difficult to evaluate 
from the low amplitude  ECG. This is also true for AA and CTAV. 
 
Both sympathetic and parasympathetic stimulation can shorter refractory period of action 
potential of the cardiac myocytes, possibly causing substrate conduction inhomogeneous 
property and then facilitating electricity reentry. AA LF and HF power components 
obtained by FFT analysis were analyzed both in absolute and normalized units. The 
LF/HF ration has been proposed to be an index of sympathovagal balance. The dynamics 
of autonomic nervous system tone can be studied to find if imbalance occurs before the 
occurrence of AF.  
 
Neural modulation can produce changes in AA ,CTA ,CTAV time series. The correlation 
between these time series might provide some measure of the state of cardiac autonomic 
nervous system, complementary to those provide by the spectral analysis of the AA.  
Since the cardiac autonomic nervous system feeds the sinus node, the auricles and the 
AV node, positive or negative correlation between any of these time series might indicate 
either an imbalance or concordance of the autonomic input between these structures 
and/or a dominance of the rhythm dependent properties in the atrial tissue or AV node.  
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2.8 Summary 
 
1. An automatic algorithm to detect and identify complex AEG signals was presented. The 
algorithm was unique, robust, and gave results at a high level, and solved the prerequisite 
problem of our study with good performance. 
 
2. Validation software was designed to validate the AV detection results, form beats and 
validate beats. It provided an intuitive tool to investigate the signal and tendencies of 
conduction time series, to validate the detect markers and form beats. The embedded 
functions in the software also allowed unsupervised classification to automatically 
modify markers and beats. These strengthened the validation performance of the 
software.  
 
3. Time series were built for the purpose of identifying predictors of postoperative atrial 
fibrillation.  
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Chapter 3 Analysis of Premature Atrial Activation and 
Time Analysis before Onset of AF 
 
This chapter studies the temporal evolution of various indices before to first protracted 
episode of AF (> 10 minutes [101]). If there is no significant change prior to the onset of 
AF, it would be useless to monitor the patients to detect impending AF.  
 
It is generally acknowledged most AF are preceded by premature atrial activations (PAA) 
that frequently originate from the pulmonary vein [62, 186-188]. Waktare et al. have 
shown an increase of ectopic activity before the onset of paroxysmal AF [189, 190]. 
Increasing frequency of supraventricular ectopic beats and of ‘warning’ short transient 
atrial arrhythmias also occur before the onset of postoperative AF [186, 187]. It was thus 
mandatory to first examine if there was an increased incidence of PAA close to the onset 
of AF. 
 
In many patients in our study, a large number of PAAs were recorded all over the two 
hours before the AF. Although PAAs preceded the onset of AF, the occurrence of PAA 
was not bound to trigger an episode of AF.  J. M. Leung has proposed that impairment of 
left atrial function is an important risk factor of post-operative AF [96].   More generally, 
patients developing AF are speculated to have heterogeneous spatial distribution of 
excitability and repolarization [7, 191-193]. This raises the possibility that substrate 
properties may evolve toward a state that facilitates the incidence of AF.  The analysis 
presents both univariate and multivariate analyses of the temporal evolution of indicators 
of the state of the atrial tissue, while the last section examines if the triggering PAAs that 
occur just before the onset of AF are endowed with specific properties. 
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Initially, the choice to analyze the two hours before the onset of AF was guided by 
previous studies in which the same period was considered [33, 136].  We decided that, at 
the end of the analysis of AF patients, this period would be considered appropriate if 
significant changes were found between some periods close to the AF onset and the 
others, while in the further periods the time series could be considered as constant. If the 
periods further from the AF had not been diagnosed as constant, we would have extended 
the analysis to a longer time period. As demonstrated in the chapter, we found significant 
changes to occur in the first hour before AF, but none in the second hour. As a 
consequence, the two hours period was used for all analysis. Among the 41 patients with 
AF, 11 patients were excluded because the quality of their signals (such as too much 
noise, or lost of contact by at least one electrode) precluded a complete and reliable 
analysis. Among the 30 remaining patients, there were 24 men (age: 69.9 ±  6.3) and 6 
women (age: 74.6 ±  2.1). 
 
3.1 PAA Analysis 
 
3.1.1 Number of LPAA (Left PAA) vs. RPAA (Right PAA) 
   
All long lasting AF (>10 minutes) episodes were immediately preceded by one or more 
premature atrial activations that originated from the left atrium (LPAA) for 26 patients 
and from the right atrium (RPAA) for 3 patients. For one patient recorded with the second 
configuration described in chapter 2, the origin was ambiguous because the electrode 
positioned in the left atrium was most often activated firstly even in regular rhythm. 
Since many analyses were performed considering PAA either a left or a right PAA, this 
patient was discarded. 
 
The number of LPAA was greater than the number of RPAA for 25/26 of the patients 
whose AF was triggered from the left atrium, and 2/3 of patients triggered from the right 
atrium (Figure 3.1). However, the proportion of LPAA (i.e. LPAA/ LPAA+RPAA) was 
very inhomogeneous.  
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Figure 3.1 Proportion of LPAA (blue) and RPAA (golden) in the second hour before AF 
onset. The abscissa represents the identification (ID) number of the patients in the 
analysis. The ordinate is the proportion of LPAA (blue) and RPAA (gold) among the total 
PAA number within each patient. Patients with ID 1 to 26 and 27 to 29 had their AF 
triggered by PAA from left and right atrium respectively, while the origin of a subset of 
PAA including the trigger was unknown for the patient with ID 30.  Homogeneity of 
proportion was rejected by 2χ  test, using either the mean number (patients 1-29, P 
<0.0001, patients 1-26 P<0.0001) or the mean proportion of left and right PPA (patients 
1-29, P <0.0001, patients 1-26 P<0.0001) as null hypothesis. Both variables were 
examined because of the huge dispersion in the number of PAA among the patients. 
 
The rate of PAA (RPAA = nb. PAA/ minute without arrhythmia) was also highly variable 
among the patients: [RPAA,min  RPAA,median  RPAA,max] = [0.02, 0.7, 37.90/min] in the two 
hours;  [0.03, 0.95, 38.11/min] in last 30 minutes;  [0.2, 2.36, 35.80/min]  in last 5 min 
before AF. 
 
  
  67 
3.1.2 Temporal Trend of PAA and Arrhythmia 
 
Temporal Trend 
  
The temporal evolution of LPPA and RPAA was studied by considering their incidence in 
successive 5 minutes intervals.  Analysis was performed either by considering for each 
patient either the rate within each interval ( RPAA
L
PAA R,R  = number of PAA in 5 minutes/(5 
min-duration of arrhythmias), Figure 3.2 A) or by the proportion of the total 2hr LPAA or 
RPAA in each 5 minute interval ( RPAA
L
PAA P,P  = number of PAA in 5 minutes/ total number 
of  PAA, Figure 3.2 B). Either from the aspect of rate or proportion, LPAA shows an 
increasing trend over the time. Each method has its own drawback, the former being 
driven by the patients with the highest numbers of PAA, while the latter can be distorted 
by patients with a small number of PAA concentrated in a few intervals.  
 
 
Figure 3.2 Mean value and standard deviation of A) PAA Rate ( RPAA
L
PAA R,R , in Panel A) 
and B) PAA Proportion ( RPAA
L
PAA P,P , in Panel B) within each 5 minutes before AF. Left 
atrium: blue line and circle; Right atrium: red line and diamond. 
 
Analysis of the Rates ( RPAA
L
PAA R,R ) 
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Because the temporal trends of  R LPAA and
R
PAAR  were significantly different (Anova 
time*L-R interaction, p=0.001, Huynh-Feldt criteria), they were analyzed separately. 
Only  R LPAA showed a significant time effect (p=0.048, Huynh-Feldt criterion). Post-hoc 
analysis was done using different sets of orthogonal contrasts. The difference between the 
first and second hour was the only significant contrast (p=0.034) and it remained 
significant even after removing the last five minutes. No contrast (linear or other) 
restricted to the last hour, the last 20 or 10 minutes was even close to being statistically 
significant. The non-significance of the  R LPAA linear increase in the second hour may 
seem surprising upon the examination of the Figure 3.2 A.  As explained below, it stems 
from the heterogeneity of the profiles among the patients.  
 
Analysis of Proportion ( RPAA
L
PAA P,P ) 
 
Since  PLPAA and
R
PAAP  both sum to 1, analysis was performed by removing the first 5 
minutes. As mentioned in Chapter 2, all ANOVAs’ on proportions were performed using 
the Freeman-Tukey transformation. Taken together,  PLPAA and
R
PAAP  shows a significant 
time effect, with or without the last five minutes (p=0.003, p=0.045 respectively), but no 
significant left-right difference or interaction. Post-hoc analysis with different sets of 
orthogonal contrasts showed a significant difference between the first and second hour, 
both with and without the last 5 minutes before AF (p<0.001, p=0.003 for both right and 
left taken separately ). Within the last hour, all significant contrasts were a consequence 
of the high increase in the last 5 minutes for  PLPAA as well as
R
PAAP .  
  
Patterns of Temporal Evolution 
 
The analysis of rate and proportion both concluded to an increase of PAA in the last hour 
before AF (left and right for proportion, left only for rate). However, the lack of 
significant contrast within the second hour also suggests that there were different patterns 
of evolution among the patients. The patterns were classified by cluster analysis of the 
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sequences of 5 minutes values in the last hour. The correlation between the mean 
sequence of each cluster was used as a measure of similarity, with a threshold of 0.576 to 
stop the aggregation (threshold corresponding to p=0.05 significance level for sample 
size of 12). Correlation was chosen because it compares the profiles, irrespective of their 
relative amplitudes.  
 
Figure 3.3 A presents the mean profiles  R LPAA  of the clusters obtained from the analysis. 
The largest cluster, gathering 11/29 patients, shows an increase of the PAA rate 
beginning 15 minutes before AF and culminating in the last 5 min. However, the rate of 
the members of this cluster was generally smaller than those of other clusters.  This 
explains why a similar trend was seen in the evolution of the mean proportions (Figure 
3.3) but not in the mean rates (Figure 3.2 A). The other three clusters, for a total of 7 
patients, displayed a sharp rise of the rates from 40 to 30 minutes before AF. Together, 
all these clusters are responsible for the linear trend of the mean rate in Fig 3.2 A. Finally, 
three other patients rather showed a progressive decrease of the PAA rates during last 
hour. The remaining 8 patients, who did not belong to any cluster, had isolated bursts of 
PAA in one or a few intervals. 
 
For  RRPAA , the most important cluster, gathering 9 patients, with another cluster of 3 
patients, showed an abrupt increase of PAA in the last 5 minute. 5 patients in this cluster 
also had a marked increase of  R LPAA in the last 5 minutes. Globally, 19/29 patients 
showed a high rate of RPAA in the last 5 minutes, which may have been preceded by 
bursts in one or a few intervals within the last hour.  The correlation between the profile 
of right and left PAA within either the last hour or half hour was highly variable, being 
beyond 0.5 for only 10 (1hr) or 5 patients (1/2 hour) respectively. 
 
Finally, the rate of PVA was also analyzed. For most patients, there were random 
fluctuations of the rate of PVA within the 2 hours, with only a few patients showing an 
increase before AF. 4 patients had higher rate of PVA than PAA without any significant 
time trend. For these, some PVA may have induced PAA by retrograde propagation. 
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Figure 3.3 Mean patterns associated to the clusters obtained by the analysis of five 
minutes (A)  R LPAA and (B)  R
R
PAA . The number of patient within each cluster is indicated. 
The abscissa axis is the time before the onset of AF (min).  
 
Non-sustained Arrhythmia 
 
As shown in Figure 3.4 A, the duration of transient atrial arrhythmias increased in the last 
30 minutes, with an abrupt rise in the last 5 minutes where it reached a mean duration of 
10.03 seconds. These non-sustained arrhythmias were made of short runs of ectopic 
activations and/or atrial tachycardia. Figure 3.4 B shows the main clusters identified 
using correlation. 23/29 of the patients were in the biggest cluster, presenting an abrupt 
jump of the arrhythmia duration time in the last five minutes, and a minor increase in the 
last 25 minutes. The other patients had burst of arrhythmias distributed in the last hour 
before the onset of AF.   
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Figure 3.4 A) mean and standard deviation of the duration of arrhythmia 
( ionArrhyDurat ) by 5 minutes interval; B) Mean clusters profile of arrhythmia duration.  
 
3.2 Post-hoc Analysis of Raw Data and Position Data 
 
The methods used to analyze the PAA rate and the arrhythmia duration (repeated 
measures ANOVA analysis of values calculated within each 5 minutes, followed by post-
hoc contrasts and finally cluster analysis), were also employed for the other variables. 
These variables were AAMean , AAStd , rMSSD , 50PNN , CTAMean , CTAVMean , 
LF , HF , HFLF , ( )HFLFLF + , AVCorrAA_ , CTACorrAA _ , CTACorrAV _ . 
They were calculated keeping only the sinus beats within each interval. These variables 
were considered as indices of the state of the tissue. The significance of the time effect 
was assessed for the raw data as well as the position data. 
 
As described in Methods, position data were obtained by allocating to each data point of 
a patient its position in the cumulative distribution of the values obtained by this patient. 
Hence, for measures such as AA, CTA or CTAV, the position of each data point was 
obtained from the 2hr time series, and the mean position calculated within each time 
interval. For measures like PAA rate, arrhythmia duration, AAStd (standard deviation) or 
LF (low frequency content of the AA time series), the values were obtained from the raw 
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data within  each five minutes interval, and position was allocated with respect the set of 
24 values obtained from  the two hours. Then, these position data were analyzed like raw 
data.  
 
As seen in Table 3.1, among all indices, only the PAA Rate ( PAAR ), the arrhythmia 
duration, the mean period of sinus rhythm ( AA ), the low frequency proportion of the AA  
variation (LFPortion= LF/(LF+HF) or alternatively LF/HF ratio) had significant 
(P<0.05) or close to significant (P<0.10) time effects for raw and position data. Table 3.2 
shows the results of the post-hoc contrast analysis for these variables. In nearly all 
instances, the significance was higher for position than raw data. 
 
The details of the AA and LF portion last hour evolution are presented in Figure 3.5 and 
Figure 3.6 respectively. The mean AA and the mean position AA showed a slight 
decreasing trend during the last hour (Figure 3.5 A). This heart rate acceleration was 
associated with the largest cluster, including 15/29 patients (Figure 3.5 B, blue line). A 
group of 3 patients oscillated from 680 msec. to 740 msec. in the last hour (red) and a 
cluster of 5 patients displayed a slightly increasing AA (green). In both these clusters, AA 
reached a maximum close to the onset of AF.  The last cluster of 3 patients did not show 
much change (cyan). The other three patients that did not belong to any cluster had 
isolated fluctuations of AA. 
 
The mean and position LFPortion (Figure 3.6 A) exhibited an increasing trend starting 
about 20 minutes before AF and peaking in the last 5 minutes. Despite the complexity of 
the profiles (Figure 3.6 B), three clusters including 17 patients showed a LF portion 
increase (blue, green, red), especially in the last 30 minutes. The other three profiles 
including 9 patients (cyan, yellow, violet) did not show any regular trend. Other 3 
patients did not belong to any cluster and showed sharp and isolated burst of LF increase.  
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Table 3.1 Test within subject effects:  (One-Way Within-Subjects ANOVA) 
 P (raw) P (position) 
PAAR  (PAA Rate) 0.035 0.007 
ionArrhyDurat  (Arrhythmia Duration) 0.030 0.009 
AAMean (AA Mean) 0.002 0.004 
( )HFLFLF +  (LF Portion) 0.025 0.087 
 
Table 3.2 Post-Hoc Analysis of Raw and Position Data of Specific Variables with 
Significant Time-effects in 2-pre AF Hours 
(The upward arrow stands for the increasing trend over the contrasted comparison 
periods, and the downward arrow stands for the decreasing trend over those periods) 
 
 
PAAR  ionArrhyDurat  AAMean  ( )HFLFLF +  
raw position raw position raw position raw position 
[120 60] 
Vs. 
[60 0] 
0.019 
 
0.007 
 
0.016 0.009 0.001 0.024   
[60 30] 
Vs. 
[30 0] 
    0.084    
[30 15] 
Vs. 
[15 0] 
     0.019 0.069 
 
0.026 
 
[10 5] 
Vs. 
[5 0] 
 <0.001 0.010 
 
0.010   0.001 <0.001 
 
 
 
 
  
  74 
 
Figure 3.5 A) evolution of mean of the raw (blue) and position AAMean (red) in the last 
hour before AF. B) Cluster analysis of AAMean during the last hour before AF. Mean 
patterns of the clusters were plotted, and the number of patients associated to each cluster 
is indicated. 
 
 
 
Figure 3. 6 A) evolution of mean of the raw (blue) and position LFPortion (red) in the 
last hour before AF. B) Cluster analysis of LFPortion during the last hour before AF.  
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3.3 Discrimination of Trigger from Non-Trigger Period 
 
In an alternative approach, the power to identify the period close to AF was assessed by 
logistic regression. The analysis was repeated for both raw and position data dividing the 
2 pre-AF hours in equal time periods of  5, 10, 15, 20, 30 and 60 minutes (variables 
analyzed in Sections 3.1 and 3.2). The power of these variables to discriminate the last 
period just before AF (triggering period) from the others (non-triggering periods) was 
assessed using forward conditional stepwise logistic regression (p<.05 entrance criteria).  
The scores of the resulting logistic model were used to build a ROC (Receiver Operating 
Characteristic) curve and select the optimal cut-off point. 
 
 Figure 3.7 shows the classification obtained for five minutes periods. The performance 
was much better with position than raw data although the same variables were selected in 
both cases. Similar results were obtained for all the partitions of the two hours: same 
selection of variables, but superior discrimination with position data.  
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Figure 3.7 Comparison of prediction of the trigger period (last interval before AF) using 
raw variables (A) and position variable (B) for five minutes intervals. Green color box 
stands for true positive, blue for false negative, red for false positive, and white for true 
negative, black for the period with missing values because of insufficient number of sinus 
beats in five minutes. The abscissa is the time from the onset of AF, and the ordinate is 
the patient identity.  
 
The results of the logistic model with the position data for different time divisions are 
shown in Figure 3.8. Panel A gives the variables kept in the model for each time 
partition, the color code indicating whether higher (red) or lower values (green) were 
predictive of the triggering period. Globally, seven variables were selected at least once, 
while PAAR (PAA rate), ionArrhyDurat (Arrhythmia Duration), AAMean (means AA) and 
( )HFLFLF + (LF Portion) were more often present. Globally, the results indicated that 
the onset AF tended to be preceded by an increased number of PAA and transient 
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arrhythmia episodes, on a background of accelerated sinus rhythm and a relative increase 
of its low frequency fluctuations. However, the changes were more informative when 
normalized using the distribution of values within each patient (position vs. raw data). 
The sensitivity and specificity (correct classification of the trigger and non-trigger 
interval respectively) remained between 65% and 85%, the total predictivity reaching a 
maximum for 30 to 60 minutes intervals. (Figure 3.8 B) 
 
Figure 3.8 A) Sign of estimated coefficient of predictors in the logistic model (red: 
positive coefficient, green: negative coefficient) for different partitions of 2 hours 
intervals before AF. B) Sensitivity (red) and specificity (black) of each model with 
cutting point calculated from the ROC curve.  
 
Table 3.3 The p value from univariate and multivariate logistic regression model with 
position data and 5 minutes partition 
 Univariate (p Value) Multivariate (p<0.05) 
PAAR  <0.001 0.002 
ArrhyDuration <0.001 0.045 
AAMean 0.002 0.010 
AAStd 0.576  
rMSSD 0.810  
pNN50 0.794  
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LF <0.001  
HF 0.016  
LFPortion <0.001 0.001 
HFPortion <0.001  
LF/HF <0.001  
CTAVMean 0.631  
CTAVStd 0.489  
CTAMean 0.632  
CTAStd 0.558  
CorrAA_AV 0.279  
CorrAA_CTA 0.316  
CorrAV_CTA 0.732  
 
Table 3.3 gives the results of the univariate and multivariate logistic regression for 5 
minutes position data. Four variables were entered in the multivariate model in the 
following order: RPAA, LFPortion, Arrhythmia Duration, AAMean. Figure 3.9 shows the 
ROC curve associated with the successive models: I, PAAR ;II, LFPortion + PAAR ; III: 
LFPortion  + PAAR + ionArrhyDurat ;  IV: LFPortion + PAAR + ionArrhyDurat + AAMean .  
It is evident that the predictor PAAR  plays the most important role, achieving around 65% 
sensitivity and specificity. Then the other two predictors LFPortion  and ionArrhyDurat  
made some sensitivity improvements. The predictor of AAMean , finally introduced in the 
model, further improved the prediction, to reach a sensitivity of 72% and a specificity of 
85%.  Table 3.4 show the results of the comparison of AUC (area under ROC curve) 
differences using the method described in section 1.3.3.  The methodology of the 
calculation of the Standard Error of the Area Under the Curve (AUC) and of the 
difference between two AUCs is the method of DeLong et al. [194]. The method 
employed the nonparametric approach to compare the areas under correlated ROC 
curves, by using the theory on generalized Mann-Whitney U-statistics for comparing 
distributions of values from the two samples [195]. The asymptotic normality and the 
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expression for the variance of the Mann-Whitney statistic was derived from theory 
developed for generalized U-statistics by Hoeffding [194].  Once the distribution of the 
variance, the distribution was defined, the standard deviation, and the confidence interval 
automatically followed.  
 
 In the table, the standard error  The results of this test much differed from those of the 
logistic regression since none of the variables entered after RPAA were diagnosed to bring 
a significant AUC difference.  
 
 
Figure 3.9 ROC curves of Model I, II, III, and IV. The circles indicated the best cut off 
points for each model. 
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Table 3. 4 The comparison of AUC (area under ROC curve) among the four methods, 
including the area difference, the standard error, the significance of the difference and the 
confidence interval.   
 
 I vs. II I vs. III I vs. IV II vs. III II vs. IV III vs. IV 
Difference of 
AUC 
0.0328 0.0353 0.0506 0.00256 0.0178 0.0152 
S.E. 0.0415 0.0351 0.0471 0.00723 0.0211 0.0233 
95% 
Confidence 
Interval 
-0.0408 to 
0.114 
-0.0335 to 
0.104 
-0.0417 
to 0.143 
-0.0116 
to 0.017 
-0.0236 to 
0.0592 
-0.0305 to 
0.0610 
Significance 
Level 
0.4301 0.3147 0.2830 0.7233 0.3992 0.5137 
 
 
 
 
3.4 Characteristics of PAA Eliciting Occurrence of AF 
 
In the second phase analysis, we examined whether the trigger PAA occurring just before 
the onset of AF were endowed with specific properties. 
 
3.4.1 Prematurity 
 
The arrhythmogeneity of an activation is often linked to its degree of prematurity  [186]. 
For each PAA, the absolute prematurity (Premabs = Time from the previous activation to 
the premature activation, evaluated at the electrode first activated in the PAA) and the 
relative prematurity (Premrel = absolute prematurity/ mean AA interval of the sinus beats 
in the minute before the PAA) were calculated. Position value of the prematurity of each 
triggering PAA (P-Prem) was obtained by finding its location in the cumulative 
  
  81 
distribution of the prematurity of all PAAs within each patient. The distribution of the P-
Prem of the trigger PAA among the patients was similar for Premabs and Premrel. As seen 
in Figure 3.10 A, the trigger P-Premabs and P-Premrel were among the 5% most premature 
for about 40% patients, but were spread uniformly for the others such that P-Premabs,rel  
≤ 0.5 for about 75% of the patients.  
 
It was suspected that the accumulation of PAA close to the onset of AF might make the 
substrate so prone to arrhythmia that any PAA could then act as a trigger. However, there 
was a low correlation between the prematurity of the trigger PAA and the rate of PAA in 
the last 5 minutes (P-Premabs, r= 0.15, P-Premrel, r= 0.24). In fact, the three patients with 
the highest rates of the PAA (> 28/min, at least twice higher than all others patients) were 
responsible for this low level of correlation. As seen in Figure 3.10 B, not very premature 
trigger PAA could occur for different rates of PAA, which suggests that information on 
the substrate must also be taken into account. 
 
                
Figure 3.10 A) Cumulative distribution among the patients of the normalized absolute (P-
Premabs, point) and relative (P-Premrel, star) prematurity of the triggering PAA. The 
abscissa is the value of P-Premabs and P-Premrel, the ordinate is the cumulative proportion 
of patients for which the trigger PAA has P-Premabs and P-Premrel ≤  the corresponding 
value on the abscissa. B) Relation between PAA rate and P-Premabs and P-Premrel. The 
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abscissa is the PAA rate in last five minutes (number/min.), and the ordinate is the 
absolute (P-Premabs, point) and relative (P-Premrel, star) prematurity of triggering PAA.  
 
3.4.2 Intra-atrial Propagation Time (CTA) of PAA 
 
Intra-atrial conduction time (CTA) was measured as the time between the first and last 
activation for each PAA. The definition of CTA in our project, however different from the 
definition of intra-atrial time in traditional ECG analysis, in fact measured the intervals 
between detected markers for the first and last activations within a beat. As seen in the 
example presented in Figure 3.11 A, the CTA of left and right PAAs were often very 
different (paired t-test between mean CTA of LPAA and RPAA of each patient, p<0.0001), 
such that they could not be pooled together for analysis. Even considering only LPAA (or 
RPAA), the dispersion of the CTA values was huge and the distribution was complex and 
multi-modal. The example of Figure 3.11 B shows a LPAA bimodal distribution, 
suggesting at least two different ectopic foci.  Hence, CTA might depend on multiple 
factors such as prematurity, previous sinus rhythm, changes in the relative position of 
ectopic focus and of the conduction path across the atria, which explains why it was not a 
useful variable to discriminate trigger from non-trigger PAA. 
 
Figure 3.11 A) Histogram of CTA distribution of LPAA and RPAA of one patient (LPAA, 
red color; RPAA, blue color).  B) Histogram of CTA of LPAA of one patient, CTA varying 
from around 10 to 80 msec. 
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3.4.3 Local Derivative (Dvdt) 
 
The maximum derivative of unipolar electrogram (Dvdt =|dV/dt|max) depends on the 
extracellular current associated with the passage of the activation front close to the 
electrode. It is related to the local excitability of the tissue, the propagation speed, form of  
wave front, the thickness of cardiac tissue beneath the electrode, the electrode-heart 
contact and resistance and the intra and extracellular resistivity [196-198]. We analyzed 
the Dvdt of the first activated channel for each PAA. Since first activations could occur 
on different channels, a normalization procedure was needed to bring the data together 
within each patient. For each channel, the Dvdt of all PAAs were collected, outliers were 
removed when bigger than 10 times the mean value, and the normalized derivatives 
within each channel were calculated as NDvdt=(Dvdt-min(Dvdt))/(max(Dvdt)-
min(Dvdt)). Afterward, the NDvdt of the first activated channel was selected for each 
PAA and a position was assigned to each data point with the usual distribution method.  
Figure 3.12 A shows the distribution of the trigger PAA NDvdt among the patients. It was 
less than 0.2 for 60% of the patient. Low NDvdt might be a consequence of  prematurity 
and/or high frequency activation prior to the PAA, which would be translated by a 
positive correlation between NDvdt and both the prematurity and the mean sinus beats 
AA  for the minute before the PAA. Figure 3.12 B shows the distribution of these 
correlations, among which around 60% were located in region I where both correlations 
were positive. 
 
To remove the effect of AA and Prematurity, the residues of the linear regression of  
NDvdt with AA and prematurity were also analyzed. For each patient, the residues were 
ranked from the most negative to the most positive to obtain the position of the trigger 
PAA. As seen in Figure 3.12 C, the residue was the most negative for ~30% of the 
patients and below 0.5 for 85%. Hence, the NDvdt of the triggering PAA was often lower 
than what would be expected from its prematurity and previous sinus rhythm, which 
suggests that it may occur in tissue with enhanced depression of excitability. 
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Figure 3.12 A) Cumulative distribution among the patients of the position of NDvdt  of 
the triggering PAA. The abscissa is the position of NDvdt of triggering PAA, and the 
ordinate is the proportion of patients having NDvdt of the trigger PAA with position ≤  to 
each level indicated by the abscissa; B) The contrast plot of correlations: the abscissa is 
the correlation between NDvdt and prematurity, and the ordinate is the correlation 
between NDvdt and AA; C) Cumulative distribution of the trigger NDvdt residue position.  
Residue of regression of Ndvdt with AA and Prematurity were obtained and ranked in 
each patient (see text). 
 
3.4.4 Cardiac Autonomic Neural Balance 
 
In order to characterize the substrate associated with each PAA, the normal sinus beats in 
the 5 minutes preceding PAA were analyzed. Position data were calculated from the 
distribution of all sinus beat, as in the section of temporal evolution. Figure 3.13 shows 
the result of analysis for AAMean and LFPortion=LF/(LF+HF), the two variables that 
brought a significant contribution to the discrimination of AF onset time in the previous 
section. LFPortion were calculated from the sinus beats AA time series for the five 
minutes preceding each PAA, and the position values were obtained from the distribution 
of these LFPortion values within each patient.  
 
Figure 3.13 A shows the distribution of the values associated with the triggering PAA 
among the patients. For AAMean(blue line), the position of trigger PAA was less than 0.3 
for 55% of the patients. For the remaining 45% patients, the position of the trigger was 
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spread uniformly from 0.3 to 1.0. The distribution of the trigger LFPortion was 
somewhat a mirror image of the AAMean. A group gathering ~40% of the patients had a 
trigger LFPortion above 0.9, 4 patients (~13%) had a low value below 0.15, the remnant 
being spread between these values. The scatter plot (Figure 3.13 B) did not show a 
significant correlation between LFPortion and AAMean of the trigger PAA’a (correlation 
coefficient 0.052, p= 0.788). This suggests that AAMean and LFPortion bring different 
non-redundant information on the state of the substrate. Hence, the relative high heart 
rate and high portion of LF components represents different meanings. The LFPortion 
might mainly represent the fluctuation of heart rate, while the higher heart rate is 
attributed to comparative increase of sympathetic tone.  
 
 
 
Figure 3.13 A) The cumulative distribution among the patients of the AAMean 
(continuous red line) and LFPortion (broken blue line) trigger PAA position. The 
abscissa is position of the trigger PAA, and the ordinate is the proportion of patients 
having a triggering PAA with a position ≤  to each level indicated by the abscissa. B) 
Scatter plot of MeanAA vs. LFPortion positions of the triggering PAA among the 
patients. 
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3.5 Uniqueness of PAA Eliciting AF  
 
Forward conditional logistic regression was used to discriminate trigger PAA (set as 1, 1 
by patient) from other PAA (set as 0, number varying among patients). As for the 
temporal analysis of section 3.3, the analysis was repeated for both raw and position data. 
The selected variables were the same for both sets of data, but position data again 
provided a better discrimination. In this section, we report only the results obtained with 
the position data. The positions (with respect to the distribution of values among PAA in 
each patient) of PAA were used as independent variables, namely Premabs, CTAMean, 
CTAVMean, NDvdt, AAMean, AAStd, LF, HF, LFPortion, LF/HF, ArrhyDuration and 
RPAA,  which were either significant predictors in univariate logistic regression analysis, 
or closely related to the substrate of PAA. 
  
Bootstrapping was used to get around to problem of the obvious discrepancy between the 
numbers of triggering (1 for each patient) and non-triggering PAA. Analysis was 
performed including from 5 to 100% of non-triggering PAA. For each sampling 
percentage < 100%, the analysis was repeated on 200 random samples. Figure 3.14 A 
displays, for each sampling percentage, the ratio of the 200 samples for which each 
variable was included in the logistic model. Clearly, four variables were always included 
irrespective of the sampling percentage: ArrhyDuration, Premabs, NDvdt, and LFPortion. 
Mean value and standard deviation of the sensitivity, specificity and the area under ROC 
curve are plotted in Panel B of Figure 3.14. These three indices did not vary much as a 
function of the sampling frequency. Hence, additional analyses were performed using all 
non-triggering PAA.  
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Figure 3.14 A) For each percentage of non-triggering PAA included in the sample, the 
ratio of the 200 runs in which each variable was included in the logistic model. The color 
bar indicate the value of the ratio; B) Mean value and standard deviation of sensitivity, 
specificity, and ROC curve area over the 200 runs for each percentage of non-triggers 
PAA. 
 
The discrimination power of each variable was also measured by using the statistical 
significance of its parameter in the univariate logistic regression. Since most patients had 
their triggering PAA on the left atrium, analysis was repeated for these patients 
considering their LPAA only. Besides, analysis was also done separately in the subset of 
these patients with high (N>100) and low number (N<=100) of PAA to verify if the 
predictive power of the variables was different in these subgroups.  
 
Figure 3.15 shows the results for the four groups of patients: all patients (Tot), patients 
triggered from the left atrium considering only their LPAA (LeLe) and among these, those 
with high or low LPAA rate (LeHi, LeLow). Figure 3.15 A gives the discriminating 
power of each individual variable (p of the null hypothesis/0.2, set as 1 if bigger than 1, 
such that the usual p 05.≤  level of significance corresponds to p/0.2 25.≤ ). For all 
patients taken together, all variables, except AAMean and CTAMean, could individually 
bring a significant contribution. AAMean also became significant when the analysis was 
restricted to the LeLe group (LPAA from patients with AF triggered by LPAA). Within 
this group of patients, CTAVMean, RPAA and ArrhyDuration provided a significant 
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discrimination only in the low LPAA rate group (LeLow), while NDvdt and LFPortion 
were significant only for the high rate group.  
 
Figure 3.15 B gives the variables that were selected by the conditional forward logistic 
regression, using a cut-off point of 0.05 or .1 for inclusion. ArrhyDuration, Premabs, 
LFPortion and NDvdt were selected in both the total and LeLe groups. ArrhyDuration 
and Premabs were selected in the LeLo groups, LFPortion and NDvdt in the LeHi group. 
 
 
Figure 3. 15 A) Relative P value of each independent variable in the logistic regression 
for four groups of patients (P/0.2, set to a maximum of 1); B: Beta values of variables of 
in the final forward conditional logistic model on different group PAA with significant 
level for entering the variables as 0.05 and 0.10, green stands for negative parameter, and 
red stands for positive parameters, white indicates non-significant predictor. (Tot, total 
PAA; LeLe, LPAA from patients with AF triggered by LPAA; LeLo, LPAA with PAA 
number<100; LeHi  with PAA number>100) 
 
3.6 Discussion 
 
3.6.1 Time Evolutionary Risk Factors 
 
Previous studies on post-CABG AF  have considered  intervals of two hours,  one hour, 
thirty minutes, or even a few minutes before the onset of the arrhythmia [134, 139, 188]. 
  
  89 
Besides, different durations of AF were considered. We initially chose two hours to 
investigate if monitoring could be useful to detect changes associated with impending 
AF. Significant differences were found for subsets of variables between the first and 
second hour, within the second hour, but never during the first hour (Table 3.1, 3.2).   
Therefore, we conclude that the 2 hours interval was an appropriate time frame for our 
study.   
 
AEG provides the local prematurity of PAA and helps to determine the origin of PAA. 
Prematurity is a local measure, in contrast to coupling time measured from QRS which is 
a global measure that includes intra-atrial and atrio-ventricular conduction time. AF was 
initiated by LPAA for 87.6% of the patients, and the proportion of LPAA was greater than 
RPAA in all except two patients (Fig. 3.2).  This differs from the result of Frost et al. who 
found the trigger PAA to originate from the left atrium in only 8 of 14 post-CABG 
patients.  However, they were using only two epicardial electrodes and were considering 
the first >30 s AF, while we chose >10 minutes AF [186].  
 
In this chapter, position data were calculated from all information recorded in the two 
hours and ended up to improve the discrimination of periods close to AF relative to raw 
data. This indicates that changes measured relative to the state of the patients might be 
more relevant that raw values.  However, position data were less effective than raw or 
other forms of normalized data in the comparison of AF and Non-AF patients presented 
in Chapter 5.  
 
Most patients had more LPAA than RPAA. Ashar reported that AF triggers most 
frequently originate in the carina region of the pulmonary veins [199, 200]. However, 
was the 26/30 dominance of trigger LPPA simply a consequence of their greater 
incidence among the total PAA, or did LPAA stems from a more arrhythmogenic 
substrate to have greater potential to trigger AF?  Here we give a discussion of the 
difference of LPAA and RPAA in the substrate point of view. On average, LPAA had 
lower prematurity, Dvdt, NDvdt, and longer CTA (Table 3.4). As shown in Figure 3.16, 
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such differences in mean value are found in 13 to 20 patients, together lower Premabs, rel  
and lower CTA in 15 patients. 
 
 
Figure 3.16 Mean value and standard deviation of LPAA (blue) and RPAA (pink) CTA, 
Premabs, CTA, Dvdt and NDvdt. The rightmost points in each panel are the average and 
standard deviation of the individual mean values. 
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Table 3.5 P value of Anova of Premabs, CTA, Dvdt and NDvdt, excluding patients with 
less than 2 LPAA and RPAA. For CTA, Dvdt, NDvdt analysis were repeated with (C) and 
without (N.C.) Prematurity as covariate. The analyses were done with patient effect 
considered as a random effect. However, the distribution of the patients CTA, Dvdt and 
NDvdt mean values were far from normal, with or without covariate. 
 
Premabs CTA Dvdt NDvdt 
 N.C. C. N.C. C. N.C. C. 
Origin(L 
or R) 
0.027 0.004 0.115 0.036 0.203 0.145 0.155 
Patient <0.001 <0.001 <0.001 <0.001 <0.001 0.304 0.456 
Origin*
Patient 
<0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
 
 If the relation of speed to prematurity was the same across the tissue and if the pathway 
of propagation was also identical irrespective of the origin of the ectopic,  then, following 
a sinus beat,  CTA should be shorter for a LPAA than for a RPAA with the same level of 
prematurity. As it can be understood from Figure 3.17, this follows from the fact that the 
front created by the LPPA would be moving toward locations that were depolarized 
sooner than the position where the ectopic is created. In this simple model, a way to get a 
longer CTA for LPAA would be to assume that the speed of propagation, in addition to 
prematurity, also depends on position. This is shown in Figure 3.18, where 
                                                
)1)(1(
1)( )( xPekx
x
α
θ
−++
=                                          (3.1) 
where P is the coupling time at each location. Assuming a slower propagation would also 
be consistent with lower Dvdt. Our results suggest that, in patients experiencing 
prolonged AF, LPPA, beside the fact that they present greater prematurity, are often 
associated to some level of enhanced depression of excitability of the left atrium (Seen 
the analytical resolution in Annexe II). This is consistent with the finding that 
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preoperative impairment of left atrial function such as a larger LA, larger LA appendage 
and lower LA ejection fraction, increases the risk of post-operative AF [96]. 
 
 
Figure 3.17 Diagram of pulse propagation either from RPAA, or from LPAA, assuming 
propagation at constant speed for the activation before the premature activation 
 
 
Figure 3.18 Simulation of eq. 3.1, with α =0.2, and k=0 (left) and k=0.5 (right). The 
premature impulse was applied at both end, with a coupling time P=1. Propagation of the 
LPAA
RPAA
L
R x
t
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first front was done by stimulation at position 0 in a resting medium (i.e. P(x) ∞→  ) The 
solid line is the conduction time vs. position of pulse from  the right, and dot line for from 
the left applied with the prematurity =1.  
 
Globally, there was an increase of RPAA in last hour before the onset of the AF, coming 
essentially from an upsurge in LPAA (Figure 3.3). This is similar to the previous 
observations that the number of ectopic beats tends to increase before the start of 
paroxysmal AF [189] [33, 201]. The analysis of the temporal RPAA evolution showed 
diverse of profiles (Figure 3.4), with 18 patients displaying some sustained increase of 
the number of LPAA in the last 40 to 15 minutes before AF. Hence, AF is not always 
preceded by an increasing trend of PAA or LPAA. 
 
Logistic regression analysis indicated that four variables were contributing more often to 
distinguish the last time periods (5, 10, 15, 20 and 30 minutes) before AF from the other 
time periods: higher heart rate, higher LFPortion, increase density of PAA and short-
transient arrhythmias. 
 
Higher heart rate is in accordance with the results of different groups that suggested that 
postoperative patients with higher heart rate were more prone to AF [24, 71, 202]. 
However, Hogue et al. rather concluded that heart rate dynamics before AF could be 
either lower, higher or even constant. [136]. Our observations did not contradict either of 
these statements. As seen in figure 3.5 A, which is a population-based approach, there is 
indeed a gradual acceleration of the heart rate before AF. However, cluster analysis of 
figure 3.5 B reveals that only 15/29 patients follow this trend. As for PAA rate, there is 
no unique pattern that could be alone predictive of impending AF.  The heart rate 
variability measures were calculated in five minutes intervals. This time frame was 
considered as a tradeoff between the stationary needed for FFT to be significant and its 
frequency resolution. Heart rate variability might be useful as a measure of the 
modulation of autonomic tone even though the connection between may sometime 
become ambiguous. Indeed, Movement and vascular perturbations that may be unrelated 
to the autonomic tone might alter the heart rate variability.  
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As discussed in Section 1.2.1 (Chapter 1), the LF component of heart rate variability is 
often considered to be a marker of sympathetic modulation, although this point of view 
remains somewhat controversial. In both raw data and position data, we found an 
increasing trend of the population mean LFPortion, in last 30 minutes,  reaching  a peak 
in last 10 minutes  before AF (Figure 3.6 B). The increase of both AAMean and 
LFPortion might be explained as an augmentation of the sympathetic and/or decrease of 
the parasympathetic tone in last half hour. However, the study of correlation between 
AAMean and LFPortion trend did not support that point of view because the correlation 
was widely distributed among the patients (correlation between 5 min. values, [min,max, 
mean ± std,]: 2hr=[-0.77,0.45,-0.12 ± 0.37]; last hr=[-.74,0.59,-0.12 ± .035];last ½ hr=[-
0.84,0.73,-0.06 ± 0.51]). That’s to say, the two variables could not be equivalent since 
LFPortion and AAMean represents two different physiological meanings. The higher or 
lower AAMean is caused by the increase of sympathetic or the decreased of  
parasympathetic tone. LFPortion reflects the fluctuation of heart rate, so it is also more 
related to the temporal fluctuation of sympathovagal action. Therefore, both variables 
entered into the final logistic regression model.  
 
Dimmer et al.  reported an increase LF/HF ratio before AF, which they attributed to a 
loss of vagal tone (0.16<HF<0.4) and a moderate increase in sympathetic tone (LF) [71]. 
In our case, there was no significant time effect for LF or HF alone.  As for heart rate, 
Hogue et  al. observed divergent autonomic conditions before AF onset:  heightened  
sympathetic  tone  in some patients,   but  either  higher  vagal  tone  or dysfunctional  
autonomic  heart  rate  control  in others [136]. This is consistent with the huge variability 
in LFPortion time course found in cluster analysis (Figure 3.6 B). 
 
Although the same variables had significant time effects and were selected in the final 
logistic regression model for either raw or normalized data, the latter always had higher 
level of statistical significance and correct classification. This comes from the huge 
variations of mean level and amplitude of changes observed for every variable among the 
patients. The normalization, based on the distribution of the values in each patient, 
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removes these differences of scale. It suggests that a relative threshold, adapted to the 
state of the patient, can be a better predictor of impending AF. 
 
 
3.6.2 Triggering vs.  Non-triggering PAA  
 
Prematurity (coupling interval) is believed to be an important index of the pro-arrhythmic 
potential of a PAA [186, 190, 199, 203]. The triggering PAAs were among the 10% most 
premature PAA experienced by each individual for ~40% of the patients, while 
prematurity was uniformly distributed for the others (Figure 3.11 A). The triggering PAA 
with long coupling time were not necessarily associated with periods with high density of 
PAA or transient arrhythmias (Figure 3.11 B). This suggests that the state of the tissue in 
which the PAA takes place must also be taken into account   
 
Figure 3.11 shows that the distribution of CTA was variant and multimodal, which 
suggests the existence of multiple foci and/or conduction paths. As a consequence, the 
correlation between prematurity and CTA was erratic among patients (LPAA, from -0.78 
to 0.65, -.21±0.36), as well as the position of the trigger PAA in the distribution (from 
0.017 to 1, .44 ±0.36). Although related, CTA is not completely equivalent to the duration 
of the P wave that was found to be prolonged in patients developing AF [28, 30, 127, 
128]. 
 
As mentioned earlier, Dvdt obtained from AEG characterizes local propagation. Dvdt of 
the trigger PAAs had a lower relative value than other PAA, even when correcting for 
prematurity and previous sinus rhythm (Figure 3.13), which suggests that that the 
substrate of local tissue was with enhanced depressed excitability. 
 
AAMean, the AA of sinus beat, and LFPortion of five minutes preceding each PAA were 
analyzed. There was a significant proportion of patients for which the triggering PAA 
was associated with lower AAMean and higher LFPortion (Figure 3.13A). However, few 
patients possessed both properties (Figure 3.13B), which suggests that these indices may 
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qualify different properties of the substrates.  Temporal analysis suggested the same 
conclusion. 
 
Forward logistic regression, in conjunction with bootstrapping, identified four stable 
independent predictors of triggering PAA: Premabs(or Premrel), NDvdt, LFPortion, 
ArrhyDuration (Figure 3.14). Together, they achieved a sensitivity and specificity ~ 80%. 
The model indicates that more premature PAA with smaller Dvdt, preceded by sinus 
rhythm with higher LFPortion and more transient arrhythmias, are more likely to trigger 
prolonged AF. The model brings together properties of the PAA per se (prematurity), of 
the substrate in which it occurs (Dvdt) and of the dynamics (LFPortion, ArrhyDuration).  
 
The same logistic model was obtained when including only LPAA for the 26 patients for 
which the trigger was also from the left atrium. Whilst prematurity appears as a stable 
discriminator of the trigger, the predictive power of the other variables differs contingent 
to the PAA density of the patient. For low PAA density patient, longer ArrhyDuration 
and, to some extent, shorter AAMean, are associated with the trigger. For high density 
PAA patients, the risk factors rather become Dvdt and LFPortion. The contribution of 
Dvdt might be explained by the fact that, when many PAA occur close to the onset of 
AF, the state of the tissue for each PAA may become more important to discriminate the 
trigger. 
 
3.7 Summary 
 
1. AF was always immediately preceded by a premature atrial PAA mainly originating 
from the left Atrium. The number of PAA and the fraction of LPAA among the patients 
were very inhomogeneous.  LPAA was more prone to elicit arrhythmia than RPAA.  
 
2. PAA rate, arrhythmia duration time, sinus heart rate, LF portion of heart rate 
variability showed significant changes over the time in last hours before the onset of AF.    
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3. Prematurity, Dvdt of the PAA, as well as LF portion and unsustained arrhythmia 
duration time in the preceding five minutes were predictors of the model to discriminate 
triggering from non-triggering PAA.  
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Chapter 4 Preoperative Risk Factor Analysis of AF and 
Non-AF Patients 
 
Pre-CABG clinical data were available for 137 patients, 108 patients from Hôpital du 
Sacré-Coeur de Montréal, and 29 patients from Institut de cardiologie de Montréal 
(ICM). 
 
The following clinical data were available for all patients and included in the analysis: 
age, sex, left ventricular ejection insufficiency (insufficient if  LVEF<60%),  
hypertension(HT), diabetes, chronic obstructive pulmonary disease (COPD), history of 
stroke, former myocardial infarct(MI), serum creatinine level, number of vessels at 
CABG surgery, beating heart or extra-corporal circulation, duration of extra-corporal 
circulation, duration of clamp time, preoperative Beta-blocker administration, 
preoperative calcium inhibitor administration, and preoperative vasopressors/inotropes 
administration.  
 
Incidence of Atrial Fibrillation 
 
41 (41/137=29.9%) patients experienced a first >10 minutes AF episode during the 
second and third 24hrs after CABG surgery. This incidence was on the same level as that 
reported in the United States (33.7%), Canada (36.6%), Europe (34.0%), United 
Kingdom (31.6%), lower than for Middle East (41.6%), but higher than South America 
(17.4%) and Asia (15.7%) [77].  
  
Statistical Methods: 
 
Univariate associations between potential predictors and AF were investigated using chi-
test (category variable), t-test, ANOVA (scale variable), logistic regression modeling and 
survival analysis (for both kind of variables).  
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All variables with significant univariate effect were further analyzed with multivariate 
logistic regression using a combinative stepwise forward conditional selection method. 
The analysis, repeated with choice among all variables, gave the same results. Model 
entry and retention criteria were set at p<0.1 and p<0.15.  The final logistic models were 
evaluated using the Hosmer-Lemeshow goodness-of-fit test [146]. The receiver operating 
characteristic (ROC) was used to compare the strength of the different models. Because 
of the disproportion between men and women (104 vs. 33), weighted logistic regression 
was used for some analyses, in which the contribution of the women to the likelihood 
function was multiplied by the male vs. female ratio.  
 
Cox regression (proportional hazards model) was used to investigate the effect of clinical 
variables upon the post-operative time of AF [149].  
 
4.1 Univariate Analysis Result 
 
4.1.1 Univariate Logistic Regression 
 
The baseline characters of the 137 patients of our study population, is listed in Table 4.1.  
The predictive power of the variables to discriminate AF from Non-AF patients was 
firstly assessed by univariate logistic regression. The analysis was repeated using 
unweighted (UW) or sex-weighted (W) logistic regression. As seen in Table 4.2, four 
variables were either significant or close to be significant for both analyses: age, previous 
myocardial infarct, and hypertension and serum creatinine. The next sections provide a 
detailed analysis of these four variables.  
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Table 4.1 Baseline characters of the 137 patients of the study population 
Group AF Non-AF 
Number ( %, among total ) 41(29.93%) 96(70.07%) 
Age (mean±std), years 68.54±7.40 62.42±9.19 
Sex (n, % among men/women) 
Men  
Women 
 
31(29.8%) 
10(30.3%) 
 
73(70.2%) 
23(69.7%) 
LVEF (n, %) 7 (17.07%) 11(11.46%) 
Stroke (n, %) 4(9.75%) 4(4.16%) 
MI (n, %) 23(56.09%) 39(40.62%) 
COPD (n, %) 4(9.75%) 10(10.42%) 
Hypertension (n, %)   30(73.17%) 56(58.33%) 
Serum Creatinine (mean±std, mmol/L) 101.08±38.170 89.29±28.793 
Diabetes (%) 13(31.71%) 31(32.29%) 
Mean Number of Vessels of CABG 
surgery (Mean) 
2.63 
 
2.63 
Beating Heart vs.  
Extra-Corporal Circulation 
4(9.75%) 
 
10(10.42%) 
Duration of Extra-Corporal 
(mean±Std), minutes 
71.07±38.89 66.27±34.54 
Cross-clamp(mean±Std), min. 44.05±26.09 42.94±25.66 
Preop. Treatment (n, %) 
Beta-Blockers 
Calcium channel  blockers 
Vasopressor/Inotropes 
 
28(68.29%) 
11(26.83%) 
2(4.87%) 
 
77(80.21%) 
23(23.96%) 
3(3.13%) 
 
% represents the rate among the AF or Non-AF group if not specified 
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Table 4.2 P value of variables in univariate unweighted and sex weighted logistic 
regression 
 UW W 
Age 0.000 0.000 
Gender 0.927 0.896 
LVEF 0.311 0.229 
Former History of Stroke 0.219 0.230 
Previous Myocardial Infarct(MI) 0.043 0.007 
Hypertension(HT) 0.057 0.072 
Diabetes 0.642 0.433 
COPD 0.989 0.814 
Serum Creatinine 0.065 0.032 
Number of Vessels of CABG surgery 0.924 0.581 
Beating Heart vs. Extra-Corporal Circulation 0.829 0.549 
Duration of Extra-Corporal 0.624 0.700 
Duration of Clamp 0.987 0.838 
Preoperative Beta-blocker 0.372 0.423 
Preoperative Calcium Inhibitor 0.408 0.294 
Preoperative Vasopressor/Inotropes 0.642 0.681 
 
4.1.2 Age/Gender 
 
As seen in Figure 4.1, the patients were rather uniformly distributed among 50 to 80 age 
groups, with a few patients below 50 and over 80. However, the proportion of AF 
patients clearly increased with age. There was also three times more male than female 
patients (104 vs. 33), but the proportion of AF was the same in the two groups (M: 
29.81%, F: 27.27%, p=0.830). 
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Figure 4.2 shows the age distribution across the (AF vs. Non-AF) and (Male vs. Female) 
groups. Two-way ANOVA indicated a significant AF vs. Non-AF effect (p=.001), with 
an estimated AF-Non-AF difference of 6.15 years (95% conf. inter.: 2.7-9.7 y.), as well 
as a significant sex effect (p<.001), with an estimated Female-Male difference of 6.8 
years (95% confidence interval: 0.9-12.8), but no interaction (p=0.957). However, the age 
dispersion of the male and female Non-AF patients was very large.  
 
Figure 4.1 Number of AF (blue) and Non-AF (red) patients in the different A) age groups 
and B) sex groups; Proportions of AF (blue) and Non-AF (golden) patients in C) age 
groups and D) sex groups. 
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Figure 4.2 Age distribution across AF vs. Non-AF and Male vs. Female groups. The 
lower and upper lines of each box are the 25th and 75th percentiles, whose separation 
defined the inter-quartile range. The middle line is the median and red diamond the mean. 
The upper and lower ‘whiskers’, the lines extending above and below the boxes, are 
located either at 1 inter-quartile from the top and bottom of the box, or at the position of 
the minimum and maximum if they are within these limits. Outliers beyond these limits 
are indicated by the +. The notches in the box are the 95% confidence interval of the 
median. All following box plot figures follow the same formula.  
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4.1.3 Artery Hypertension (HT) 
 
Table 4.3 R (AF): Risk of AF in the group without (Non-HT) and with (HT) 
hypertension. RR: relative risk 
 N Non-HT R(AF) HT R(AF) RR(HT/Non-
HT) 
P( 2χ )
Total 137 51(37.2%) 0.196 86(62.8%) 0.349 1.78 .057 
Men 104 41(39.4%) 0.195 63(60.6%) 0.365 1.87 .081 
Women 33 10(30.3%) 0.200 23(69.7%) 0.304 1.52 .434 
 
As seen, in Table 4.3, the ratio of hypertensive to non-hypertensive patients is 
approximately 2 to 1 in both sex groups, with a relative risk of AF greater than 1.5 for 
hypertensive patients.  
 
Figure 4.3 Distribution of Age as a function HT and AF among. A) male and B) female. 
The symbols of four groups: NAFNHT, Non-AF without HT; NAFHT, Non-AF with HT; 
AFNHT, AF without HT; AFHT, AF with HT. 
 
However, the interplay of hypertension and age made its real AF predictive power harder 
to assess (See Figure 4.3). On one hand, hypertensive patients tended to be older in both 
sex groups (Male: 64.57 vs. 59.5, Female 70.2 vs. 67.8), which made them more prone to 
AF. Were the differences simply a consequence of age promoting both AF and 
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hypertension, or rather the expression of a risk factor whereby hypertensive patients 
became more liable to AF at a lower age? Upon 3-ways ANOVA of age, Sex (p=0.001) 
and AF (p=0.001) effects were diagnosed as significant, but not HT (p=0.576).  There 
was also an indication of a potential HT*AF interaction (p=0.076), patients without 
hypertension and AF having a propensity to be younger. The small differences of age 
existing between hypertensive and non-hypertensive AF patients (HT vs. Non-HT, Men: 
66.5 ± 8.0 vs. 67.9 ± 5.1, Women= 73.3 ± 5.5 vs. 76.5 ± 6.4) somewhat mitigated to the 
role of hypertension as an independent risk factor, at least in the male group.  
 
4.1.4 Prior Myocardial Infarct (MI) 
 
Table 4.4 R(AF): Risk of AF in the group without (Non-MI) and with (MI) 
 (RR: relative risk) 
 N Non-MI R(AF) MI R(AF) RR 
(MI/Non-MI) 
P( 2χ ) 
Total 137 75(54.7%) 0.227 62(45.3%) 0.371 1.64 .064 
Men 104 60(57.7%) 0.233 44(42.3%) 0.386 1.66 .092 
Women 33 15(45.5%) 0.200 18(54.5%) 0.333 1.66 .392 
 
The patients were almost equally divided between the groups with and without prior 
myocardial infarct (MI), but the former had a 2/3 increase of risk.  Figure 4.4 details the 
relation between age, sex, AF and MI. In the men group, Age remained the main 
predictor of AF in both the MI and Non-MI groups. For women, the AF vs. Non-AF age 
difference was much reduced in the MI group, suggesting that it could be an age-
independent AF predictor for this group.  
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Figure 4.4 Distribution of age in the groups with and without previous MI and AF for A) 
male and B) female. NAFNMI, Non-AF without MI; NAFMI, Non-AF with MI;  
AFNMI, AF without MI; AFMI, AF with MI. 
 
4.1.5 Serum Creatinine 
 
A simple T-test indicated a different serum creatinine levels (Non-AF:  89.29±28.793 vs. 
AF: 101.08±38.170 mmol/L, p=.05). However, upon closer scrutiny, the situation was 
more complex. There was a marked difference between sexes (Figure 4.5 A), and two-
ways (AF, Sex) ANOVA diagnosed only the sex effect to be significant (p=.01). 
However, the Non-AF vs. AF differences varied among the different age groups (Figure 
4.5 B).  Since age was a predictor of AF, the level of serum creatinine could be helpful to 
reduce the number of false positive among older age groups. HT has a significant effect 
on serum creatinine level. ANOVA analysis on the two effects of HT and AF, neither of 
them is significant (HT: 0.102, AF: 0.135, HT*AF: 0.986). In Figure 4.6 B, it seemed 
there is effect of HT between Non-AF and AF. The non-significance might be caused by 
the confounding of serum creatinine level of HT, Non-AF patients with Non-HT, AF 
patients. 
 
 
 
  
  107 
                                       A                                                                     B 
 
Figure 4.5 A) Bar plot of mean and standard deviation of serum creatinine level in AF vs. 
Non-AF according to gender. AFMale: AF and Male; NAFMale: Non-AF and Male; 
AFFemale: AF and Female; NAFFemale: Non-AF and Female (Sex effect=0.01).  B) 
Mean serum creatinine of different age groups. The ordinate of both panels is the serum 
creatinine level.   
                                      A                                                                    B 
 
Figure 4.6 A) mean and standard deviation of serum creatinine level as function of HT 
and AF. NAFNHT:Non-AF and Non-HT, AFNHT: AF and Non-HT, NAFHT: Non-AF 
and HT, NAFHT: AF and HT (Effect: HT: 0.102, AF: 0.135, HT*AF: 0.986).  B) Mean 
of serum creatinine level in AF vs. Non-AF according to HT. The ordinate of both panels 
is the serum creatinine level.  
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4.2 Multivariate Logistic Regression Analysis 
 
Both weighted and unweighted stepwise forward multivariate logistic regressions were 
finally applied using the complete set of variables that was analyzed with univariate 
regression. The regression was run using a p=0.1 liberal criteria of inclusion. Table 4.5 
summarizes the final results. Age and serum creatinine were included with similar β  in 
both multivariate models, age always entering as the first and most important predictor. 
Preoperative myocardial infarct was included in the weighted model, but was less 
significant in the unweighted analysis model, meaning that its discriminative power was 
slightly more important for women. HT was never included in the multivariate models, a 
consequence of its correlation with age as discussed in the above section. 
 
Table 4.5  Beta values and probability of the variables included in the logistic regression 
models. Weighted(W) and unweighted (Non-W) univariate (U) and multivariate (Mv) 
models. The numbers in parenthesis is the order of entry of each variable in the stepwise 
models. For variables not included in a model, the significance of the variable evaluated 
at the last step of the iteration is indicated. 
 Uv.  Non-W Uv. W. Mv UW Mv W 
Age 
 
β  0.086 0.0847 0.086  (1) 0.101 (1) 
p <0.001 <0.001 0.001 <0 .001 
Infarct 
 
β  0.768 0.8331  0.711 (2) 
p 0.043 .0077 0.145 0.036 
Creatinine 
 
β  0.012 0.0123 0.011  (2) 0.012 (3) 
p 0.065 0.0317 0.066 0.025 
HT 
 
β  0.795 0.6318   
p 0.057 0.072   
 
  
  109 
Because AF proportions in men and women were similar, sex was not a significant 
univariate predictor. However, results of section 4.2.2, showing about 5 years difference 
between men and women for both AF and Non-AF patients, suggested that the predictive 
power of age could be improved by introducing a correction for sex. However, the gain 
was not sufficient for sex to be included in the models, probably because of the wide 
dispersion of age among Non-AF women. The same result was obtained in 
complementary analyses in which an additional age*sex variable was also considered. 
 
A logistic regression model provided score for each patient, which was used to build a 
receiver operating characteristic (ROC) curve. It supplied a global assessment of the 
model and a procedure to select an optimal threshold for discrimination [204]. The ROC 
of three models (I: Age, II: Age+Serum Creatinine, III: Age+ Previous myocardial infarct 
+ Serum Creatinine) pictured the improvement of prediction brought by the introduction 
of each variable. Since the β  values of age and serum creatinine were similar for both 
the unweighted and weighted models, the β  values from the weighted regression were 
used for Model III. The threshold to compute the sensitivity and specificity was selected 
as the level associated to the shortest distance to (1-specifity, sensitivity) = (0, 1) (see 
Figure 4.7).   
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Figure 4.7 ROC curves from logistic regression Model I, II and III. The circles of the 
curves correspond to the optimal sensitivity and specificity for each model. 
 
Table 4.6 presents the results of the three models for total population, as well as men (M) 
and women (W) separately. The men and women indices were calculated using the same 
cut-off thresholds. Serum creatinine yielded an around 5% increase of sensitivity and 
specificity.  Previous myocardial infarct improved the specificity, but did not change (vs. 
Model I, II) and even reduced (vs. Model II) the sensitivity. However, it improved much 
the specificity and accuracy for women, which was expected since it was included in the 
weighted logistic regression model only. In summary, Model II had the highest sensitivity 
and medium, whilst Model III had the highest specificity. 
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Table 4.6 Indices of Model I, II, and III on men, women and total population 
 Model I Model II Model III 
Sensitivity 
60.98% 65.85% 60.98% 
51.61% 
(M) 
90% 
(W) 
58.07% 
(M) 
90% 
(W) 
51.61% 
(M) 
90% 
(W) 
Specificity 
67.71% 71.88% 79.17% 
78.08% 
(M) 
34.78% 
(W) 
76.71% 
(M) 
56.52% 
(W) 
80.82% 
(M) 
73.91% 
(W) 
Accuracy 
65.69% 70.07% 73.72% 
70.19% 
(M) 
51.52% 
(W) 
71.15% 
(M) 
66.67% 
(W) 
72.11% 
(M) 
78.79% 
(W) 
Miss-
Classification 
34.31% 29.93% 26.28% 
29.81% 
(M) 
48.48% 
(W) 
28.85% 
(M) 
33.33% 
(W) 
27.89% 
(M) 
21.21% 
(W) 
Positive 
Predictive Test 
44.64% 50% 55.56% 
50% 
(M) 
37.5% 
(W) 
51.43% 
(M) 
47.37% 
(W) 
53.33% 
(M) 
60% 
(W) 
Negative 
Predictive Test 
80.25% 83.13% 82.61% 
79.17% 
(M) 
88.89% 
(W) 
81.16% 
(M) 
92.86% 
(W) 
79.73% 
(M) 
94.44% 
(W) 
ROC Area 0.69792 0.71989 0.72726 
M *: Male; F *: Female; 
Sensitivity=True Positive/ (True Positive+False Negative); 
Specificity=True Negative/ (True Negative+False Positive); 
Accuracy=(True Positive+True Negative)/( True Positive+ True Negative + 
False Positive + False Negative); 
Miss-Classification=1-Accuracy; 
Positive Predictive Test=True Positive/ (True Positive + False Positive); 
Negative Predictive Test=True Negative/ (True Negative+False Negative); 
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Model I was equivalent to putting a threshold on age. When logistic regression was run 
for men only, age was the single significant predictor. As seen in Figure 4.8, the errors of 
Model I came from old patients without AF (F+: False positive, 31 patients) or young 
patients with AF (F-: False negative, 16 patients), showed in Figure 4.8. Ideally, 
supplementary variables should act to decrease the scores of the F+ and increase that of F-
, without altering the classification of the true positives (T+) and negatives (T-).  
 
Figure 4.8 Distribution of age of TP, FP, TN and FN obtained by Model I. The diamond 
square points indicate the mean value of each group. TP: True Positive; FP: False 
Positive; TN: True Negative; FN: False Negative. 
 
Model II introduced serum creatinine. Classification was improved for 6 F+ (becoming T, 
1 man and 5 women) and 2 F- (becoming T+, 2 men). Figure 4.9 shows the distribution 
graph of serum creatinine of TP, FP, TN and FN obtained by Model II. The diamond 
square points indicate the mean value of serum creatinine in each group. However, it also 
created 2 F+ (2 men). This explains why the variable was not included in the model if 
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only men were considered. The main effect was increasing the specificity for women 
from 34.78% to 56.5%. A new variable of multiplication of creatinine and age was 
generated to repeat the regression analysis. In Model II, this variable was also entered 
into the model, but the ROC curve remained almost the same, and the sensitivity and 
specificity were not improved.  
 
Figure 4.9 Distribution of serum creatinine of TP, FP, TN and FN obtained by Model II. 
The diamond square points indicate the mean value of serum creatinine in each group.  
 
Model III added the variable of myocardial infarct. Compared to Model II,  it improved 
the classification of  9  T-, (4 men ,5 women); 1 T+ (a man), at the expense of two  2  F+, 
(1 man and 1 woman) and 3  F-  (3 men). Figure 4.10 shows the proportion of history 
infarct in four groups TP, FP, TN and FN. The specificity of women increased from 
56.52% to 73.91%, and men from 76.71% to 80.92%, while sensitivity of men decreased 
from 58.07% to 51.61%.  
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Figure 4.10 Pervious myocaridal infarct proportion in four groups TP, FP, TN and FN. 
  
To summarize, serum creatinine improved the female specificity and male sensitivity, 
and the myocardial infarct mainly improved the female specificity. Initial analyses 
suggested that sex could be a predictor in the model. However, the variables of 
myocardial infarct and serum creatinine had more significant role than sex.  
 
4.3 Cox Regression 
It might be presumed that patients with higher preoperative risk could develop AF sooner 
after surgery. Figure 4.11 shows the post-operative without AF Kaplan-Meier survival 
curve and cumulative hazard functions for all patients [205, 206]. There was a quasi-
exponential increase of the number of AF from the second to the fourth post-operative 
day.  
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Figure 4.11 Survival curve and cumulative hazard function of AF with respect post-
operative time (A: Survival function, B: Hazard Cumulative Hazard function). 
The baseline hazard function measures survival independently of the covariates. Forward 
and backward stepwise Cox regression was applied to the same set of variables that were 
considered for the logistic regression in the previous section. The analysis was performed 
with entry and removal probability, i.e. 0.05 and 0.10 respectively. As for unweighted 
logistic regression, both age ( β =0.081, p<0.001), serum creatinine ( β =0.009, p=0.026) 
were the variables included in the both forward and backward final models. This has been 
expected since the preoperative risk was related to the final probability of surviving 
without AF.  
 
Figure 4.12 shows the survival curves for three groups defined by the AF probabilities of 
the logistic regression model,  Model III, presented in the previous section : 1) P ≤ 0.2; 2) 
0.2< P ≤ 0.4; 3) P> 0.4. As expected, the final survival proportion was lower for the 
higher AF probability groups. However, the initial onset of AF was not delayed among 
the three groups. Among AF patients, the correlation between the AF onset time and the 
preoperative probability was weak and non-significant (r=-0.107, p=0.535). This suggests 
that the preoperative variables can to a certain extent predict who will get AF, but does 
not seem to be predictive on the time when AF will occur. A similar analysis of patients 
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classified by age groups (40, 50, 60, 70 and 80) produced the same results, which is not 
surprising since age was the main contributor to the probability (Figure 4.13, left panel). 
The same kind of conclusion was also drawn by examining the survival curve as a 
function of gender (Figure 4.12, right panel). 
 
Figure 4.12 Survival curves of three groups of Patients with different preoperative risk 
score classified in three groups.   
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Figure 4.13 Survival curves by the functions of age group and sex 
 
In addition, the risk score also presented very low correlation with the total PAA number, 
arrhythmia duration time among AF patients. This also indicated that the preoperative 
risk score plays the role of static risk factor in the occurrence of postoperative AF.  
 
4.4 Discussion 
 
Age appeared as the most important predictor of postoperative atrial fibrillation after 
CABG surgery, the mean age of the AF patients being around 6 years older than Non-AF 
patients (Men: ~67 vs. ~61 years, women: ~68 vs. ~75 years). Different studies of post-
CABG AF have reached the same conclusion [74, 81, 97, 100, 117, 207]. The association 
has been attributed to age-related changes such as shorter effective refractoriness, longer 
atrial conduction times, atrial stiffening, and splitting of the atrial excitation waveform 
caused by the pectinated trabecula [4, 208]. It has also been suggested that unavoidable 
trauma to sympathovagal fibers originating from the deep or superficial cardiac plexus 
during surgery may enhance the pro-AF effect of preexisting atrial electrical changes 
caused by aging [81]. 
 
There was around 3 times more men than women in our sample (104 vs. 33), but the 
incidence of AF was the same in the two groups. Despite the fact that women patients 
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were on average older, and that the difference of age between AF and Non-AF patients 
was the same in the two groups (ANOVA and Figure 4.12), sex did not appear as 
independent predictor in univariate or multivariate (as sex*age) logistic regression model.  
Our results concurred with Auer et al. who concluded that sex was not an independent 
risk factor, but contradict Zaman et al. who reached the inverse  conclusion results [80, 
100, 209]. However, it cannot be said that gender has absolutely no effect. The main 
improvement in predictive power from logistic regression model from Model I to Model 
III appeared in the specificity for women (Table 4.5). Many women were false positive 
with the model incorporating age only because the average age of the women Non-AF 
group was the same than the AF men group.  
 
Hypertension is associated with left ventricular hypertrophy, which impair ventricular 
filling, induce left atrial enlargement, and slow down atrial conduction velocity [210]. 
The changes in cardiac structure and physiology leading to hypertension also predispose 
to a higher risk of developing AF. Conventional therapy of atrial fibrillation currently 
focuses on interventions to control heart rate, rhythm, and the prevention of stroke by 
anticoagulant medications, rather than treatment of hypertension. In patients with AF, 
aggressive treatment of hypertension may reverse the structural changes in the heart, 
reduce thromboembolic complications, and retard or prevent the occurrence of  AF [210]. 
Nevertheless, our study concluded that the role of hypertension in the occurrence of post-
CABG AF is for the less dubious.  Hypertensive patients had indeed a 78% increased risk 
to of AF, an effect close to significance in univariate analyses (Table 4.2 and 4.3). 
However, it did not appear as a predictor in the final logistic model, contradicting the 
conclusion of  Svedjeholm et al. [117]. In our sample, the effect of HT was confounded 
by age.  
 
To some extent, the same age confounding effect was also present for  pervious 
myocardial infarct (MI) (Figure 4.4), though it was still present particularly in the 
weighted version of the final logistic model (Table 4.3, 4.4 and 4.5). Many studies have 
demonstrated that MI has the potential to provoke AF (for review  [211], [212]), although 
the mechanism is still not clearly understood. In this setting, the risk of AF is increased 
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by elevated heart rate, left ventricular dysfunction and impaired hemodynamic. High 
heart rate suggested that the cardiac autonomic nervous system might be involved. Left 
ventricular dysfunction and impaired hemodynamic hinted to a mechanical effect. 
Reduced ejection fraction coming from left ventricular dysfunction or hypertension could 
result in an additional expansion of the atria before opening of the atrio-ventricular valves 
that may induce pro-AF remodeling   Reversely, AF can often complicate MI acute 
myocardial infarction (AMI) by reducing the pump function of the heart 
 
 
Serum creatinine is the commonly used indicator of renal function. Renal dysfunction is 
defined by a serum creatinine level of at least 177 µmol/L, accompanied by an increase 
of at least 61.9 µmol/L from baseline [77]. Serum creatinine is usually higher in male 
patients than female patients whether developing AF or not [94, 95, 213]. Radmehr 
evaluated the effect of preoperative increased level of serum creatinine. It was found that 
higher serum creatinine level group had higher frequent postoperative atrial fibrillation, 
so he proposed that serum creatinine level preoperatively is a marker of increased early 
mortality and outcome after CABG [94] . In our sample, the level of creatinine was 
higher for AF group for patients older than 60 years, whereas the relation was even 
inversed for younger patients (Figure 4.5). This result is difficult to explain, and may 
result from the limited size of our study population.  
 
The purpose of using weighted likelihood logistic regression was to circumvent the 
disproportion of the male and female population in our sample.  Sex did not show up as 
an independent predictor in our analysis, but it showed some level of interplay with other 
factors such of age, previous MI, serum creatinine. The difference between the 
unweighted and weighted model was the higher level of significance of previous MI in 
the latter. MI mainly improved the prediction specificity for women, at the expense of 
sensitivity for men. The final complete model achieved a sensitivity of around 60%, and 
specificity of around 80%.  
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It is natural to think that AF should occur sooner in patients with higher preoperative risk. 
However, the survival curves rather showed that AF occurs at the end of the first 
operative days irrespective of the preoperative risk. However, the hazard rate was both 
higher and more sustained in the high risk group (Figure 4.11, 4.12). As suggested in 
chapter 3, some changes, beyond preoperative risk, might condition the appearance of 
AF, which is the topic of the next chapter. 
 
4.5 Summary 
 
1. Age was the most important predictor of postoperative atrial fibrillation after CABG 
surgery. The level of serum creatinine and prior myocardial infarct were also 
preoperative predictors. Serum Creatinine played the role to improve the female 
specificity and male sensitivity, and the myocardial infarct mainly improved the female 
specificity.  
2. The preoperative risk score could to a certain extent predict who would develop AF, 
but were not predictive on the time when AF would occur. 
  
  121 
 
Chapter 5 AF vs. Non-AF Clinical Predictor Analysis 
 
In this chapter, we compare AF and Non-AF patients to find predictors that can 
discriminate the two groups. AF and Non-AF patients are compared with respect to the 
preoperative risk factors obtained in chapter 4 and the time series considered in chapter 3. 
For each AF patient, the last 2 hours before AF were retained as in chapter 3. Each AF 
patient was matched with two Non-AF patients. For these, the two hours corresponding 
to the same post-operative time were selected (Figure 5.1) 
 
 
Figure 5.1 Time windows of AEG signals for an AF patient and its matched Non-AF 
control. 0 represents the time of beginning of post-surgery. T for AF patient is the time of 
occurrence of AF, T for control (Non-AF) patient is the same post-operative time.   
 
The AF group of 29 patients was the same that was analyzed in Chapter 3. After 
excluding the noisy and incomplete recordings, 87 Non-AF patients were available. 
Ideally, each AF patient should have been matched according to sex, preoperative risk 
T: Occurrence of AFT-2hrs
2 hrs before onset of AF
0 
Beginning of post-operation 
AF patient 
T: Same Time post-op time than AF patientT-2hrs
Corresponding time window of 2 hrs before time T 
0 
Beginning of post-operation 
Matched 
Non-AF patient 
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and date of surgery. The second criterion was intended to get the same distribution of 
preoperative risk in both groups. The third criterion was aimed at bringing homogeneity 
in the surgery and post-surgery handling.  
 
The matching procedure was the following 
1. Sort the AF patients in risk ascending order ([ AFiR ,i=1,29, AFiR < AF1iR + ] ); 
2. Starting from the first AF patient, find the 10 closest non-AF patients with 
AF
i
AF~ RR ≥ . If less the 10 are available, include the closest patients 
with AFi
AF~ RR < ; 
3. Among these 10 Non-AF patients, find the two patients whose date of surgery is 
the closest to that of the AF patient.  For close surgery date, select the patient that 
has the same sex than the AF patient. 
4. Remove the AF and matched Non-AF patients. 
5. Repeat steps 1 to 4 until the last AF patient.  
 
The dates of the surgery were spread over a period of 64 months.  The analyses of chapter 
4 had shown a significant difference of age and pre-operative risk between AF and Non-
AF patients. Our set of Non-AF patients was not large enough to reach an equal 
distribution of preoperative risk score in the two groups ( testtp − =0.0070). The 
characteristics of the final control group were as following: 58 control patients (Sex: 
Male 45, Female 13, Age: 65 ± 8.2, PreopScore 0.2964 ± 0.1503) to be compared with the 
AF group (Male 23, Female 6, Age: 68.8 ± 6.3, PreopScore: 0.3911 ± 0.1514).  
 
5.1 Univariate Analysis  
 
We firstly present detailed analyses of the variables that were shown in chapter 3 to 
display significant temporal changes prior to the onset of AF, namely RPAA, 
ArrhyDuration, AAMean and LFPortion. It is followed by the results of the multivariate 
analyses to discriminate between AF and Non-AF patients.   
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In some analyses, we introduced the concept of Relative Difference (RD) variables. 
 It measures the change of a variable ix   at time i relative to a reference value 0x  as: 
001.0
RDx i +
−
=
o
oi
x
xx            (5.1) 
where 0.001 avoids divergence when  00 =x . 
 
5.1.1 Analysis of PAA 
 
As in AF group (section 3.1.1), the total number of PAA varied widely among Non-AF 
patients (Min. 0, Max. 811, Median. 5, mean 49). It should be mentioned that 77% of the 
PAA were concentrated in 4 patients ((444+445+500+811=2200)/2843), while 24 
patients have only 3 or less PAA. As shown in Figure 5.2 and confirmed by the 
Kolmogorov-Smirnov test (P< .001), the distribution of the PAA number in the two 
groups (AF: Min. 3, Max. 4539, Median 87, mean 575) was different, The main 
dissimilarities between the two groups came from the ~30% of Non-AF patients with 0 or 
1 PAA, and from ~20% of the AF patients with more than 1000 PAA. There were no 
correlation between the preoperative risk and the number of PAA, neither in the AF 
(r=.187, p =.33) nor the control group (r = -0.001, p=.996). 
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Figure 5.2 Cumulative distribution of the PAA number in AF and Control group. The 
distribution of the PAA number in the two groups, AF (blue line) and Control (red line) 
was quite different. 
 
5.1.1.1 LPAA and RPAA 
 
Also as for AF patients (section 3.1.1), the fractions of LPAA and RPAA (LPAAFraction 
and RPAAFraction, total number of LPAA or RPAA divide the total number of PAA of 2 
hours) were very inhomogeneous among the control patients (Figure 5.2).  
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Figure 5.3 Fraction of LPAA (blue color) and RPAA (golden color) for each patient of 
the control group. Patients 48 to 58: no PAA detected. Homogeneity of the proportions 
was rejected by 2χ  test (<0.001) using either the mean number (all patients) or the mean 
proportion (patients 1-47) of left and right PAA. 
 
It is noteworthy that 92% of the RPAA occurred in three patients (811,499,426) that had 
respectively none, one and 18 LPAA, while 47% (445) of the LPAA were concentrated in 
one patient that did not have any RPAA. Among the 47 patients with a number of PAA 
>0, 64% had a LPPA proportion >.5, which is a slight but not significant excess, in 
contrast with what we found in AF patients. 
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 In the forward stepwise logistic regression model, both the total number of PAA and 
LPAAFraction (set to .5 for patient without PAA) brought a significant contribution to the 
discrimination of AF and Non-AF patient (P=.017 and .001 respectively, Figure 5.4), 
while the preoperative risk (PreopRisk), which was highly significant alone, was not 
included in the final model (P=.135, if added to the final model). Hence both the number 
of PAA and LPAAFraction can partly discriminate AF from control patients (Non-AF). 
The fact that an increase of PAA rate was often detected prior to the onset of AF in the 
previous analyses (section 3.1.2) calls for a comparison of the dynamics in the two 
groups. 
 
Figure 5.4 ROC curves  from a  logistic model including the total number of  PAA and 
the LPAAFraction. In the forward stepwise logistic regression model, the total number of 
PAA and LPAAFraction both brought a significant contribution to the discrimination of 
AF and Non-AF patient. For the first mode l (red ROC curve), the predictor is 
LPAAFraction; for the second model (blue ROC curve), the two predictors are 
LPAAFraction and PAA are included.  
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5.1.1.2 PAA Rate ( PAAR ) and Proportion ( PAAP ) Analysis 
 
As in section 3.1.2, PAA temporal evolution was studied by calculating PAA rate ( PAAR = 
number of PAA within 5 minutes interval/5 minutes minus non sustained arrhythmia 
duration) and proportion ( PAAP = number of PAA within 5 minutes/total number PAA in 
two hours, set to 1/24 if total number PAA=0). The evolution trends of PAAR  and PAAP  of 
AF and control patients are shown in Figure 5.5. 
 
 
Figure 5.5 A) Mean value and standard deviation of PAA rate ( PAAR ) within each 5 
minutes for the 2 hrs of Control (Non-AF) and AF Group. B) Mean value of PAA 
proportion ( PAAP ) within each 5 minutes for the 2 hrs. Control (Non-AF, diamond shape, 
red line); AF(circle shape, blue line). 
 
As expected from the results of the section 5.1.1.1 logistic regression, ANOVA analysis 
of RPAA showed significant group (AF vs. Non-AF) effect (AF: 23.2 ± 4.7 vs. Non-AF: 
2.0 ±  3.3 PAA/5 min., P< .001). However, both RPAA and PPAA also had a significant 
time*group (AF vs. Non-AF) interaction effect, stemming from the lack of time effect in 
the control group.   
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Figure 5.6 The 8 biggest groups from cluster analysis of PAA rate in control group 
(Patients without PAA were excluded). 
 
Figure 5.6 presents the results of the cluster analysis of the control RPAA temporal 
evolution. Most patterns displayed minor isolated burst over a constant trend. Some 
patients showed long lasting period of sustained PAA rates.  
 
5.1.1.3 LPAA Analysis  
 
Our previous analyses have demonstrated the importance of LPAA as trigger of AF. 
Figure 5.7 displays the temporal evolution of the LPPA rate ( LPAAR ) and LPAA Fraction 
(LPAAFraction= number of LPAA/ number of PAA within each 5 minutes interval, set 
to .5 if no PAA in the interval). Both variables showed a significant group and 
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group*time effect (p< .0001). In fact, the time effect was significant in AF group 
(p<.001), but not in Non-AF group.  
 
 
 
Figure 5.7 A) mean value of LPAA number within each 5 minutes during 2 hrs. B) Mean 
value of LPAA Fraction within each 5 minutes during the 2 hrs. (AF: blue line and circle 
shape; Control: red line and diamond shape). 
 
5.1.2 Non-sustained Arrhythmia 
 
The evolution of the arrhythmia duration (ArrhyDuration) is shown in the left panel of 
Figure 5.8. ANOVA showed again significant group and group*time (P< .001) effects. 
Post-hoc analysis showed that there were significant contrast between the [120 60] vs. 
[60 0], and [10 5] vs. [5 0] periods in AF group, but none in the control group. The 
analysis of RD (Relative Difference) of arrhythmia duration time (using the first 5 
minutes as reference) yielded to the same conclusion.  
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Figure 5.8 A) The mean value and standard deviation of arrhythmia duration time (sec.) 
in each five minutes; B) The mean value of relative difference value of arrhythmia 
duration for AF and Control. The relative difference (eq. 5.1) was calculated using the 
value of the first 5 minutes as reference. (AF: blue line and circle shape; Control: red line 
and diamond shape). 
 
5.1.3 AA Trend and AA Relative Difference Trend 
 
The analysis of AA trend (calculated from normal sinus beats) in AF patients showed a 
subset of patient with an increase heart rate preceding the onset of AF (Section 3.2 & Fig. 
3.5). Such a trend did not exist in the control group (Fig. 5.9 and 5.10). ANOVA showed 
that the time (p=0.001, Huynh-Feldt), time*group (p=0.055) effects were significant or 
closely significant, while the group effect was not significant (p=0.761), meaning that the 
mean heart rate was the same in the two groups.  No significant time contrast existed in 
Non-AF group.  
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Figure 5.9 The trend of raw AA (A) and relative difference (B) AA, the latter calculated 
using the time period of the first 5 minutes as the reference.  AF: red and diamond; Non-
AF: blue and circle. As in chapter 3, only normal sinus beats were considered. 
 
 
Figure 5.10 Cluster analysis of AA raw (Panel A) and relative difference data (Panel B). 
In panel A and B the mean trends of 8 more populated groups were plotted respectively.  
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5.1.4 LFPortion of AF and Control Patients 
 
In the analysis of the pre-AF temporal evolution (Section 3.3) and of the trigger PAA 
(Section 3.5), LFPortion ( ( )HFLFLF + ) was a predictor of the onset of AF. The 
evolution of mean of LFPortion and of its relative in the AF and Control group are 
plotted in Panel A and B of Figure 5.11, respectively. The analysis was done with 
ANOVA. Except for the last 5 minutes interval, the mean LFPortion was always slightly 
higher in the control group, although the group effect was not significant (p=.11).  There 
was again no significant time effect in the control group. 
 
Figure 5.11 The trend of mean of LFPortion (A) and of its relative difference (B). (AF: 
blue, circle; Control: red, diamond) 
 
5.2 Model Building to Discriminate AF from Non-AF Patients   
 
This section investigates whether and to which extent the preoperative risk and the 
variables extracted from AEG can discriminate AF from Non-AF patients. The following 
variables were considered: PreopRisk, PAAR ,
L
PAAR , LPAAFraction,  AAMean , 
AAStd , rMSSD , 50pNN , CTAMean , CTAVMean , CTAStd , CTAVStd , LFPortion , 
AVCorrAA_ , CTACorrAA _ , CTACorrAV _  (the definition each variable was given in 
chapter 2.). The AEG variables were computed over 5, 10 and 15 minutes periods. 
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Logistic regression was performed with different choices of time intervals (i.e. BTI= 5 to 
15 minutes). 
 
5.2.1 Logistic Regression Based on BTI (Basic Time Interval) Data 
 
In the first type of analysis, all time intervals were classified as AF (1) for AF patients 
and Non-AF (0) for control patients, and then analyzed together by logistic regression. As 
aforementioned, the preoperative risk score (PreopRisk) was also included. Forward and 
backward regressions were applied with entering and removing criteria of 0.05 and 0.10 
respectively. Only the variables entered in both instances were kept and a final forward 
model was run with these variables. The same set of variables was selected for all BTI. 
The only exception was LFPortion, which was kept because it was significant for the 5 
and 10 min. BTI, but not in 15 BTI.  
Table 5. 1 Beta value of predictors in the final forward logistic regression model for 5, 
10, 15 minutes intervals 
 5 min. 10 min. 15 min. 
PreopRisk 2.744 2.902 2.726 
PAAR  .143 .217 .235 
LPAAFraction 1.398 2.222 2.286 
LFPortion -2.326 -1.978  
pNN50 -13.597 -14.154 -.774 
CTAVMean .014 .014 .013 
CTAVStd .032 .067 .083 
CorrAA_AV -1.006 -1.190 -1.046 
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Table 5.1 shows β  values of the variables entered in the final models, a positive and 
negative corresponding to an increase and decrease AF occurrence risk respectively. The 
higher value of LFPortion (expected from Figure 5.11), pNN50 and CorrAA_AV have 
protective effect. Inversely, the increase of PAAR , LPAAFraction, CTAVMean and 
CTAVStd lead to higher risk. The temporal evolution of the scores for three BTI (Figure 
5.12) as well as their sensitivity and specificity (i.e. nb. of time intervals correctly 
classified as 1 or 0, Table 5.2) show that the three models provided similar 
discrimination. Figure 5.12 shows that the separation between the groups increases as 
time gets closer to the onset of AF. 
Table 5. 2 Sensitivity, specificity, and ROC area of models of 5, 10 and 15 minutes BTI 
 Sensitivity Specificity ROC Area 
5 min. 75.07% 70% 0.813 
10 min. 79.64% 69.44% 0.821 
15 min. 80.27% 67.32% 0.815 
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Figure 5.12 The time evolution of mean and standard deviation of the risk scores of 5, 10 
and 15 minutes BTI (A, B, C) logistic regression model in AF (red) and Non-AF (blue) 
groups.  
 
The left panels of Figure 5.13 show the temporal evolutions of pNN50, CTAVMean, 
CTAVStd and CorrAA_AV along the 2 hours time in each group for 10 minutes BTI. 
There are clear and sustained differences between the AF and Non-AF groups justifying 
the inclusion of these variables in the logistic regression models, as well as the sign of 
their contribution in the model. However, the cumulative distributions of the average 
within AF or Non-AF (right panels) reveal that the differences mainly result from an 
excess subset of Non-AF patients in the upper or lower range of values. This explains 
why no significant group effect was found upon ANOVA analysis, as documented in 
Table 5.3. The comparisons of the AUC (area under ROC curve) differences of the 
  
  136 
successive models obtained in the eight steps of the logistic regression are presented in 
Table 5.4. It shows that most predictors produced significant changes.  
 
 
Figure 5.13 Left panels: temporal evolution of pNN50, CTAVMean, CTAVStd and 
CorrAA_AV (from top to bottom) in AF (blue circle) and NAF (red diamond) groups. All 
values were computed from normal sinus beats in each 10 minutes interval. The average 
values were also calculated for each patient. The last point in each panel shows the mean 
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and standard deviation of these averages in each group. The right panels show the 
cumulative distribution of these averages within each group.   
 
Table 5. 3 p value of Group (AF vs. Non-AF), Time, and Group*Time effects upon 
ANOVA analysis of each variable of 10 minutes BTI data 
 Group Time Group*Time 
PreopRisk .007   
PAAR  .001 .04 <.001 
LPAAFraction <.001 .008 .113 
sdLFPortion .193 0.565 .005 
pNN50 .423 .841 .650 
CTAVMean .173 .624 .832 
CTAVStd .174 .544 .805 
CorrAA_AV .342 .700 .494 
 
 
Figure 5.14 shows that the stepwise evolution ROC curves according to the predictors 
entering order into logistic regression model of 10 minutes BTI data. The main 
improvements come from the first four variables as PAAR , PreopRisk score, and 
LPAAFraction, and CTAVMean. The index of likelihood of the 8 stepwise models shows 
increase when new predictor enters (Table 5.5). The sensitivity refers to the ratio of the 
number of BTI correctly classified as AF over the number of BTI of all AF patients 
together, while specificity is a similar measure for Non-AF patients.  
 
.  
  
  138 
 
Figure 5.14 ROC curves of stepwise logistic regression models for 10 minutes BTI by the 
order of predictors entering into the models: PAAR , PreopRisk, LPAAFraction, 
CTAVMean , 50pNN , AVCorrAA_ , CTAVStd , LFPortion . 
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Table 5. 4 Comparison of AUC (area under ROC curve) among the successive models 
obtain in the eight steps of the logistic regression 
 
The following variables were successively entered in the model: RPAA, PreopRisk, 
LPAAFraction, CTAVMean, pNN50, CorrAA_AV, CTAVStd and LFPortion, in model I 
to VIIII. Line 1 and 2: Difference of AUC and its standard deviation, line 3: 95% 
confidence interval of the difference, line 4: significance of the difference. 
 
 
 
 
 
 
 
 
 
   I vs. II   II vs. 
III  
 III vs. 
IV  
 IV vs. 
V  
V vs. VI   VI vs. 
VII  
 VII vs. 
VIII  
  
Difference   0.00973   0.0401  0.0214   0.00369  0.00423   0.00568  0.00145 
  
 S.E.   0.0184   0.0106  0.00671  0.00454  0.00291   0.00389  0.00248 
 
 95% 
Confidence 
Interval  
-0.0264  
to  
0.0459  
 0.0193 
 to  
0.0608  
 0.00828 
to  
0.0346  
 -
0.00521 
to  
0.0126  
 -
0.00148  
to  
0.00994  
 -
0.00195  
to  
0.0133  
 -
0.00342  
to  
0.00632  
 Significance   0.5794   0.0002  0.0014   0.0187   0.1467   0.1447  0.5598  
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 Table 5. 5 Sensitivity, specificity, and ROC area of stepwise logistic regression models 
by the order of variables entering into the models 
 Sensitivity Specificity ROC Area 
-2Log 
likelihood 
PAAR  0.721557 0.783626 0.74839 1180.251 
PreopRisk 0.691617 0.703216 0.73865 1095.245 
LPAAFraction 0.730539 0.709064 0.77873 1035.528 
CTAVMean 0.658683 0.817251 0.80015 1014.186 
pNN50 0.754491 0.719298 0.80384 1000.350 
CorrAA_AV 0.784431 0.719298 0.81574 982.955 
CTAVStd 0.790419 0.710526 0.81997 975.811 
LFPortion 0.796407 0.694444 0.82141 970.039 
 
Finally, the stability of the logistic regression modeling was tested by bootstrap applied 
10 minutes BTI data. Random samples were constructed from the 1440 (12*(29+58)) 
time intervals of all patients with samples sizes of [150 240 330 420 510 600 690 780 
870 960]. 100 different random samples were produced for each sample size, which were 
analyzed with forward conditional logistic regression.  Then, the fraction of the 100 
samples in which each variable was selected as a significant predictor (p<0.05) was 
computed and is displayed in Figure 5.15.  We considered a variable to be stable 
predictor if it was selected in more 70% of the samples with the last and larger 960 
sample size of (960/1440). According this criterion, the stable predictors were 
PreopRisk, LPAAR , PAAR , LPAAFraction, pNN50, CTAVMean, CorrAA_AV. In the 
following, the logistic regression model, including these 7 variables is referred as Model 
0.  
 
  
  141 
We also gathered the β  coefficients of these stable predictors of all samples in which 
they were selected. The mean and standard deviation of these β  are shown in figure 5.16 
for each sample size. The beta coefficients converged to rather stable values as the 
sample size was enlarged. The final Model 0 was computed using for each variable the 
mean β  value obtained from the larger sample size.  
 
 
Figure 5.15 For each sample size (represented by the abscissa value), the fraction of 100 
random samples in which each variable was selected as a significant predictor (p<0.05). 
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Figure 5.16 mean and standard deviation of the β  coefficients of the 7 stable predictors 
as a function of the sample size. (The value of the constant was added). For each 
sampling size, the mean and standard deviation of the β  value of each variable were 
computed from all the samples in which it was included as a significant predictor.  
 
5.2.2 Modified Models for AF and Non-AF Prediction  
 
Model 0 had two characteristics: 1) the number of  Non-AF patients was twice that of 
AF; 2) all time intervals were labeled as 1 (i.e. AF) for AF patients, which favours 
variables with group difference that are not or are weakly time-dependent. Four 
additional logistic regression models were considered to study the robustness of the 
discrimination and take into account time-dependent change. In order to balance the 
contribution of AF and Non-AF patients, the weight of all intervals belonging to AF 
patient were doubled to even the contributions of the two groups. This model is referred 
as Model I.  The analyses of chapter 3 have shown that there were temporal changes in 
AF patients. Three other models were examined to investigate whether better 
discrimination could be achieved by trying to take these changes into account. In Model 
II, the status variable was set to 0 for time intervals belonging to the first hour, and 1 for 
those in the second hour for AF patients. In Model III and Model IV, the time intervals of 
AF patients were assigned to different weights. For Non-AF patient, the weight of each 
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interval was set to 1/N (N= number of time intervals for each patient). For time intervals 
from AF patients, weights either increased linearly (Model III) or followed a hyperbolic 
tangent (Model IV, Figure 5.17), with a sum equal to 1. These weights were chosen to 
assess how rewarding more a prediction of AF closer could change the selection of 
predictors and the quality of the discrimination. Results are presented for 10 minutes BTI 
data. 
 
Figure 5. 17 Weights assigned to AF and Non-AF time intervals in Model III and Model 
IV. Linear (red, model III) and hyperbolic tangent (blue, model IV) weights for AF time 
intervals, constant weights (magenta) for Non-AF time intervals. The data is 10 minutes 
BTI data. The sum of the weights is 1 for all cases.  
 
Bootstrapping method was applied to the four models in order to study the stability of the 
models as it was done in Model 0. 100 realisations were done for each sample size, and 
figure 5.18 shows the fraction of these in which each variable was selected as a 
significant predictor: Model I (A), Model II (B), Model III (C) and Model IV (D). 
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Figure 5.18 For each sample size, appearing in the abscissa, 100 random samples were 
constructed from the full set of intervals. The figure show the fraction of these in which 
each variable was selected:  Model I (A), Model II (B), Model III (C) and Model IV (D).  
 
As for model 0, the variables appearing in more than 70% of the highest sample size 
realizations were selected and were considered to be stable predictor. In Table 5.6, the 
mean beta coefficients (the same calculation method as Model 0) of these stable 
predictors are showed. In Table 5.6, Model 0 and Model I almost had the same 
predictors. The common ones, which had also very similar beta values, were: PreopRisk, 
PAARate, LPAAFraction, pNN50, CTAVMean, CorrAA_AV. LPAARate appeared in 
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Model 0 and not Model 1, while it was the inverse for LFPortion and CorrAV_CTA.  The 
difference of Model 0 and Model I laid in the weights of AF time intervals, which were 
doubled in Model 1. Since all time intervals of AF patients were classified AF and had 
the same weights, the predictors were variables with stable group difference.  
 
For Model II (AF patients intervals of the first hour classified as 0, but all intervals with 
the same weight), the number of stable predictors was reduced to 4: PreopRisk, 
ArrhyDuration, PAARate, LPAAFraction.  Because the samples were constructed from a 
set where the number of intervals coming from Non-AF patients was twice that of AF 
patients, PreopRisk was still selected. Nevertheless, because AF patients intervals of the 
first hour classified as 0, the selection of the predictors was biased toward those having 
not only group difference (AF vs. Non-AF), but also significant time effect.  
 
Model III and Model IV were constructed as alternative to highlight the variables with 
time-dependant changes in the AF group. Many new variables were selected as 
predictors. The stable ones of both models were PreopRisk, LPAARate, ArrhyDuration, 
PAARate, pNN50, rMSSD, LFPortion, CTAVMean, CTA, CorrAA_AV, CorrAA_CTA, 
CorrAV_CTA. Among those predictors, some were reflecting the group differences, but 
many were linked to change occurring before onset of AF. Compared to Model 0, I, and 
II, the last two models were more complicated. All the predictors appearing in two or 
more models showed identical function, either proarrhythmic or protective.   
 
In order to compare the prediction performance of five modeling methods, the stable 
predictors and the mean β  values of the stable predictors were employed to build the 
prediction model. The mean β  values were calculated as the same way as in Model 0 
analysis in section 5.2.1. The prediction indices were evaluated by the prediction model 
running over the complete data set. Table 5.6 shows the comparison of the prediction 
performance of the five models. The five models had similar sensitivity, specificity, and 
ROC curve area, but Model III provided the poorest performance for all the three indices.  
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The Sensitivity and specificity measured the classification of the time intervals, 
irrespective of which group the patients came from. We introduced an alternative index, 
prediction accuracy, pertaining to the discrimination of the patients, which brings a more 
appropriate measure of the performance from the monitoring point of view. It was 
calculated by assuming that a patient became classified as AF as soon as a first time 
intervals was classified as such. Model 0 to Model IV all achieved 100% accuracy for AF 
patients, whereas the accuracy for Non-AF patients always remained around 40%, a bad 
performance of prediction for Non-AF patients.   
  
Table 5. 6 The mean value of beta coefficients of stable predictors of Model 0,I,II,III,IV 
 Model 0 Model I Model II Model III Model IV 
PreopRisk 3.2456 3.2259 1.7693 3.3663 3.4492 
PAARate 0.20138 0.19586 0.087225 0.18203 0.17814 
LPAARate 0.024412   0.014696 0.012062 
ArrhyDuration   0.25511 0.15763 0.1885 
LPAAFraction 1.9328 1.9239 1.5909 1.9343  
AA     -0.0029401 
pNN50 -16.1096 -16.388  -20.7817 -17.9611 
rMSSD    0.033205 0.043766 
LFPortion  -2.4539  -1.5424 -1.2832 
CTAVMean 0.013489 0.013127  0.01012 0.01035 
CTAVStd    0.044525 0.040076 
CTA    0.011708 0.01376 
CorrAA_AV -1.3072 -1.3066  -0.85636 -0.58995 
CorrAA_CTA    -0.36647 -0.33485 
CorrAV_CTA  -0.76795  -0.58638 -0.44437 
Constant -5.1238 -4.6291 -3.8176 -4.3322  
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Table 5. 7 Indices of five models (excluding the missing value periods, and missing value 
patients) 
 Sensitivity Specificity ROC 
AF 
Accuracy 
Non-AF 
Accuracy 
Model 0 77.54% 72.58% 0.8193 100% 41.38% 
Model I 75.15% 75.18% 0.8158 100% 41.38% 
Model II 72.89% 72.13% 0.7766 100% 36.21% 
Model III 79.04% 71.28% 0.8363 100% 39.66% 
Model IV 79.64% 70.13% 0.8337 100% 39.66% 
 
5. 3 WMAM (Weighted Moving Average Method) For Model Prediction 
Improvement and Monitoring 
 
The reason for the low Non-AF patient prediction accuracy was that there were many 
sparse, isolated alarms. It was hypothesized that a weighted moving average method 
(WMAM) could improve the accuracy for Non-AF prediction. We consider a WMAM 
model in which the final score was a function of the current and two previous time 
intervals. To the select the weights ( ( ) ( ) ( )[ ]21 −− iii βββ ), the method of the odds 
ratio maximization of in logistic regression, gave us the way to calculate a set of optimal 
weights of WMAM method. First, the score of each time interval was computed from 
each prediction model. Then, logistic regression was run, using the scores of the current 
and two previous intervals as independent variables. The dependant variable was set to 0 
or 1 depending on the time interval of Non-AF or AF patients, i.e., all the time interval 
status of each AF were set as 1, and those of Non-AF were set as 0. The normalized beta 
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values (i.e., { })1(),1(),(min(/)( +− iiij ββββ  and then rounded to nearest tenth decimal 
values) obtained for each model for 10min BTI data are given in Table 5.8. 
Table 5. 8 Normalized beta coefficients obtained by logistic regression 
 β (i) β (i-1) β (i-2) 
Model 0 3 0 1 
Model I 2.5 1 1 
Model II 4 2 1 
Model III 2.2 1 1 
Model IV 2.6 1 1 
 
To simplify the calculation, the final score assigned to each interval was calculated as: 
( ) ( ) ( ) ( ) ( ) ( ) ( )( ) ( ) ( )21
2211_
−+−+
−∗−+−∗−+∗
=
iii
iscoreiiscoreiiscoreiiScoreFinal βββ
βββ     (5.1) 
, which corresponds to the logarithm of the odds ratio divided by the sum of the beta.  
 
As in the previous section, the prediction accuracy of AF and Non-AF was calculated by 
assuming that a patient was classified as AF as soon as the score of one interval was 
above the threshold. The evolutions of the accuracy vs. cut-off point value are shown in 
Figure 5.19. These curves were turned to ROC curves by plotting the accuracy of AF vs. 
1- accuracy of Non-AF. The rule of ROC analysis was then be used to select optimal 
thresholds, which are plotted as magenta dots in Figure 5.19. However, the slope of the 
curves around the operation point, which measures the dependability of the prediction as 
a function of the threshold, should also be minimal. As seen in Figure 5.19, Model II 
would be rejected in the light of this criterion. 
 
Figure 5.20 shows the classification provided for each patient and each time interval 
using the optimal ROC threshold for each model (panels A, B, C, D, E corresponding to 
Model 0, I, II, III, IV, respectively). The ordinate is the time from 100 minutes to the 
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onset of AF, or the corresponding monitoring time Non-AF. The abscissa is the patients 
ID (1-29, AF; 30-87, Non-AF). The correctness of the prediction is indicated by a color 
code: red, true positive (i.e. interval from AF patient classified as AF); green: false 
negative; white, true negative; magenta, false positive; black, missing independent 
variables because of insufficient sinus beats.   
 
The temporal evolution of the accuracy of AF and Non-AF are shown in Figure 5.20. 
Ideally, the Non-AF accuracy should remain relatively high and constant, while the AF 
accuracy should increase as the onset of arrhythmia get closer, but reach a high level soon 
enough to allow a prophylactic intervention. Taking into account the stability of the 
accuracy vs. the value of threshold (robustness of the model), the high value requirement 
of prediction accuracy for both AF and Non-AF patients, as well as the simplicity of the 
model (the less number of predictors, the better under the same performance 
circumstances), Model 0 and Model I appeared as the two best choices. Model II, III and 
Model IV were discarded because either they were too sensitive to the cut-off point, or 
had lower AF accuracy or were too complicated.  One hour before the end of monitoring, 
around 70% Non-AF patients were correctly classified by Model 0 and I, while around 
75% of AF patients were correctly predicted.   
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Figure 5.19 Prediction accuracy of AF and Non-AF vs. cut-off point. The magenta points 
are the optimal ROC cut-off points and their corresponding prediction accuracy values. 
 
 
 
 
Figure 5.20 Classification of each time interval for Model 0, I, II, III, IV, (A to E) using 
the optimal threshold shown in Figure 5.19. The ordinate is the time from 100 minutes to 
the onset of AF, or corresponding monitoring time for Non-AF. The abscissa is the 
patients ID (1-29, AF; 30-87, Non-AF). Color code: red, true positive; green: false 
negative; white, true negative; magenta, false positive; black, missing independent 
variables because of insufficient sinus beats.  
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Figure 5.21 Prediction accuracy of AF and Non-AF prediction over the time based on 
ROC threshold for Model 0, I, II, III and IV. The abscissa is the time before the onset of 
AF, or the corresponding monitoring time for Non-AF. The ordinate is prediction 
accuracy for AF (red) and Non-AF (blue). 
 
5.4 Discussion 
 
In this chapter, different weighted and unweighted methods were used to construct 
logistic regression models. A final WMAM logistic regression approach, combining the 
scores of neighbouring time intervals, was used to improve the accuracy of the 
prediction. In contrast with the position data used in Chapter 3, raw data and relative 
difference variables were considered in the analysis. In chapter 3, there was a triggering 
PAA and a triggering time period for each AF patient. Position data strengthened the 
differences between the trigger PAA or time period and the others within each patient, 
irrespective of the amplitude of these differences. In the modeling process, the dependant 
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variable of the trigger PAA/Time period was assigned the value 1, and all others a value 
0. However, the calculation of position data was based on the distribution of data over the 
complete monitoring interval, which makes this method inapplicable in a context of 
monitoring.  As an alternative, we used the normalized data in which all differences were 
expressed relative to an initial reference period. Result of the logistic and cumulative 
logistic regressions with normalized data were not reported because it did not help to 
improve the discrimination between AF and Non- patients. The specificity and sensitivity 
of the models were either too poor, or too complex including as much as 20 variables. 
 
Five methods were investigated, differing by the weights allocated either to AF and Non-
AF patients or to the different time intervals for AF patients. In all instances, the 
preoperative risk was a significant predictor. The preoperative risk, specified by the 
patient age, previous infarct, and serum creatinine, has a long term impact on the 
occurrence of postoperative AF, a point on which there is no dispute [74, 97, 100, 207, 
214-216].  
 
Bootstrapping was used to evaluate the stability of the predictors. Predictors were 
considered as stable if there were appearing in a large fraction of the samples, herein 70% 
for the larger sampling rate. This was done to alleviate the limitation coming from the 
smallness of the database and provide robustness to the final model since it became 
relatively insensitive to the choice of subsets of observations. A second measure of 
robustness, which was considered for the final WMAM models, was the slope of the 
accuracy around the optimal threshold. A robust model should maintain a high and stable 
AF and Non-AF prediction accuracy for some range of threshold around the optimal 
choice. Besides being robust and accurate, a good model should also include a minimal 
number of significant predictors.  
 
Among the five models, Model 0 and Model I were best in fulfilling the three criteria. 
Besides the preoperative risk score, their common predictors were PAARate, 
LPAAFraction, pNN50, CTAVMean, CorrAA_AV.   LFPortion, was in Model I only, but 
was also appearing in Model 0 when it was run over the complete set of patients. It will 
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nevertheless be discussed because its importance in the analysis of AF patients in Chapter 
3.    
 
Before trying to infer what each predictor might mean in term of physiological difference 
between AF and Non-AF patients, it must be remind it would be misleading to consider 
that all predictors contributed equally among the patients and that the difference between 
AF patients from Non-AF patients is homogeneous. As shown in the cluster analyses of 
Chapter 3, specific changes were usually restricted to distinct and restricted subsets of AF 
patients, and different predictors were found to reflect the changes before the onset of 
AF. Thereby, many variables ended up being included in the logistic regression model. 
Relating the changes indicated by the different predictors to all patients might lead to 
controversial arguments. Therefore, the following attempt to explain the mechanism of 
change between AF and Non-AF associated to each predictor can only applicable to a 
subset of patients.  
 
Two of these predictors were related PAA:  PAARate, LPAAFraction. Repetitive measure 
ANOVA analysis showed that PAARate had significant group effect as well as a time 
effect restricted to the AF group. Since the analysis of Chapter 3 found that LPAA were 
more prone to initiate AF, it was not surprising that LPAAFraction appeared as a 
predictor. 
 
pNN50 is the ratio of the number of consecutive sinus beats with AA >50ms to the total 
number of sinus beats in five minutes intervals. The concept was first proposed by Ewing 
to study the neural autonomic balance from ECG recordings [217, 218]. Mietus et al. also 
proposed that enhanced discrimination between a variety of normal and pathological 
conditions could be obtained by using various pNN thresholds. In their study, there found 
higher pNN50 in healthy control versus congestive heart failure patients, healthy young 
subjects versus healthy old subjects [219]. In our study, lower pNN50 appeared to 
increase the risk in a subset of patients to develop AF, which is consistent with their 
results. Vikman et al. also proposed that decreased complexity of sinus beats interval 
dynamics played the role of marker of both altered regulation of sinus node behavior and 
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an increased possibility of atrial firing from a single ectopic focus before the spontaneous 
onset of AF, which together predispose the spontaneous onset of AF [201]. Ewing et al. 
proposed pNN50 to be more likely a measure cardiac vagal integrity and that lower 
pNN50 in patients with altered hearts came from parasympathetic damages [218]. 
According to this point of view, lower pNN50 in AF patients, associated to 
parasympathetic tone withdraw, should lead to an increase of the LFPortion.  However, 
this would contradict the observation that AF group had a lower LFPortion than Non-AF 
group. In fact, there was no strong correlation between pNN50 and LFPortion in the AF 
group, thereby explaining why the two variables might be included in the model. Herein, 
we can only conclude that low pNN50, which occurred in a subset of AF patients, could 
be related to impaired neural autonomic interaction, especially low level of 
parasympathetic tone.   
 
In the models, the heart rate variability was not a significant predictor to differentiate AF 
from Non-AF patients although a subset of AF patients showed brief periods of sudden 
changes in heart rate variability, which possibly reflected transient fluctuations of the 
autonomic control. These abrupt changes might make the substrate more prone to 
develop atrial fibrillation, primarily in individuals predisposed to arrhythmia by virtue of 
preoperative factors and frequent PAA. 
 
In Chapter 3, the results showed an increase of LFPortion before the AF onset in a 
subgroup of patient, suggesting in these an increased of the sympathetic tone fluctuation.   
In this chapter, Figure 5.11 showed LFPortion to be slightly lower in AF group except 
for the last five minutes. Even though this difference came from a subset of patient as 
mentioned in Section 5.2.1, high LFPortion appeared as a stable, protective predictor in 
Model I, II, III, and IV. The two results seemed contradictory. This might be explained as 
follows: There was indeed an increase of the  LFPortion  in  a subset of patients close to 
the onset of AF, but globally, its mean value over the two hours remains higher in the 
Non-AF group. It should be mentioned that, because the onset of AF is often preceded by 
PAA and transient episodes of arrhythmia, the FFT spectrum calculation, which relies on 
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deletion of PAA and arrhythmia and interpolation, may enhance the low frequency 
portion of the spectrum.  
 
Longer CTAVMean appeared as a risk factor in both Model 0 and I. CTAV is known to be 
modulated by cardiac autonomic nervous and to be related to the electrophysiological 
properties of the AV conduction pathways [220-226]. The cardiac autonomic nervous 
system simultaneously regulates SA and AV node. Indirectly, the change of the heart rate 
also influenced the variability of AV conduction time [227-230]. Increased 
parasympathetic tone or decreased sympathetic tone usually leads to an augmentation of 
the AV conduction time. Besides, an increase of the inhomogenity of action potential 
propagation would also prolong the AV conduction time. Reduced coronary blood flow 
can result in a prolongation of  the myocytes action potential [231] and to impaired  
propagation  of  the sinus impulses through the atria and the auriculo-ventricular 
conduction system [232, 233] .  Therefore, longer CTAVMean may results from structural 
difference, lower sympathetic (or higher parasympathetic) tone or perfusion defect. 
 
Many studies on ECG proposed that a prolonged signal-averaged P-wave duration has 
been shown to be an independent predictor of AF after cardiac surgery [24, 234, 235].  
However, Amar did not find  P wave duration time to discriminate between AF and Non-
AF patients [236].  We found CTA to be longer in the AF group (mean, AF: 56.5 msec., 
Non-AF: 52.65 msec.). However, the difference was not large enough to be significant 
upon repeated measures ANOVA, as well as univariate or multivariate logistic 
regression. Detailed analysis showed that the longer CTA for AF patients was caused by 
only a subset and lead to a higher group mean value. Some studies proposed that the P 
wave dispersion was predictor to AF patients [30, 32, 237, 238]. As for CTA, we found a 
slightly larger CTA standard deviation in the AF groups, which was not large enough to 
become significant in any of the analyses.  
 
The correlation between the AA (sinus beat interval) and CTAV (atrio-ventricular 
conduction time), was found to be a predictor, with slightly more negative value in the 
AF (mean: -.082 vs. -.021). This correlation translates the rhythm dependence of the 
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atrio-ventricular conduction time, which was more important in a subset of AF patients. 
If the change of atrial rhythm depends mainly on neural inputs, then their concordant 
influence on both AA and CTAV  (i.e. either should be reduced or increased together) acts 
to erase the negative rhythm dependant correlation. This suggests that an imbalance 
between the neural input to the atrial and atrio-ventricular node might exist is some AF 
patients.   
 
Above all, the mechanisms leading to post-CABG AF appears to be very complex, with 
contribution of different interacting physiological factors. Our study suggests that 
patients developing AF may have a vulnerable substrate, which might result from 
different factors such as age or prior structural heart diseases. The conduction property of 
atrium tissue is widely influenced by the autonomic neural balance and heart rate 
variability can reflect the autonomic modulation. This modulation may create a more 
vulnerable substrate. The trigger of AF is a premature atrial activation, but its ability to 
initiate an AF depends on the vulnerability of the atrial substrate.  
  
5.5 Summary 
 
1. Five models were proposed to discriminate AF from Non-AF patients. The choice of 
predictors and the values of their coefficients for score computation were made using 
a bootstrap method to enhance the robustness of the models.  They had similar 
sensitivity, specificity, and ROC curve area, while with a poor performance for Non-
AF patients; 
2. The Accuracy of Non-AF prediction was improved by a moving average extension of 
these models. Two models were selected, based on the stability of accuracy with 
respect to change in threshold; 
3. The common predictors of the two best models were Preoprisk, PAARate, 
LPAAFraction, pNN50, CTAVMean and CorrAA_AV; 
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4. There was no correlation between Preoprisk and PAARate. High PAARate and 
LPAAFraction were both predictors of AF group despite their wide distributions 
among both Non-AF and AF patients; 
5. Reduced pNN50 and more negative CorrAA_AV were AF risk factor, both suggesting 
reduced autonomic tone; 
6. Longer CTAVMean was also a risk factor, which could be linked to depressed or 
inhomogeneous substratum for conduction. 
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Chapter 6 Originality, Limitation and Future 
Development of the Study 
 
6.1 Originality of the Study 
 
Using three-channel AEG instead of the standard Holter ECG recordings can provide 
information that are difficult or even impossible to obtain from the latter, such as the 
origin of premature atrial activation (LPAA or RPAA), the precise duration of  atrial 
arrhythmias, the local coupling time between atrial activations or their local derivatives. 
However, it has necessitated the development of a new timing algorithm that proved to be 
reliable and effective. The adaptive filtering of the signals and adjustment of  the 
detection threshold, the utilization of global and individual channel pseudo- energy, as 
well the A-V distinction based on dual  band pass filtering are the most innovative aspect 
of the method. The reliable detection and discrimination of atrial and ventricular 
activations is a problem that also come up with the sensing electrode of devices such as 
pacemaker and implantable defibrillator, for which the algorithm could be eventually 
adapted. The project also required the development of validation software to validate 
markers, as well as to define and validate beats. It encompasses different options 
available in commercial software such as Burdick Vision Premier, and Spike, and brings 
some innovative ideas, for instance the classification module, the modification and 
suspicious detection showing, or the find module which make the software very 
convenient in doing validation. This software system is already used for other projects in 
our laboratory.  
 
The analysis proceeds in three steps: 1) preoperative discrimination of AF and Non-AF 
patients; 2) temporal evolution in AF patient and discrimination of trigger versus non-
trigger PAA; 3) discrimination of AF and Non-AF patients AF using preoperative risk 
and the different time series. 
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1. Preoperative risk factors 
 
The preoperative risk score could to a certain extent predict who will get AF, but was not 
predictive on the time when AF occurred. Age appeared as the main preoperative 
predictor, complemented by the level of serum creatinine and prior myocardial infarct. 
Creatinine improved the female specificity and the male sensitivity, while the history of 
myocardial infarct mainly impacted the female specificity.  
2. Analysis of AF patients 
Position data, whereby data were normalized with respect the distribution within each 
patient, were more effective in discriminating both the time interval closest to the AF and 
the triggering PAA. AF was always immediately preceded by a PAA mainly originating 
from the left Atrium. However, the number of PAA and the fraction of LPAA among the 
patients were very inhomogeneous, LPAA being more prone to elicit the arrhythmia than 
RPAA. The time interval close to AF was characterized by increased transient 
arrhythmias, PAA rate, sinus heart rate and LF portion of heart rate variability. However, 
these changes were not homogeneous in the AF population, each occurring in a subset of 
the patients as illustrated by cluster analysis. Trigger PAAs were characterized by shorter 
prematurity, depressed Dvdt and the higher incidence of non-sustained arrhythmias in the 
few minutes before the trigger PAA. 
 
3. Comparison of AF and non-AF patients 
 
Five logistic regression models to discriminate AF from Non-AF patients were compared, 
differing in the weights given either to AF and Non-AF patients or to the different time 
intervals before the AF onset. A bootstrap method was used to identify the more stable 
predictors, and a moving average formulation was introduced to improve the accuracy of 
the discrimination. Two models were finally selected, based on the criteria of robustness, 
accuracy, and practicability. In these, around 70% Non-AF and 75% of AF patients were 
correctly classified in the last hour before AF. The common AF predictors of these 
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models were increased PAA rate and fraction of PAA initiated in the left atrium, lower 
pNN50 and correlation of atrio-ventricular conduction time vs. AA, as well as prolonged 
of atrio-ventricular conduction time. 
 
6.2 Study Limitation 
 
Ideally, the development of the logistic regression models should have been as that of the 
timing algorithm: choice of variable and parameter determination through a test set of 
data, assessment an independent validation set. However, the limited number of available 
patients precludes from using this procedure. Bootstrapping was used to somewhat get 
around this shortcoming, but the pitfall of over-fitting still remains. We consider that 
results are fairly indicative of the characteristics of AF and Non-AF patients, but the 
accuracy of the model should still be tested on a larger and different population.  
 
The building of the model was based on off-line validated data. Validated data would 
obviously not be available for online monitoring.  Therefore, the robustness to noise and 
false detection still needed to be tested.  
 
 
6.3 Future Development 
 
The construction of the prediction model was based on multiple time series extracted 
from the AEG. However, it is possible that other variables that can be computed from 
AEG could improve the accuracy. One interesting variable, which has been proposed 
Pagé et al., is that the integral surface subtended by unipolar atrial waveform. [143, 239]. 
It was used as a measure of neural modification of action potential duration in canine 
preparation. In these studies, the dogs were in atrio-ventricular block, such the ventricular 
activation was not interfering with the atrial signal. In patients, the atrial repolarization is 
at least partially masked by the ventricular activation.  When part of the atrial 
repolarization is available, as in Figure 6.1, the area could still bring relevant information 
about local neural input, particularly for site close the origin of PAA. It could be also 
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interesting to investigate if a method could be devised to restitute the complete atrial 
repolarization, as it was done for ECG T-wave in a context of atrial flutter [240].  
 
Figure 6.1 Activation integral surfaces of wave 
 
Other variables might also be considered, such as  fractal dimension that measures the 
heart rate complexity and for which patients with various cardiac pathology has been 
shown to differ  from normal subjects [136]. Moreover, other time series could also bring 
significant contribution. Our guess is that the monitoring of the pressure could be 
particularly useful, particularly in association with heart rhythm. In some case, 
fluctuations of the hearth rhythm could be a response to vascular events that must 
certainly occur after an open-heart surgery.  
 
Finally, a moving average version of the logistic regression model was introduced to take 
into account with the temporal evolution of the AF vs. Non-AF discrimination. Other 
methods, such as Bayesian survival analysis could offer interesting alternative [241]. In 
fact static Bayesian network has been used in the context of beat classification and 
fibrillation [242-245] . Adapting this algorithm for time changing prediction could be 
interesting.  
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